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SU M M A RY
The work included in this thesis describes studies in the spermatogenic process in the 
dog, and the approach used was to attempt supression of LH and testosterone in the 
testis and study the mechanisms affected by this interference to the normal testicular 
environment.
The first two dogs were treated with an unsuccessful progesterone implant and then 
with subcutaneous injections o f Medroxyprogesterone acetate, the results did not show 
an effect in the circulating blood plasma levels of either LH or testosterone, or in the 
testicular tissue. However it appeared to have an effect at epididymal level as seen by 
changes to the epithelium and the spermatozoa found in this section.
Therefore GnRH agonists were considered. A Nafarelin derivative administered by 
osmotic subcutaneous pumps was used in two dogs, however, due to problems with the 
pumps, the treatment was ineffective until changed to daily subcutaneous injections. 
The results of this treatment showed that it did produce testicular changes which were 
reflected on the supression of LH but more so of testosterone. There was a length of 
treatment related change in the testicular tissue, as evidenced by the partial or total 
elimination of germ cells from the seminiferous tubules.
To further study the changes at testicular level, the isolation, purification and culture of 
Leydig cells was also undertaken. For this purpose testicular tissue from dogs, rats and 
mice was used. The results indicated that the procedure for handling the cells was 
producing viable cells capable of responding to exogenous treatments when assessed by 
their testosterone producing capacity.
Subsequently the techniques thus developed were applied to the Leydig cells that were 
obtained from dogs and mice that were treated with daily subcutaneous injections of 
Nafarelin acetate. As far as the testosterone produced by the Leydig cell cultures from 
the two treated dogs the results were inconclusive as they had opposite responses to 
what was expected. However the results on the detection of testicular GnRH-like 
receptors suggests that the GnRH agonist acted directly on the pituitary and not in the 
gonad as is the case in the rat.
It was concluded that a larger animal sample is required to further understand the 
mechanisms involved in testicular function in the dog.
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CHAPTER 1
GENERAL INTRODUCTION
i
I. INTRO DUCTIO N_____________________________________________
A male's reproductive potential depends on his capacity to produce and deposit in 
the female, semen capable of achieving good fertility.
The production of the male gamete, throughout the process of spermatogenesis, 
involves the interaction of man y factors. How this is achieved has been the 
subject o f much research undertaken mainly in the rat and mouse. In domestic 
animals, such as ruminants, the pig and the horse there have been many studies, 
but fewer in the dog.
The male reproductive tract can be divided into the gamete producing organ, the 
testis, the epididymides where maturation and storage of the spermatozoa takes 
place and the accessory glands. In the dog there is only one such gland, the 
prostate, which produces seminal plasma which is the vehicle for transport of the 
gametes through the ejaculatory duct, namely the penis.
In the embryo the germinal cells develop initially in the yolk sac, from where 
they migrate towards the undifferentiated genital ridge positioned behind the 
kidneys. In the male, the arrival of these cells triggers the transformation of the 
ridges into testes by changing the original arrangement o f its somatic cells into 
seminiferous tubules which will accommodate the germ cells, known as 
gonocytes. The gonocytes are present until puberty is reached (Ashdown, 1987).
TESTES
There are 2 main components of the testis. Firstly the seminiferous tubules 
which contain the Sertoli cells and the various stages of germ cells from which 
the spermatozoa are produced. The second component is the interstitial tissue 
around the seminiferous tubules which contains the blood vessels, nerves and the 
Leydig cells which produce testosterone.
In the dog, the testes are located in the abdomen at birth, but normally within a 
few days they migrate to their normal position outside the body by passing 
downwards through the internal and external inguinal rings coming to rest in the 
scrotum which is a distended pouch of skin. The scrotal sac is composed of an 
outer layer of thin pigmented skin, within which lies the capsule of the testis 
known as the tunica albuginea which consists o f 3 layers, the external one the 
tunica vaginalis o f visceral peritoneum, the tunica albuginea proper and the 
tunica vasculosa (Setchell and Brooks, 1988). In the dog, the testes are ovoid 
shaped and their axes are directed dorsocaudally. There is considerable 
variation in size of testes according to breed, with average dimensions of 3 x 2 x
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1.5 cm. weighing approximately 11 grams (Christiansen, 1984). In the dog it is 
not unusual to find one testis lying directly behind the other (Allen et al. 1979).
The vascular supply to the testis is provided by the testicular arteries which 
originate from the aorta proximal to the kidneys and from the renal arteries. 
These reach the testis within the spermatic cord which also contains the veins 
draining blood from the testes which are at a lower temperature than that of the 
rest of the body (Waites and Setchell 1990). Within the spermatic cord, these 
veins coil around the arteries, thereby providing a temperature control mechanism 
which cools the arterial blood before it reaches the testes. This cooling is further 
aided by the cremaster muscle which, on contraction or relaxation, raises or 
lowers the testes from its position near the body wall (Christensen 1979; 
Christiansen 1984; Ashdown 1987, Setchell and Brooks, 1988; Waites and 
Setchell, 1990).
Innervation of the testes is provided by the superior spermatic nerves which arise 
from the spermatic ganglion close to the origin of the testicular artery. The 
nerves and arteries run in parallel until they reach the testes. In addition, there 
are the inferior spermatic nerves which originate in the pelvic plexus. These 
latter nerves, together with branches of the hypogastric nerve, also supply the 
cauda epididymis (Christensen, 1979; Setchell and Brooks, 1988).
SEMINIFEROUS TUBULES
Each seminiferous tubule is a double-ended convoluted loop, surrounded by 
peritubular cells, myoid cells and fibroblasts. The number of layers of myoid 
cells can vary according to species. Spermatogenesis occurs within seminiferous 
tubules and several of these are grouped into lobules by thin connective tissue. 
Both ends of each tubule are connected to the rete testis, a network of channels 
through which the spermatozoa and fluid that accompanies them pass to the 
efferent ducts which link with the epididymis (Dym and Fawcett, 1970; Setchell 
and Brooks, 1988).
The spermatogenic cycle that takes place in a given area of the seminiferous 
tubule refers to the series of transformations that the germ cells must undergo to 
become mature spermatozoa . It starts as the spermatogonia found closest to the 
basal membrane, by successive transformation move toward the lumen of the 
tubule where they arrive as spermatids and are released into the lumen as 
spermatozoa. This is also occurring all along the length of the tubule and this
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sequential chain of changes is known as the spermatogenic wave (Gamer and 
Hafez, 1987).
SERTOLI CELLS
As well as the developing germ cells, the seminiferous tubules contain the Sertoli 
cells which also originate from the somatic cells. The Sertoli cells lie between 
the spermatogonia on the basement membrane and provide the support and 
nutrition required by the spermatogonia while they undergo transformation. It is 
a triangular shaped complex structure whose base lies on the basement membrane 
of the seminiferous tubule with the remainder of the cell extending into the lumen 
o f the tubule (Setchell, 1982). There is extensive ramification of the cytoplasm 
of the Sertoli cell which allows close association of the different sizes and shapes 
o f the various stages of spermatogenesis (de Kretser and Kerr, 1988).
There is a physiological relationship between the Sertoli cells and adjacent germ 
cells which is suggested by the fact that changes occur both in the Sertoli cell 
shape and the nucleus depending on the stages of the spermatogenic cycle. The 
nucleus may often be polygonal in appearance following the release of 
spermatids which occupy the lower edges of the Sertoli cell during their 
development. At other times elongated when the germ cells penetrate into the 
basal aspects of the epithelium or flattened when lying along the basal lamina of 
the seminiferous tubules, interspersed between spermatogonia (Ritzen et al. 
1981; Setchell 1982; de Kretser and Kerr, 1988).
Sertoli cells contain only limited amounts of rough or granular endoplasmic 
reticulum and only a few condensed vacuoles which are usually associated with 
cells actively engaged in the synthesis o f proteins. This is surprising in the light 
o f the evidence that Sertoli cells synthesise inhibin and the androgen binding 
protein ABP (Ritzen et al. 1981; de Kretser and Kerr, 1988). However they 
contain large amounts of smooth endoplasmic reticulum associated in many 
species with lipid inclusions (Setchell, 1982).
To date, neither the precise role of the smooth endoplasmic reticulum of the 
Sertoli cell is clear nor the role of the numerous lipid inclusions present in their 
cytoplasm (Setchell, 1982). It is believed that they may represent the 
metabolism or synthesis of certain steroid compounds, known to occur in isolated 
Sertoli cells. They may also represent phagocytised material that the Sertoli 
cells have removed from the developing germ cells. Sertoli cells are known to
4
C h a pt e r  1
be active in phagocytosis and have strong hydrolytic enzyme properties. They 
are thus equipped to deal with the removal of degenerating germ cells and excess 
spermatid cytoplasm. In several species, Sertoli cells are involved in the 
absorption of fluid from the immature spermatozoa. This involves the formation 
of a tubule which lies in the cytoplasm of the head of the spermatid and ends as a 
bulbous region in the cytoplasm of the Sertoli cell. This connection is broken 
shortly before spermiation, when the spermatid is released into the lumen of the 
seminiferous tubule (de Kretser and Kerr, 1988).
The desmosome-like junctions which exist between Sertoli cells and the 
basement membrane, form part of the blood testes barrier. They divide the 
seminiferous tubular epithelium into separate compartments, the basal or exterior 
compartment where spermatogonia and preleptotene spermatocytes are found and 
the interior or adluminal compartment containing spermatocytes and spermatids. 
The primary spermatocytes pass from the basal into the adluminal compartments 
by way of these desmosome-like junctions. Another type of junction, the gap 
junction, exists between Sertoli cells and also between Sertoli and germ cell. 
The germ cells which communicate with the Sertoli cell by this type of junction 
are the primary spermatocytes in the pachytene stage (Waites and Setchell, 
1990).
FSH receptors have been identified on the cell membrane of both Sertoli cells 
and spermatogonia. Both these types o f cell are located in the basal 
compartment of the seminiferous tubules, thus making them more accessible to 
this hormone which reaches them via the blood vessels located in the interstitial 
tissue (Waites and Setchell, 1990). Evidence that this is the case is the fact that 
cultured Sertoli cells produce an FSH inhibiting factor known as inhibin, 
indicating that the cell itself controls the amount of FSH which it requires 
(Steinberger and Steinberger, 1976).
LEYDIG CELLS
In 1850, Franz Leydig reported that the spaces between the seminiferous tubules 
were occupied by conspicuous masses of cells which contained fatty vacuoles 
and pigments. He suggested that these cells were modified connective tissue. 
In 1903, Bouin and Ancel showed evidence that these Leydig cells provided the 
hormonal stimulus for the production of sperm and the maintenance of male 
sexual characteristics. However it was not until Gallagher et a l  (1929) named 
the testicular hormone "testosterone " and later was associated with the lipid
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inclusions in the Leydig cells that the true role of this cell in the synthesis of 
testosterone was established.
In most laboratory species, Leydig cells are located close to the blood vessels in 
the interstitial tissue. However, in other species including the dog this is not the 
case as they are scattered in groups throughout the tissue. In the dog, there are 
relatively large numbers of Leydig cells which lie closely packed together. Why 
this species develops such large masses of Leydig cells is not yet understood. 
The size and structure of Leydig cells varies according to the stage of the 
spermatogenic cycle (de Kretser and Kerr, 1988).
In mammals, Leydig cells are polygonal and have round or oval dark-staining 
nuclei containing two nucleoli (de Kretser and Kerr, 1988) and a thin rim of 
peripheral heterochromatin and a dark staining cytoplasm (Themmen et al. 1986). 
In studies in which isolated Leydig cells are used and examined under the phase 
contrast microscope, they have been identified by a characteristic luminous 
yellowish halo around them (Schumacher et al. 1978; Gale et al. 1982; Joffre et 
al. 1984).
The membrane of the Leydig cell contains the LH receptors coupled to adenylate 
cyclase. These receptor sites are receptive to both LH and hCG (Reeves, 1987). 
Smooth endoplasmic reticulum is present in abundant quantities in the cytoplasm 
of the adult Leydig cell. This is a feature o f cells that specialise in lipid 
metabolism, being large enough to accommodate the enzymes required to 
transform the cholesterol into steroid hormones (Alberts et al. 1989). The 
endoplasmic reticulum of some species including the dog can present concentric 
formations which surround lipid droplets. Their functional significance remains 
unknown, although it is believed that their presence may provide specific 
requirements in those species in which they are found (de Kretser and Kerr, 
1988).
The cytoplasm of dog Leydig cells contain a relatively high proportion of lipid 
inclusions which represent sites o f storage of cholesterol. The transformation of 
cholesterol into pregnenolone occurs inside the mitochondria, possibly on the 
surface of the christae. This appears to be associated with the arrival of LH 
from the pituitary, as demonstrated by the fact that stimulation of such cells 
with LH or GnRH results in a rapid disappearance of the bulk of the lipid bodies 
and an increase in testosterone in the circulating plasma (de Kretser and Kerr, 
1988).
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The Golgi apparatus of the Leydig cells of mammalian species is well defined, 
but as yet its role is not fully understood, although it appears that it plays an 
important part in the secretion of glycoproteins by Leydig cells. The manner in 
which testosterone is released from the Leydig cells appears to be just speculative 
and it is suggested that similar to progesterone from the luteal cells of the ovary, 
testosterone is released as granules (Gemmel and Stacy, 1979).
In most mammals there appears to be two generations of Leydig cells, the first 
appearing during late foetal life or very early in the postnatal period (Wartenberg, 
1981) and they secrete the androgens that masculinize the foetus. The 
development of this first generation of cells appears to be controlled by the foetal 
pituitary hormones. At the initiation o f puberty, the second adult generation of 
Leydig cells makes its appearance. These derive from interstitial mesenchymal 
cells and are fibroblastic in appearance until they differentiate and acquire the 
Leydig cell characteristics, such as development of mitochondria, smooth 
endoplasmic reticulum and Golgi apparatus. The development of the mature 
Leydig cells appears to be mostly dependent on LH (Sharpe, 1982). It is 
possible that FSH might be involved in the process of transforming macrophage 
and mesenchymal cells into Leydig cells (de Kretser and Kerr 1988).
Some interesting findings associated with the study of the Leydig cell, are that 
although they are thought to disappear, for the most part, from the testes of young 
men from about one year old until just before puberty, the levels o f testosterone 
in the spermatic vein is five times that o f the circulating plasma at this particular 
time. If these prepubertal boys are injected with hCG, there is a marked increase 
in their circulating plasma testosterone. How this can occur in the absence of a 
population of Leydig cells is not clear (Rivarola et al. 1970).
ENDOCRINE CONTROL OF TESTICULAR FUNCTION.
The Sertoli and Leydig cells which govern testicular function are controlled by 
the higher brain centres by way of a long loop feed back mechanism which 
involves the hypothalamic-hypophyseal-gonadal (HHG) axis. The GnRH, 
produced by the hypothalamus, is transported rapidly to the pituitary via a local 
short feedback mechanism. The pattern of GnRH secretion is oscillatory and the 
frequency is low (Vickery and McRae, 1984). The stimulated pituitary then 
produces the gonadotrophins, LH and FSH, which are transported in the 
circulating plasma to their target organs. In the male there is a constant pulsatile 
pattern of the two gonadotrophins which continues throughout adult life. There
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are no surges of LH as are found in the female preovulatory peaks (Reeves, 1987; 
Waites and Setchell, 1990).
FSH and LH affect both the Leydig and Sertoli cells of the testes. The major 
role o f LH is to stimulate the Leydig cells to produce testosterone and that of 
FSH is to stimulate the Sertoli cells thus controlling their ability to produce the 
nutrition, enzymes, proteins and ABP (Gamer and Hafez, 1987) required for the 
developing spermatozoa. Some of the testosterone produced by the Leydig cells 
diffuses into the interstitial fluid and by crossing the blood testis barrier reaches 
the Sertoli cell, where in some species a proportion becomes aromatised into 
oestrogens (Pudney et al. 1985; Rosselli et al. 1992). These oestrogens are used 
by the Sertoli cells in the process of nurturing the developing spermatozoa. In 
the rat, aromatization of testosterone by the Sertoli cells only occurs during the 
immature stage of development of the male. However once it has reached 
maturity, the Leydig cell takes over as the main producer of oestrogens in the 
testis (Sachs et al. 1988). This aspect o f testicular function in the dog has not as 
yet received much attention.
Most of the testosterone reaching the Sertoli cell becomes attached to the 
androgen binding protein (ABP), which transports it to the epididymis, where it 
is required for maturation of the spermatozoa. A proportion of the testosterone 
enters the circulating plasma where it plays a role in regulating normal libido, 
prostatic function and development o f other male characteristics, such as 
muscular development in certain areas of the body for example neck (Sharpe,
1987). The concentration of testosterone in the circulating plasma is less than 
that o f the interstitial fluid. This is due mainly to the testicular levels being 
diluted in the higher volume of circulating plasma. However, it suggests the 
importance of higher levels of testosterone required locally for testicular function 
(Maddocks and Sharpe, 1988).
PARACRINE CONTROL
Interaction between the Leydig, Sertoli and germinal cells integrates part of a 
local extra short loop or paracrine control. This appears to involve complicated 
mechanisms which are the subject of many studies, some o f which are mentioned 
here ( Sharpe, 1984; Tahka, 1986; Papadopoulus et a l  1987; Findlay, et 
al. 1987; de Kretser, 1990). At present, the relationship whereby the Sertoli 
cells control the production of testosterone by the Leydig cells, is thought firstly 
to involve the germinal cells within the tubules. These cells control Sertoli cell
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function by exchange of substances through the gap junctions (Kasuga et al. 
1989; Ojeifo, et al. 1990; Waites and Setchell, 1990). One of these is a 
Sertoli cell produced GnRH-like substance which is received by GnRH-like 
receptors in the Leydig cells (Sharpe, 1984).
The myoid cells which are in very close contact with the Sertoli cells, may also 
play a role in the intercommunication between Leydig and Sertoli cells as it 
appears that they have androgen receptors. Indeed, it has been demonstrated that 
communication takes place between myoid and Sertoli cells by the production of 
a very large molecule by the former cells which appears to aid the Sertoli cell in 
modulating the production of ABP. Myoid cells receive oxytocin from the 
Leydig cell which allows them to contract, whereby they also contribute to the 
transport of the seminiferous tubule fluids containing the spermatozoa (Sharpe, 
1986; Rosselli et al. 1992).
TESTICULAR FUNCTIONS
SPERMATOGENESIS
At puberty, the gonocytes in the testes start transforming into spermatogonia just 
before puberty is reached and they are found in the basal compartment of the 
seminiferous tubules which is the one closest to the basal membrane. Three 
types o f spermatogonia have been classified namely A, Intermediate and B 
spermatogonia. A subsequently subdivide into A0  (also known as As) A j,
A3 and A4  The mitotic division of these spermatogonia is at random for A0. 
But for A \  to A4 , intermediate and B, their divisions are co-ordinated to the 
spermatogenic cycle (Setchell, 1982). Type B spermatogonia are transformed 
into preleptotene primary spermatocytes containing double the amount of nuclear 
DNA where the chromosomes are as yet unidentifiable within the nucleus. This 
proceeds to the long meiotic prophase with leptotene, which involves the pairing 
of homogeneous chromosomes. During zygotene, pairs of chromosomes 
undergo synapses, and in pachytene the crossing over of chromosomal material 
occurs, such that on separation in diplotene, the chromosomes now contain 
different genetic material from those in the parent cell. Anaphase I now follows, 
when each member of the bivalent chromosome moves to the opposite end of the 
cell. In telophase I, the cell divides resulting in daughter cells which contain the 
haploid number o f chromosomes and the haploid amount of DNA., this ends 
meiosis I. Meiosis II begins without duplication of DNA with the very short 
prophase II leading to metaphase II where the chromatids become broader, coiled
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and shorter. Anaphase II follows with the separation of the chromatids and 
equal numbers of chromatids moving to opposite poles. The cell now divides 
during telophase II and produces two haploid daughter cells, the spermatids 
(Dym, 1977; Setchell, 1982; de Kretser and Kerr, 1988; Alberts et al, 1989).
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SPERMIOGENESIS
Spermiogenesis is the transformation of spermatids into immature spermatozoa. 
It is a process by which a conventional cell is converted into a highly organised 
motile structure. The changes include formation of the acrosome, changes in the 
nuclear position, development o f the tail, reorganisation of the organelles, 
separation of the spermatids from the supporting Sertoli cells and entry into the 
freedom of the lumen of the seminiferous tubule (de Kretser and Kerr, 1988).
In the nucleus the chromatin condenses to form larger and more dense particles 
which eventually fuse to form a homogeneous mass whose density varies 
between species. During condensation of the chromatin, dramatic changes in the 
shape of the nucleus occur to end in the typical elongated head shape, with 
various minor differences according to the characteristics of the spermatozoa of 
each specific mammalian species. It is also at this stage that, in the majority of 
the mammalian species, the nucleus changes from its central position within the 
round spermatid to an eccentric position (de Kretser and Kerr, 1988; Alberts et 
a l  1989).
The acrosome arises from cisternae containing granules produced by the Golgi 
complex of the newly formed spermatid. Both cisternae fuse to form just one 
vesicle and the granules move toward the nucleus of the cell which will become 
the head of the sperm, where they become attached. As more material is 
produced by the Golgi apparatus, the acrosome is enlarged (Setchell, 1982) and 
depending on the species it can cover between 25-60% of the nucleus surface. 
The acrosome contains a variety of lysosome enzymes for example 
hyaluronidase, which are used in the penetration of the zona pellucida of the 
ovum. The protein acrosin is also involved in this process (Bedford, 1982). At 
the equatorial region which is round the middle o f the sperm, the acrosome 
becomes accentuated, and it is this aspect of the acrosome which remains after 
the rest of the acrosomal contents have been released, just prior to penetration of 
the ovum (de Kretser and Kerr, 1988).
The neck region contains the proximal and distal centrioles and its truncated apex 
points distally and from it emerges the tail of the sperm. Anteriorly there is the 
implantation fossa. From the neck region arise the nine longitudinal cross 
striated fibres, which fuse together to varying degrees to form the rest of the tail.
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The tail of the spermatozoa originates from the centrioles of the spermatids and 
moves to the periphery of the cell. The axial filament which positions itself at 
the opposite pole to that of the acrosome which arises from the centriole lying 
nearest to the cell membrane. The axial filament consists of nine microtubules 
which are arranged concentrically at whose centre are two single microtubules. 
An invagination of the cell membrane at this same area then occurs forming a 
cleft, into which the tail of the sperm fits like a ball and socket joint, and the 
initial region of the flagellum or tail forms the neck region ( de Kretser and Kerr,
1988).
Studies of the detail of the axial filaments forming the sperm tail have been 
published in man, mouse and rat but little research of this aspect has been 
undertaken in the dog. In the mammalian species, the mitochondria form a spiral 
sheath of variable length in the midpiece neck region. The number of spirals 
forming the sheath apparently varies between species for example the mouse 90, 
the bat 15 and the rat 350 (de Kretser and Kerr, 1988). However no reference is 
made to this aspect in the dog.
Associated with the final stages of spermiogenesis is the shedding of a portion of 
cytoplasm which contains the remnants of the Golgi apparatus. This cytoplasm 
extrusion is phagocytised by the Sertoli cells (de Kretser and Kerr, 1988). A 
small portion of this cytoplasm remains connected to the spermatid and once the 
connection is broken it gives rise to the proximal cytoplasmic droplet (Gamer and 
Hafez, 1987). Surrounding the spermatozoa and the acrosome is a complete 
outer membrane namely the plasma membrane and thus any displacement of the 
acrosome indicates a change in the outer membrane of the sperm and thus an 
abnormality (Setchell, 1982).
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STEROIDOGENESIS
Although there are species differences in the steroidogenic process of 
testosterone production by the Leydig cells, the basic steps seem to be as follows.
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LH is a protein hormone which binds to specific receptors on the cell membrane 
of Leydig cells. It activates adenylate cyclase which catalyses the conversion of 
adenosine triphosphate (ATP) into cAMP ( the second cell messenger) which in 
turn produces specific mRNA. This mRNA enters the cytoplasm and is 
translated to steroidogenic enzymes which regulate steroid production and the 
regulation of the passage of cholesterol from the cytoplasm into the mitochondria 
which controls the rate of steroid sunthesis. It is then transformed into
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pregnenolone by the C27 side chain cleavage enzyme. The pregnenolone is then 
taken up by the endoplasmic reticulum and in the dog is transformed by a 17 a  
hydroxylase into dehydroepiandrosterone which is transformed by 30HSD into 
androstenedione, and then into testosterone by 17pOHSD (Hall, 1988; di 
Zerega and Sherins, 1981).
EPIDIDYMIS
The spermatozoa from the seminiferous tubules leave from the rete testes, travel 
through the efferent ducts which are a series of tubules that vary in number from 
4 to 20 according to the species and then enter the single convoluted duct, the 
epididymis. The length of the epididymis varies greatly between species for 
example in man it is up to 3 to 4 metres, in horses up to 80 metres (Robaire and 
Hermo, 1988), 40 metres in the bull 60 in the boar (Reeves, 1987). Most of the 
research carried out on this aspect of the male reproductive tract has been in the 
rat. However, from the few studies that have been undertaken in other species, 
the differences between the rat and other mammals do not appear to be great 
(Robaire and Hermo, 1988).
The epididymis arises from the mesonephric duct and develops, during gestation, 
under the influence of testosterone. It is of interest to note that the epididymis 
and the kidney have the same origin and this may explain the complex functions 
that the epididymis can undertake, many of which are similar to those undertaken 
by the kidney for example the presence of ionic gradients in the epididymis, 
analogous to those of the kidney (Harper, 1982; Ashdown, 1987; Robaire and 
Hermo, 1988).
The epididymis has a relatively slow period of growth prior to puberty, when it 
undergoes rapid enlargement, thought to be associated with the initiation of 
testicular production of testosterone. Similarly, there is a change in the content 
o f the epididymal fluid, in association with the appearance of ABP, the levels of 
which are also greatly increased around puberty. ABP is the transport 
mechanism for testosterone from the seminiferous tubule to the epididymis (Lobl 
et al. 1983; Robaire and Hermo, 1988).
A muscle layer surrounds most o f the tube and is thickest in the lower regions of 
the epididymis, as it approaches the vas deferens. External to the muscle layer 
there is loose connective tissue which contains the nerves and blood vessels. 
Anatomically the epididymis can be divided into three regions, the head or caput,
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the body and the tail or caudal region. Maturation of the spermatozoa takes 
place in the first two regions and storage is the main function of the caudal 
region, the tail of the epididymis is palpable in normal adult male domestic 
animals (Ashdown, 1987), including the canine.
The histology of the epididymis identifies three separate regions, which do not 
coincide with the anatomical divisions. The epididymal walls are composed of 
pseudostratified columnar epithelium resting on a basal lamina and a lamina 
propia surrounded by smooth muscle. The epithelium lining each area is 
composed of basically the same types of cell but in differing proportions and in 
each region the cells have some aspects specific to that part. There are three 
types of epithelial cells found throughout the length of the epididymis. The 
three types are principal columnar cells, clear narrow shaped cells and halo cells, 
which have a dense nucleus, showing patches o f peripheral condensed chromatin, 
surrounded by a palely staining cytoplasm (Robaire and Hermo, 1988; Hamilton 
1990).
The principal columnar cells of the initial segment of the epididymis, while 
sharing many common features with such cells in the other areas of the 
epidiymis, show features distinct to this region. In the initial segment, the 
principal cells make up 80% of the total cells while basal cells contribute 1 2 %, 
3% are narrow cells, with the remaining 5% halo cells. Lymphocytes with 
pycnotic nuclei are found scattered between the epithelial cells of this region. 
Most o f the cells in this region have a few tall microvilli or stereocilia which 
form a brush border, almost obliterating the lumen (Robaire and Hermo 1988; 
Hamilton 1990).
The majority of the cells in the middle section are clear cells with a highly 
vacuolated apical region with numerous dense granules present both above and 
below the nucleus. The nucleus is elongated and palely staining and shows a 
prominent nucleolus. In this area the percentage of principal cells declines, 
while the numbers of clear and halo cells increase to 30%. The lumen of the 
epididymis is greater than in the initial section because the height of the principal 
cells is decreased (Orsi, 1983; Robaire and Hermo, 1988; Hamilton, 1990).
In the terminal segment, the lumen is at its widest and the main characteristics of 
the epithelial cells lining this section are that they have ovoid nuclei and their 
apical aspects have microvilli (Orsi, 1983; Hamilton, 1990).
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It is now accepted that the blood testis barrier existing between the seminiferous 
tubules and the interstitial tissue continues into the epididymis. The actual site 
o f this barrier in the epididymis would appear to be at the luminal surface of the 
principal cells, where the typical tight junctions are found. The exact role of this 
barrier has not yet been defined, but it is obvious that it protects the spermatozoa 
from foreign or toxic substances, for example serum albumin does not pass the 
barrier (Robaire and Hermo, 1988).
The epididymis itself can undertake de novo synthesis of testosterone.(Robaire 
and Hermo, 1988) However this activity must be minimal as epididymal atrophy 
occurs after castration. Thus, most o f the androgen required for epididymal 
function is delivered from the seminiferous tubules attached to ABP ( Lobl et al. 
1983). Some epithelial cells o f the epididymis can also take up proteins and 
other particulate matter, most probably by endocytosis. The epididymis is also 
engaged in spermiophagy, the removal o f dead sperm from the lumen (Ashdown,
1987). An interesting finding concerning the contents of the epidiymis in the rat, 
is that there is a substance present in quantity in the caput region which has an 
immobilising effect on the spermatozoa, thereby maintaining their energy whilst 
in storage, and only on release from this region do they become highly motile. 
However, this substance has as yet not been found generally in mammals 
(Robaire and Hermo, 1988). The epithelial cells of the epididymis are also 
capable of the uptake of small molecules from the circulation. Some of these are 
secreted directly into the lumen of the duct. Others are involved in the synthesis 
and metabolism of steroids and prostaglandins. On the other hand, some of the 
epithelial cells can themselves synthesise and secrete small molecules and an 
array of glycoproteins such as carnitine and inositol (Robaire and Hermo, 1988; 
Hamilton ,1990).
It is a matter of some controversy as to the exact role of the epididymis in 
spermatozoa achieving fertilising potential whether it is a passive role which may 
come about simply because of the time that the spermatozoa are exposed to the 
epididymal environment as they go through this convoluted tube. On the other 
hand, the maturation process may actually involve changes to the spermatozoa 
which require stimuli produced by the epididymis. It is interesting to note, that 
even though the spermatozoa, once they have passed through the head and body 
o f the epididymis, have the ability to penetrate ova, and it is not until they 
actually reach the cauda of the epididymis, that they have acquired motility and 
are able to fertilise eggs (Robaire and Hermo, 1988).
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As in the ram, (Lino, et a l 1967) it appears likely, that the sperm in the cauda of 
the epididymis of the dog are all voided to the exterior. This can take place in 
one of three ways, namely by ejaculation, masturbation, or urination (Harper, 
1982; Ashdown, 1987). It has been shown that in the fertile male dog, 
spermatozoa are always present in urine. Therefore, it would seem that there is a 
constant excretion of spermatozoa. This tends to suggest that absorption of dead 
sperm from the epididymis does not tend to occur in the dog (Ferguson and 
Renton, 1988).
An important function of the epididymis is to absorb some of the large volume of 
fluid accompanying the sperm. However in the bull and hamster and possibly 
in man, this takes place in the efferent ducts. Most of the fluid emerging from 
the testes is absorbed in the head and body regions mainly by passive diffusion. 
Absorption of this fluid and the transport o f the ions is dependent on testosterone, 
probably by a method very similar to that of the kidney (Harper, 1982; 
Hamilton 1990). Changes in ion concentration takes place in the different 
regions o f the epididymis, with variations between species. In the rat, potassium 
rises steadily throughout the epididymis, while chloride levels remain stable, the 
lowest concentrations being found are those of calcium, whereas sulphur and 
magnesium are more concentrated in the body of the epididymis (Harper, 1982).
The spermatozoa are transported from the seminiferous tubules into the rete testis 
in a passive way suspended in the fluid secreted by the Sertoli cells and assisted 
by the re-absorption of the fluid in the efferent ducts which pulls them into the 
head of the epididymis. Once they reach this point the transport through the 
epididymis becomes more active as it involves hydrostatic pressure, muscular 
contractions and cilliary movement. This journey takes about 10-12 days days 
in most mammals, with more than 50% of this time being spent in the tail 
(Courot, 1981; Harper 1982; Ashdown, 1987) where they retain their 
fertilising ability for 30 days (Robaire and Hermo, 1988).
ENDOCRINE CONTROL OF EPIDIDYMAL FUNCTION.
Knowledge to date suggests that the main hormone involved in epididymal 
function is testosterone. Withdrawal o f androgens results in atrophy of the 
epididymis, degeneration of the epithelial cells and their function including 
transport of ions across the epididymal epithelium. All these functions such as 
the transport of spermatozoa are dependent on androgens. And in particular 
dihydrotestosterone plays an important part in the spermatozoa's acquisition of
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fertilising ability. Testosterone is transformed into dihydrotestosterone in the 
epididymis and LH and FSH are needed for transport of testosterone which is 
bound to the ABP produced by the Sertoli cell ( Lobl et al. 1983; Robaire and 
Hermo, 1988).
ACCESSORY GLAND THE PROSTATE
The prostate in the dog is a symmetrical globular gland, that weights between 1.7 
and 14.5 grams depending on the size of the dog and is normally found in the 
middle of the pelvis, over the cranial part of the symphysis pelvis, surrounding 
the pelvic urethra (Christiansen, 1984). Its glandular epithelium is simple 
columnar or pseudo stratified, with a few basal cells found among the columnar 
cells. In the segment closest to the urethra, the epithelium changes to the 
transitional type found in the bladder and the prostatic urethra (Dym, 1977).
LIBIDO AND EJACULATION:
In the male, the desire to seek sexual contact is defined as sexual motivation, or 
libido. His ability to copulate is referred to as performance or potency. This 
male behaviour, is controlled by androgens transported in the circulating plasma, 
acting on brain centres. In animals with previous sexual experience, behaviour 
will remain unchanged for some considerable time, after removal of the gonads. 
However, progressive loss in intensity and frequency and total disappearance 
does eventually occur (Sachs and Meisel, 1988).
Libido, manifests itself by the intensity of the animals arousal to the visual and 
olfactory stimuli, provided by the oestrous female, by her presence and 
willingness to cooperate with the male's mounting attempts, and by how 
successfully copulation and ejaculation are achieved. There are time variations 
between species in initiation of copulation and actual ejaculation. In dogs and 
other canids, ejaculation commonly begins prior to intromission and before the 
swelling of the bulbus of the penis results in the locking or tying of the male to 
the female. This may last for 30 minutes or more (Sachs and Meisel, 1988).
Ejaculatory organs
The emission of spermatozoa, suspended in epididymal fluid, from the cauda 
epididymis through the vas deferens, is by contractions produced by increased 
sympathetic nerve activity, which also closes the neck of the bladder this 
prevents retrograde ejaculation, once the sperm reach the coliculus seminal is,
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they mix with the secretion from the accesory glands, in the case of the dog, 
prostatic fluid only, thus producing the ejaculate (Christiansen, 1984; Robaire 
and Hermo, 1988). The ejaculate proceeds to enter first the pelvic urethra into the 
penile urethra. The penis of the dog, is made up of two areas of cavernous 
tissue, which surround the urethra one is the corpus spongiosum penis and 
glandis, and the corpus cavernosum penis, which when filled with blood, 
provides the turgidity necessary for intromission and copulation (Christensen, 
1979; Christiansen, 1984). In the, dog part of the penile corpus cavenosusm 
ossifies to produce the os penis, which facilitates penetration of the vagina by the 
erected penis, and also aids to its retention within the vagina (Williams-Ashman,
1988). The penis is housed in the prepuce, which is a layer of skin covered with 
hair (Christiansen, 1984).
Ejaculate fractions
The ejaculate of the dog is made up of three fractions, the first of which is clear 
and watery originates from the prostate and is voided during the thrusting 
movements made while attempting to gain intromission this first fraction is a 
means of flushing out the urethra. Once the thrusting movements have ceased 
the second a sperm rich fraction is then ejaculated and by this time, due to 
enlargement of the bulbus of the penis, the "tie" to the female has occurred. 
The third and last fraction from the prostate is again clear and continues to be 
ejaculated in a pulsatile fashion for as long as the "tie" is maintained, which is 
until ejaculation has been completed and the bulbus is relaxed. This last 
fraction of the ejaculate is produced by the prostate and is similar to the first 
fraction, except that it contains the residue of the second or sperm rich fraction 
(Christiansen, 1984; Allen et a l 1979).
MANIPULATION OF MALE FERTILITY.
Many of the original studies o f male fertility in both humans and domestic 
animals, were attempting firstly to develop methods of assessing and improving 
fertility and secondly storage of the male gamete by freezing in liquid nitrogen 
for future use in artificial insemination. However recently, interest has arisen in 
the human field in methods of male contraception. This aspect of manipulating 
male fertility is also of special interest in the dog as the stray dog problem and 
the spread of rabies is now of world wide importance (Faulkner, 1975; Wildt 
and Seager, 1977; Christiansen, 1984; Gonzalez et al. 1989; Carter, 1990; 
Eng and Fishbein 1990; Olson and Moulton, 1993).
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One of the main lines of research is the development of contraception methods 
in the human male has been to attempt to suppress gonadal steroid production 
which was already being used as a means of treatment for steroid-dependent 
prostatic cancer. Another approach investigated has been to suppress the 
production of viable sperm, either temporarily or permanently by interference 
with the transport and/or maturation of sperm in the epididymis. Most of these 
studies into male contraception have been in the man and only a few have been 
carried out in the dog.
METHODS AIMED AT REDUCING CIRCULATING PLASMA 
GONADOTROPHIC HORMONES.
The hormonal approaches investigated have included the use of progestogens and 
androgens, used either singly or in combination. With the development of 
GnRH analogues, the use of both agonist and antagonists as a means of 
contraception have also been investigated.
PROGESTOGENS
In the canine species progestogens were used initially in the bitch as a means of 
oestrus control (Van Os, 1982; Evans , 1978; Evans and Sutton 1989). However 
they are now routinely used in the dog for control of undesirable sexual and 
social behaviour (Gerber and Sulman 1964; Gerber et al. 1973; Evans and 
Sutton 1989). Most of these studies have been of a clinical nature with few 
references as to the changes in circulating plasma concentrations achieved in the 
animals treated. However Wright et a l  (1979), did measure testosterone 
concentrations in a group of 4 mixed sheep-dogs treated with a single 4 mg/kg 
injection of Medroxyprogesterone acetate and found that testosterone levels had 
been reduced by 58%, measured 7 weeks after the injection. However this was 
the mean of the dogs and there was not enough information as to the number of 
samples taken. They also reported no evidence of testicular degeneration or 
changes in semen characteristics. The action of progestogens is presumed to be 
achieved by the drug producing a negative feedback on the hypothalamus, 
resulting in suppression of gonadotrophin release from the pituitary and 
consequently a suppression of gonadal function.
ANDROGENS
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In the human, androgens such as testosterone, were thought to be an ideal method 
of achieving an increased negative feed back to the hypothalamus whilst 
maintaining male libido. However, the long acting ester, testosterone 
oenanthate, which has been the most widely tested, was considered not to be very 
practical as it required weekly injections, as did testosterone propionate and other 
testosterone esters used. This, added to the fact that the results were not totally 
satisfactory as not all o f the men in which it was used achieved azoospermia, 
resulted in this method not being widely used. In addition, undesirable side 
effects, such as weight gain and skin problems such as acne, occurred quite 
frequently in patients treated this way (Paulsen et al. 1982; Knuth et al. 1987; 
Wu, 1988).
In an attempt to avoid these problems, androgens were combined with 
progestogens. This resulted in azoospermia not always being achieved, even 
when high doses were used and the undesirable side effects still occurred. The 
most effective combination used, in the human to date, is testosterone plus depot 
Medroxyprogesterone acetate, which has produced azoospermia in 60% of the 
men treated. The incidence of side effects of a similar nature to those resulting 
from testosterone treatment, was low (Paulsen et al. 1982; Knuth et al. 1987; 
Wu, 1988).
Oral administration of androgens has also been tried in humans but blood levels 
are not continuously suppressed by this route of administration, therefore the 
intermittent stimulation of Leydig cells could be enough to allow 
spermatogenesis to continue (Knuth et al. 1987).
GnRH ANALOGUES (Agonists and Antagonists).
GnRH antagonists work by causing pituitary desensitisation but they must be 
constantly present in the circulation. This means that the cost of the high doses 
required has somewhat restricted their use. However, their inhibitory effect is 
superior to that achieved with agonists (Rivier et al. 1985).
More of the information available is on the effects of GnRH agonists in 
suppressing production of gonadotrophins. The original idea behind the 
development of synthetic analogues of GnRH both agonist and antagonist, was to 
use them to stimulate gonadotrophin production in cases of human infertility. 
However it was found that their long term use had the opposite effects because 
the initial response was indeed an increase o f gonadotrophin production b u t , the
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treatment eventually led to a reduction in the release of gonadotrophins. This 
effect is thought to be due to a desensitisation process at hyphophyseal level due 
to down-regulation of GnRH receptors. Reducing the hyphophyseal 
gonadotrophin secretion directly affects the gonads but the mechanisms involved 
in this down-regulation are as yet not fully understood (Kastin et al. 1972; 
Cusan et al. 1979; Bambino et al. 1980; Akhtar, et al. 1984; Doelle, 1984; 
Corbin et a l  1985; Fraser, 1985; Vickery, 1986).
There is also evidence from work in the human, rat, mouse and monkey that the 
effect o f GnRH agonists differs according to the species. For example, in the rat 
the effects are both at hypothalamic and gonadal level, due to the presence of 
GnRH like receptors in the rat testis. In the human and primates, the effect 
appears to be solely at the hypothalamic level (Hsueh et al. 1981; Bhasin et al.
1986). Mice appear not to respond to the inhibitory effects ( Bex, et al. 1982), 
rats are partially responsive (Vickery et al. 1983) and primates are also somewhat 
resistant to treatment (Bhasin et al. 1986).
On the other hand, dogs appear to be extremely sensitive to the effects of GnRH 
agonists (Vickery, 1986). In intensive studies into the use o f GnRH agonists in 
the dog, Vickery using several different GnRH agonist formulations including 
Nafarelin acetate, found the same initial increase in the circulating plasma levels 
of LH, FSH and testosterone that occur in other species, indicating that this 
initial increase disappears as treatment progressed. He also reported a decline in 
prostatic size, testicular volume with alterations to the testicular structure, 
erection period was shorter and lower ejaculated volume. The degree of 
response varied according to either the potency or the dose of the agonist 
(Vickeiy and McRae, 1984; Vickery et al. 1984; Vickery et al. 1985;
Vickery, 1986; Vickery et al. 1989; Lincoln, 1992).
In the human, there seems to be an age related difference in response to GnRH 
agonists. In elderly human males, suffering from prostate cancer, who are 
usually weakened by their illness, the effect of GnRH agonist treatment is drastic 
enough to suppress circulating testosterone to levels similar to those seen after 
castration. This, as expected, results in cessation of spermatogenesis. On the 
other hand, in younger men receiving the same treatment for contraception 
purposes, the response in suppressing circulating plasma testosterone 
concentrations is not as good (Vickery, 1986).
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Anabolic steroids, such as 19-nortestosterone (19-NT) and 19-NT- 
hoxyphenylpropionate, are known to suppress male fertility, but even though they 
have been in clinical use for many years, their potential as possible 
contraceptives has only recently received attention. This has come about 
because of their wide use amongst male athletes and their subsequent effect on 
fertility. However, further studies are required before any substantial evidence 
of their capability as antifertility drugs can be reported (Wu, 1988).
METHODS AFFECTING EPIDIDYMAL FUNCTION
Another approach to manipulation o f fertility is by affecting epididymal function 
by interfering either with sperm maturation or sperm transport. Drugs such as 
alpha chlorohydrin have been investigated, which act mainly on the epididymis. 
They cause changes in the vasculature and alter the composition and amounts of 
epididymal fluids. This drug also has a direct effect on sperm during their 
transit through the epididymis reducing their motility, altering the spermatozoal 
membrane and so reducing the sperm fertilising capabilities. The species in 
which this drug has been studied are the rat, guinea pig, hamster, mice, ram and 
pig (Ratnasooriya 1982; Wu 1988).
Another group o f substances which were also investigated were 6  CDG sugars, 
such as 6 -Chloro- 6  deoxyglucose. When given to marmoset monkeys they 
diminished the motility of their spermatozoa, apparently by interfering with their 
energy producing metabolism (Wu, 1988).
Oestrogens inhibit spermatozoa maturation and increase their rate of transport 
through the epididymis. Some research has been undertaken on this aspect in 
rats, hamster, mice and it appears that part o f their effect is due to an increase in 
the peristaltic contractions in the epididymal tubule. However, the use of 
oestrogens has been associated to the thromboembolic phenomena in the human 
and so far no reliable method of their use has been published (Ratnasooriya, 
1982).
Methoxamine, a sympathomimetic drug, temporarily reduces the fertility in male 
rats, but there seems to have no effect on their ability to mate. The route of 
administration was by implants placed adjacent to the epididymis. Almost no 
spermatozoa were seen at 3-7 days after insertion and there is an increase in the 
number of tailless spermatozoa in the epididymis. Methoxamine appears to have 
a direct toxic effect on the spermatozoa and apparently creates a hostile
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environment at this site by reducing the blood supply to the epididymis . It also 
accelerates transport of sperm through the epididymis (Ratnasooriya 1982).
USE OF NON-HORMONAL PREPARATIONS
In China, the use of a variety of drugs have been investigated. These include 
gossypol, isolated from the cotton plant, and Trypterigium wilfordii. In vitro, 
gossypol inhibits the motility o f epididymal and ejaculated spermatozoa. 
Histologically it appears to degenerate spermatids, Sertoli cells and late 
pachytene spermatocytes. However its use in vivo produces many side effects 
such as fatigue, decreased libido, hypokalemia and gastrointestinal problems. In 
about 1 0 % of the human study subjects it caused irreversible infertility which 
does not make it an ideal method in the human. The total glycosides extracted 
from Trypterigium wilfordii, were found to decrease epididymal spermatozoa 
viability, but it is still being studied in order to identify the active constituents 
(Wu, 1988).
METHODS AFFECTING EJACULATION
In the human, inhibition of ejaculation has been reported as secondary effects, of 
the administration of sympatholytic drugs such as Guanethidine, Reserpine, 
Bretyliam and Bethimedine which are used in antihypertensive therapy. There 
were no apparent changes to libido, but during treatment azoospermic ejaculates 
were produced. Guanethidine when given to rats caused damage to "short 
adrenergic neurones" that innervate the vas deferens and epididymis. Another 
find was that it appeared to cause spermatoceles in the cauda epididymides, with 
many non motile and tailless spermatozoa being found in the rest of the 
epididymis (Ratnasooriya, 1982).
A group of anti-psychotic drugs (Reserpine, Tetrabenazine, Haloperidol), are 
known to cause disturbances in ejaculatory function and caused suppression of 
ejaculation in dogs. This was thought to be associated with interference of the 
transmitters in the brain's monoaminergic systems involved in ejaculation 
(Ratnasooriya, 1982).
Oxytocin and prostaglandins are involved in producing the epididymal 
contractions required to expel the spermatozoa through ejaculation, therefore 
blocking their action should result in azoospermia. Methallibure, an oxytocin 
blocking drug, when used in rabbits inhibited the amount of spermatozoa in the
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ejaculates. A similar effect was observed, with prostaglandin synthesis 
inhibitors, like Indomethacin (Ratnasooriya, 1982).
An anti-androgen drug, Cyproterone acetate, has also been tried in humans. 
Normal epididymal function is androgen dependant and it was assumed that local 
interference would disrupt epididymal metabolism and cellular arrangement. 
However, this anti androgen drug required two months to take effect and it not 
only decreased testosterone produced locally, but in the general circulation as 
well, thus affecting libido which makes it unacceptable for human use 
(Ratnasooriya, 1982; Paulsen et al. 1982; Knuth and Nieschlag, 1987).
INMUNOLOGICAL APPROACH
At present a great deal of research is being directed towards finding effective 
contraceptive vaccines for female use against, gonadotrophins, inhibin and 
spermatozoa. Inactivation of peptides involved in sperm-zona adhesion, sperm 
activation, sperm oocyte fusion and sperm activated oocyte cleavage, GnRH 
(Wu, 1988; Bhasin et al. 1986; Lincoln, 1992). But so far this approach is still 
in the realms of research and no commercial vaccines are as yet available.
In the male dog, some work has been done in immunisation against LH and 
GnRH, with varied results (Gonzalez et al 1989). Chemical occlusion of the 
epididymis by chemical substances applied directly to the tail o f the epididymis 
(Pineda, 1978 ) has also been attempted or directly into the testis (Naz and 
Talwar, 1981). However, so far the only method known to effectively suppress 
male dog fertility is the surgical removal of gonads.
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A IM  OF THE THESIS.
The aim of the work was to attempt to alter spermatogenesis in the dog by 
suppressing the release of gonadotrophins from the pituitary and to endeavour to 
identify the role o f the Leydig cell in the production of spermatozoa. This thesis 
initially describes the administration of either Medroxyprogesterone acetate or 
GnRH agonists to several adult male dogs and records the clinical, histological 
and circulating plasma hormonal changes recorded during and at the end of each 
treatment period. It then describes and discusses the investigations undertaken 
to determine a suitable method for the isolation and culture of dog Leydig cells. 
The final section describes the findings after the administration of a GnRH 
agonist to two male dogs incorporating the changes determined by the results 
from the first experiments. It then describes the subsequent studies of Leydig 
cell cultures, using cells collected from normal and from the dogs treated with 
GnRH agonists.
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MEDROXYPROGESTERONE 
ACETATE (MPA) EXPERIMENTS
C h a pt e r  2-A
1. INTRODUCTION
As spermatogenesis is controlled by the hormones FSH and LH released from 
the pituitary and transported to the testes by the circulating plasma, it seems 
reasonable to attempt to manipulate spermatogenesis in male dogs, by 
suppression of these gonadotrophins. Initially, a progestogen was used for this 
purpose, as it is known to suppress gonadotrophin release from the pituitary. 
Adult male beagles were treated for varying periods of time and their circulating 
plasma LH and testosterone concentrations monitored prior to, and throughout 
the treatment period. In addition, semen was collected as often as possible, in 
advance of, and throughout the experimental period. Following sacrifice, 
samples were collected from scrotal contents and prostate for subsequent 
examination by histological and histochemical methods.
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2. MATERIALS AND METHODS
Animals used
Animals used
Name Breed Age Weight Body condition
(years) (kgs)
Fred Beagle 7 25 good
Gus Beagle 4 17 good
Animals were maintained in colony accommodations, fed a diet of canned meat 
and meal. They were exercised twice daily for about half an hour and their 
external genitalia was examined frequently prior to attempts at semen collection.
2.1. EXAMINATION OF REPRODUCTIVE ORGANS 
TESTIS
Size: A piece of string was cut to the dorsoventral length of each testis another to 
the width, determined by passing the string around the middle of the scrotum. 
Each piece of string was then measured against a ruler and the results recorded in 
centimetres.
Consistency. The consistency of the gonads was evaluated by manual palpation 
and any variations from normal noted.
EPIDIDYMIS
The presence of each tail o f epidiymis was determined by manual palpation as 
well as evidence of the body and tail areas on the medial aspect of each testis 
noted.
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PROSTATE
The size and position of the prostate was determined by introducing a lubricated 
gloved finger into the rectum
2.2. ULTRASOUND SCANNING OF SCROTAL CONTENTS AND 
PROSTATE
The scanner used had a 9.5 MHz sector transducer with annular phased array 
capability (Apogee CX, Interspec Inc. Aldermaston, Berks. UK). Prior to 
scanning the dogs were prepared by first clipping the hair of the scrotum and 
posterior abdominal region. Medical ultrasound gel was applied to the skin. 
Scanning was done with the dogs in a standing position.
Measurements made
Prostate. Long axis: length of right and left lobes .
Cross section: height and middle of right and left lobes.
Testes. The testes were scanned through scrotal wall and maximum width and 
height recorded in cross section. Measurements were taken after scanning in the 
different planes and the maximum measurement for each parameter was 
recorded.
2.3. LIBIDO
Libido was evaluated as follows :-
0 Male not interested either in the female or in the manual stimulation, no 
signs o f erection.
1 A delayed response either to the presence of the bitch or to manual 
stimulation. Semen was only collected after a delay of at least five minutes 
stimulation.
2 Response to manual stimulation produced an erection within a few minutes 
o f handling the penis. Semen was ejaculated almost immediately afterwards.
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3 Normal response with a bitch, male very happy and excited, mounted very 
quickly. Erection and ejaculation occurred within two minutes.
2.4. SEMEN COLLECTION
Material required for collection.
Latex cone
Glass centrifuge tube attached to cone (Figure 14)
Plastic thermos bottle
(To transport semen from collection to evaluation area).
1.-Stimulation of the male .
A: Using a teaser bitch in oestrus.
B: Without a bitch.
A) Using a teaser bitch in oestrus.
The male dog was presented to a bitch in oestrus and allowed to sniff around the 
vulva for a few minutes. When the bulbus glandis started to enlarge, the penis 
was extruded such that the enlarged bulbus glandis was exteriorised from 
prepuce. The penis was then held behind the bulbus glandis and directed 
towards the collecting latex cone (Figure 14). After ejaculation of the first 
fraction when the dog showed violent thrusting movements, the penis was 
directed backward between the animal's hind legs, in the same position as in 
natural mating. Some first fraction was collected along with the entire second 
fraction and as soon as the third fraction started to be produced the collection was 
stopped.
B) Without a bitch present.
In order to collect from the dogs when a bitch was not available, the animals were 
always taken to a specific site of collection where a bitch had previously been 
used. The penis was stimulated by digital manipulation by rubbing over the 
prepuce with forward and backward movements of the hand over the area of the
30
C h a p t e r  2-A
bulbus glandis. As soon as the bulbus started enlarging, the penis was 
extruded and the ejaculate collected as discussed above.
2.5. SEMEN EVALUATION
Immediately after collection the volume and colour of ejaculate were evaluated.
Colour classified as observation
White Normal, not contaminated.
Yellow Abnormal urine contamination
Red, pink Abnormal, blood contamination.
Motility
.Material required to evaluate motility.
Prewarmed glass slides (Gold Star, Chance Propper Ltd. England)
Pasteur pipettes (Bilbate, Ltd., Daventry, England)
Glass cover slips (Chance Propper Ltd. England)
Microscope
Procedure. Immediately upon arrival in the laboratory, motility was evaluated 
by placing a drop of ejaculate on a prewarmed glass slide and a cover slip was 
placed over it. The movement of the sperm was observed under the 10 x 
objective and scored for the percentage of progressive motility seen in the slide.
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The score was as follows
Motility scale Limits %
5 90-100
4 80-90
3 70-80
2 60-70
1 50-60
Live dead spermatozoa evaluation.
Material required
Nigrosine-Eosin stain 
Glass slides 
Pasteur pipettes.
Reagents for Nigrosine-Eosin stain
Nigrosine 5.0 grams
Eosin (yellowish) 0.84 grams
Sodium citrate 1.45 grams
Distilled water 50.00 mis
All reagents were purchased from BDH Merck, Thomliebank Glasgow, Scotland.
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The Nigrosine-eosin was prepared as follows:
1.- Dissolve the sodium citrate in water.
2 .- Dissolve the eosin in 8 - 1 0  ml o f the citrate solution.
3.- Heat the remainder of the citrate solution by placing into a 100 °C 
water bath and then adding the nigrosine.
4.- Add the eosin/citrate solution.
5.- This was then heated for 20 minutes and the mixture occasionally 
mixed.
6 .- The beaker was covered when not stirring to prevent evaporation.
7.- The solution was then filtered while still warm.
Smear preparation: A nigrosine-eosin smear was prepared as follows: Using a 
Pasteur pipette one drop of semen was placed on a clean dry microscope glass 
slide to which an equal amount of nigrosine-eosin stain was added. The stain had 
been prewarmed to 32°C in a water bath. Using the tip of a clean dry pipette, 
both the semen and the stain were thoroughly mixed and left to settle for 30 
seconds. Then a smear was made and air dried. Once dried, a drop of immersion 
oil was placed over the slide for examination under the 100 x objective. One 
hundred cells were counted and the number of dead sperm was recorded as those 
that absorbed the stain and therefore looked pink. Those that did not stain and 
appeared clear were recorded as live.
Concentration
Concentration was determined using a hemocytometer by the method of Zaneveld 
and Polakoski (1977).
1. A 1:20 dilution was prepared by adding 20 microlitres of ejaculate to 400 
microlitres of a 10% formalin solution in an Eppendorf vial.
2. The suspension was thoroughly mixed by shaking the vial 10 microlitres of 
this suspension was placed in both chambers of a standard haemocytometer.
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3. The spermatozoa settled on the bottom of the chamber and once they stopped 
drifting the count was made.
4. The spermatozoa found in the 4 small comer squares and the central ones in 
the large central square were counted. The multiplication factor was thus 50,000.
The formula used to calculate sperm concentration was:
1. -Sperm concentration = no. of sperm counted x multiplication factor x 
dilution factor.
2. -The dilution factor was 20.
3. -The multiplication factor was 50,000, because 5 squares were counted.
4. - Therefore: Sperm concentration = Number of sperm x 50,000 x 2 0 .
SPERMATOZOA ABNORMALITIES
Using a nigrosine-eosin stained smear and the 100 x magnification, one hundred 
individual sperm were carefully examined for abnormalities of the head, neck and 
tail, as well as for changes in the acrosome.
Acrosome evaluation.
Smear preparation: A nigrosine-eosin smear was prepared as follows: Using a 
Pasteur pipette one drop of semen was placed on a clean dry microscope glass 
slide to which an equal amount of Nigrosine-eosin stain was added. The stain 
had been prewarmed to 32°C in a water bath. Using the tip o f a clean dry 
pipette, both the semen and the stain were thoroughly mixed and left to settle for 
30 seconds. Then a smear was made and air dried. Once dried, a drop of 
immersion oil was placed over the slide for examination under the lOOx 
objective. One hundred cells were counted and the some evaluation, Spermac 
stain (Stain Enterprises, P.O. Box 152, Wellington, Rep. S. Africa 7655) was 
used according to the method of Oettle (1986). A smear was prepared by 
placing a drop of semen on a clean glass slide and by spreading it across with the 
aid of another glass slide, allowed to dry in air and stained as according 
instructions.
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2.6. PROCEDURES FOR BLOOD SAMPLING :
Blood samples were collected by:
a) Venepuncture: A sterile 21 gauge 1 inch needle attached to a 10 ml lithium 
heparin monovette tube (Sarstedt, Leicester England) was used and 5 ml. samples 
were taken.
b) Cannulation. Prior to cannulation the animal was sedated with 0.5 ml of ACP 
(C. Vet Ltd. 2 mg/ml). The skin over the jugular vein was clipped, washed with an 
antiseptic solution (Pevidine BK Vet. Prods. Ltd.) and rinsed with absolute 
alcohol. The skin around the point of entry of the cannula was infiltrated with 
2ml of Lignocaine-A (Univet Ltd.).The jugular vein was then cannulated using a 
G18 Intraflon 2 trochar catheter iv length 38 mm x diameter 13 mm. (Teflon, 
V ygon). Once inserted, the cannula was secured by adhesive tape and a bandage. 
Finally the cannula was flushed in situ with 2 ml of 0.5% solution of heparin in 
warmed saline.
Procedure for collection of blood sample from testicular vein :
This was done according to the method of Sharpe & Maddock (1988). The 
animal was premedicated with ACP and general anaesthesia induced with 
Thiopentone sodium (Thiovet. C. Vet. UK) The tunicae albuginea and 
vaginalis were incised exposing the veins on the surface of the testis. Either a 
26 or a 30 gage needle was inserted into one of the larger testicular veins and 1-2 
ml of blood were collected using a 2 ml heparinised syringe.
Subsequent treatment o f  blood samples.
Blood samples were centrifuged at 3000 g for 1 0  minutes and the separated 
plasma stored in 2 ml Eppendorf tubes, and stored at -20 °C.
2.7. DOG TREATMENT
1st Treatment. 100 mg progesterone subcutaneous implant (Organon 
Laboratories, Ltd. Cambridge, England UK). The implant was inserted
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through a small incision in the neck. The skin around the area was previously 
infiltrated with 2 ml of Lignocaine-A..
2 nd Treatment. 75mg/ml subcutaneous injection of Depoprovera, 
Medroxyprogesterone Acetate (MPA), (Upjohn Ltd, Crawley UK) administered 
once.
3rd Treatment. 1 0 0  mg/ml subcutaneous injection of Depoprovera, 
Medroxyprogesterone Acetate (MPA), (Upjohn Ltd. Crawley UK), was 
administered as a single dose.
2.8. HORMONE ASSAYS
The analysed hormones were progesterone, LH and testosterone. 
PROGESTERONE ESTIMATION
Plasma progesterone concentration was determined using a progesterone enzyme- 
linked immunosorbent assay kit (Ovucheck Bovine Plasma, Cambridge Life 
Sciences PLC.) as described by Eckersall and Harvey (1987). All samples were 
assayed in duplicate.
1 0  pi o f standard or sample was added to wells precoated with an antibody, 
followed by the addition of 2 0 0  pi of progesterone labelled with phosphatase 
alkaline. After 30 minutes incubation at room temperature, the wells were 
washed 3 times with distilled water and 200 pi o f a solution (pH 9.8) containing 
1M diethylanolamine and 0.5 mM magnesium chloride acting as the enzyme 
substrate added and incubation continued for a further 30 minutes in the same 
conditions. The reaction was stopped by adding 1 0 0  pi of a solution containing
0.5mM di-potassium hydrogen orthophosphate and 5mM ethylenediamine 
tetracetic acid (EDTA), (pH 10.0). A spectrophotometer (Titertek Multiscan 
Plus) was utilised to read the absorbance at 405nm. The curve was plotted and 
results calculated using a personal computer connected to the spectrophotometer 
and programmed for calibration of data from Elisa assays (Titersoft, Flow 
Laboratories). Cross reactivity with steroids other than progesterone has been 
calculated by the manufacturer and was found to equal 6 6 , 16, 4.5, 3.3 and 3.0% 
with 11-alpha-hydroxyprogesterone, 5-pregnan-3-B-ol-20-one,5-B-pregnan-3,20- 
dione,5-alpha-pregnane-3,20-dione and deoxycorticosterone acetate respectively
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and was insignificant (<1%) with other steroids. Limit of detection calculated 
by Eckersall and Harvey (1987) was 0.5 ng/ml. The inter-assay coefficient of 
variation calculated after assaying the same control sample in 16 assays was 
12.34% at 4 ng/ml. The intra-assay coefficient o f variation estimated by 
assaying the same sample in 1 0  replicates was 1 1 .3 % at 4  ng/ml.
LUTEINIZING HORMONE ESTIMATION.
Preparation o f  buffers.
General purpose buffer 0.5M phosphate buffer (pH7.4) was prepared and stored 
at room temperature.
358.15g di-sodium hydrogen orthophosphate dodecahydrate (Na2 HP0 4 . 
I2 H2 O, MW=358.15 (Fison Laboratory Supplies, Loughborough, England) were 
dissolved in 2  litres distilled water.
39g sodium dihydrogen orthophosphate dihydrate (NaH2 P0 4 .2 H2 0 , MW= 
156.01: Formachem Ltd. Strathaven, Scotland) were dissolved in 500 ml distilled 
water.
When both solutions were homogeneous and clear, 475 ml of solution 2 was 
added to 2 litres of solution 1 and pH was checked.
LH  assay buffer: Fresh assay buffer was made weekly by dissolving 5g bovine 
serum albumin (Sigma Chemical Co., St. Louis, USA) and 2g sodium azide 
(BHD Chemicals Ltd. Poole, England) into the general purpose buffer followed 
by the addition of 1 ml iso-octylphenoxy-polyethoxyethanol (Triton X-100, BDH 
Chemicals Ltd. Poole, England).
Procedure: Plasma LH was measured by the double antibody radio-immunoassay 
method of Boyns et al. (1972) with modifications as follows. Iodination, was 
described by Renton et a l  (1991) 100 pg purified ovine LH (LER 1374A, kindly 
donated by Dr. L Reichert, Albany Medical College) was reconstituted with 500 
ul 0.5M"! phosphate buffer and aliquots of 100 pi (2pg LH) each were put into 
conical iodination tubes (Sarsted Ltd, Leicester, England ) and stored at -80°C. 
A freshly prepared solution of chloramine T (10 mg in 10 ml 0.05M”* phosphate 
buffer pH 7.4) was added and left for 30 seconds. The reaction was stopped by 
the addition of a freshly prepared solution of sodium metabisulphite ( 2 0  mg. in 
10 ml 0.05 M phosphate buffer (0.05M phosphate buffer containing 0.9% (w/v)
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sodium chloride, 0.5% (w/v) bovine serum albumin (BSA) and 0.1% (w/v) 
sodium azide). For every assay, the working solution was prepared by further 
diluting the label with assay buffer to give 1 2 0 0 0  to 17000 counts per minute per 
1 0 0  pi.
The first antibody used, rabbit anti-rat LH serum (CSU120) at a dilution of 1:20 
in assay buffer (0.05 M‘ l phosphate buffer containing 0.25% w/v BSA, 0.1% 
(w/v) sodium azide and 0.05% (v/v) triton X-100) was supplied by G.D. 
Niswender who has successfully used this antibody for canine LH assays 
(personal communication). The standard used was purified pituitary canine LH 
(LER 1685-1; Dr. L. Reichert) to which it was found necessary to add LH-free 
serum (prepubertal bitch blood) and serial dilutions were made at concentrations 
ranging from 50 to 0.788 ng /ml. Recovery studies revealed that the addition of 
12.5 ng. o f canine LH/ml gave a recovery value of 81% and the addition of 
6.25 ng of canine LH/ml gave a recovery of 6 8 %.
The second antibody used was Dynospheres donkey anti-rabbit provided by the 
Royal Infirmary, Glasgow (McConway et al. 1989).
The assay was set up to include 4 tubes for total counts (TCs), two tubes for non­
specific binding (NSB), and two tubes for each of the standards and samples. In 
all assays, 1 0 0  pi o f assay buffer was added to the (0 ) standard tubes and 1 0 0  pi 
o f every standard or plasma samples was added to the other identified tubes. 
The first antibody was then added (100 pi) to all tubes except the TCs and NSB 
tubes. Assay buffer (100 pi) was added to the NSB tubes.
The reagents were mixed by gentle shaking of all tubes and incubation was 
carried out overnight at 4°C. The following day, 1 0 0  pi of the radioactive label 
was added to all tubes, reagents were mixed and incubation continued overnight 
at 4°C. Separation of the bound and free fractions was achieved by addition of 
100 pi of second antibody to all but the total counts (TCs) tubes followed by a 
further incubation at room temperature for at least one hour.
Physiological saline (1 ml) was added to all tubes except the TCs. Centrifugation 
at 2000 g at 4°C for 25 minutes was carried out and the supernatant aspirated and 
decanted. The precipitated pellet was counted using an auto gamma scintillation 
spectrometer (Packard 5230, Berks England). The curve was plotted and results 
calculated using a computer program (SAS Immunoassay Program 632014).
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Plasma samples of known high and low LH were included twice in every assay to 
act as quality controls.
The limit of detection defined as twice the standard deviation of the blank values 
(i.e.maximum binding) was 2.96-50 ng/ml assessed over 1 0  assays. The inter 
assay coefficient of variance calculated from 1 0  assays was 2 .6 % at 12.67 ng 
LH/ml and 13.55 % at 3.018 ng LH/ml. The intra-assay coefficient of variance 
was 3.89 %  and was assessed by the duplicate samples of a randomly selected 
assay and was calculated by the method of Chard, 1982 as follows.
Where: d= the difference between duplicate estimates 
X= the mean of duplicate estimates.
N= the number of duplicate estimates.
The composite standard curve from 1 0  assays is shown in Figure 13.
TESTOSTERONE EVALUATION.
Plasma testosterone was measured by the double antibody ether extraction radio 
immunoassay (RIA) as previously described by Cook and Beastall (1987). The 
125I Histamine-testosterone prepared by chloramine-t method (Cook and Beastall,
1987), was kindly provided by Dr.C.E.Gray of the Department of Pathological 
Biochemistry, Royal Infirmary, Glasgow UK. The rabbit-antibody to 
testosterone (AB-1030) was obtained from Bioclinical Services Ltd. (Cardiff, 
UK. ) According to the suppliers, the testosterone antibody was raised against a 
testosterone-3-(O-carboxy methyl) oxime-bovine serum albumin conjugate and 
shows the following cross-reactivity: testosterone, 100%; 5 alpha
dihydrotestosterone, 16%; 5 alpha-androstane-3 alpha 17- diol, 5.8%; 5 alpha- 
androstane-3 beta, 17 beta diol, 3.7%;androstenedione, 2.1% 
dihydroepiandrosterone, 0.04% and cortisol <0.01%. Testosterone standards 
ranging from 0 -3 4 . 8  nmol 1"1 » were prepared by serial dilutions in donkey serum 
(9SO77-220) which was provided by SAPU. This donkey serum was obtained
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from a pool of blood obtained from a gelding and two female donkeys and 
contained non-detectable levels of testosterone in RIA. Donkey anti-rabbit 
(DAR) and normal rabbit carrier serum (NRS) were provided by SAPU.
1 0 0  microlitre of sample or standard in duplicate was pipetted into 13 x 1 0 0  mm 
clean borosilicate glass tubes (Ciba-Coming, Essex, UK.) 3 ml di-ethyl ether 
(Analar grade, Merck, Thomliebank, Glasgow, Scotland) was added and tubes 
were vortexed for 5 min in a Baird and Tatlock Multivortex Shaker (Searle 
Instrument, Harlow, England). A methanol-dry ice bath was used to freeze the 
aqueous layer and the ether phase containing testosterone was carefully decanted 
into clean 10.5 x 70 mm borosilicate assay tubes. Ether was evaporated in a 
fume cupboard using a Tecam SC-3 sample concentrator (Techne, Cambridge, 
UK) connected to a vacuum pump.
The dried extraction residues were re-dissolved in 300 ul assay buffer (0.05M 
phosphate buffered saline, 0.25% w/v bovine serum albumin, pH 7.4 ) vortexed 
and 1 0 0  ul of the primary anti-testosterone antibody (1:6000 ) and 1 0 0  pi of the 
tracer (containing approx. 10,000 cpm) were added. The tubes were vortexed 
again and incubated at room temperature for 2 h. Thereafter, 500 pi of the 
double antibody reagent containing DAR and NRS (1:80 and 1:1000 
respectively) was added and the tubes were incubated overnight at 4°C. The 
antibody-bound fraction was separated from the unbound by centrifugation at 
1,500 g for 25 min at 4°C using a MSE Mistral 6 L Centrifuge (Fisons 
Instruments, Sussex, UK) and the supernatant was aspirated using a finely drawn 
metal pipette connected to an aspirator pump attached to a running water tap. 
Counting and calculation was done in a Gamma counter Minaxi, Auto Gamma 
5000 series (United Technologies Packard UK).
Using this technique, the efficiency of testosterone ether extraction was found to 
be over 96% following vortexing for 2-4 min. (Cook and Beastall 1987). This 
was verified by Mutayoba,1994 who used 100 pi aliquots of donkey serum 
spiked with a known amount of standard testosterone (1.45, 12.5 and 32.6 nmol 
1), which were extracted using 3 and 10 ml di-ethyl ether for 4 and 10 min and 
run in a normal RIA. Extraction using 3 ml of ether and vortexing for 4 min 
produced similar testosterone recoveries (range 96.3-101.4%) as those obtained 
by using 10 ml of ether and extraction for 4 (range 95.2-102.9%) or 10 min 
(range 97.8-104.1%). In subsequent assays the volume of 3 ml ether and 
extraction of 5  min was used and no recoveries were monitored.
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The limit of detection was 1.39 to 34.80 and was defined from the point where 
the standards CV changes to more than 2 2 %. The inter assay coefficient of 
variance calculated from 8  assays was 21.37% at 7.58 nmol/1 and 28.2 %  at 2.78 
nmol/1. The intra-assay coefficient of variance was 9.8% and was assessed by 
the duplicate samples of a randomly selected assay by the same method and 
formula as indicated for LH. The composite standard curve from 8  assays is 
shown in Figure 12.
RIA Buffer (pH 7.4)
Reagents.
Stock solutions were prepared as follows:
A.- 0.25M Sodium dihydrogen orthophosphate
Made by dissolving 9.8 grams NaH2 PC>4 . 2 H2 O (MW 156.01) in distilled water to 
make up to 250 ml
B.- 0.5M Disodium hydrogen orthophosphate
Made by dissolving 35.5 grams Na2  HPO4  anhydrous (MW 141.96) or 89.54 grams 
Na2 HP0 4 . I2 H2 O (MW 358.17) in distilled water and make up to 500 ml.
RIA Buffer was prepared as follows:
Stock solution:
1.- Dissolve 17.5 g sodium chloride + 0.5 g Merthiolate (Thiomersal) in 250 ml 
distilled water.
2.- Add 30 ml solution A and 120 ml solution B and mix.
3.- Check the pH and if necessary adjust to pH 7.4 with NaOH or HC1 solution.
4.- Make the solution up to 2 litres with distilled water, mix and recheck the pH.
5.- Store at 4 °C for up to 6  months.
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Diluent buffer
RIA buffer plus 0.251% BSA (Sigma). This buffer is prepared fresh for each 
assay
2.9. HEMICASTRATION
Premedication: 0.5 ml of 10 mg/ml Acepromazine Maleate BPC (ACP- C-Vet. 
Ltd) was injected intramuscularly. General anaesthesia was induced with iv 
Thiopentone sodium at a dose of 30 mg/kg.
1. The dog was positioned in dorsal recumbency, with his hind limbs stretched 
out and tied to the operating table.
2. The hair between the thighs and the posterior abdomen was clipped and 
thoroughly washed with an antiseptic solution (Pevidine-A) and then rinsed with 
70% alcohol.
3. The testicle to be removed was pushed forwards out of the scrotum and an 
incision made over the tensed testis cutting through the skin and subcutaneous 
tissue
4. The testis and spermatic chord were exteriorised.
5. The exposed spermatic cord was ligated with gut and then severed.
6. The testis was then removed.
7. The subcutaneous tissue was then sutured with simple interrupted sutures .
8. The skin was also sutured with simple interrupted sutures with silk.
9. After the procedure, 1.7 ml of Duphapen LA ( Duphar Veterinary Limited) 
was injected s/c for the following 2 days.
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2.10. TISSUE PROCESSING FOR HISTOLOGY
Fixative used for all histology samples was Bouin's fluid (Culling, 1974).
Reagents used for Bouin's fluid
Picric acid, saturated aqueous solution 75 ml
Formalin (40% formaldehyde) 25 ml
Glacial acetic acid. 5 ml
Preparation o f  Bouin's fluid.
The picric acid was placed into a flask into which the formaldehyde and glacial 
acetic acid were added and then mixed. This solution will last indefinitely 
without degrading.
Tissue fixation. Pieces of tissue of approximately 0.5 cm 3 were immersed in 
Bouin's fluid for 12- 24 hours.
Processing o f  fixed  tissue samples: These samples were processed in an 
automatic Histokine 24 hour tissue processor (Shandon Elliot Ltd.) The complete 
process took 29 hours.
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The process stages were
2 Hours 70% methylated spirit.
2 Hours 70% methylated spirit + 5% phenol.
2 Hours 90% methylated spirit + 5% phenol
2 Hours absolute alcohol + 5% phenol
1 Hour absolute alcohol + 5% phenol
1 Hour absolute alcohol + 5% phenol
4 Hours 2% celloidin in methyl benzoate.
1 Hour histoclear
1 Hour histoclear
1 Hour histoclear
6 Hours paraffin wax
6 Hours paraffin wax
Preparation of Histological Sections
Using an optical microtome (Spencer AO 821, American Optical Company, 
Buffalo 15, NY, USA) 5 micron thick sections were cut from the paraffin blocks 
containing the samples, mounted on glass slides and dried in an oven at 56°C for 
one hour.
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2.11. HISTOCHEMISTRY
I.-Haematoxylin and eosin (H & E)
Haematoxylin and eosin stain were prepared and used according to the method of 
Mayer (1903).
Reagents.
Haematoxylin 1.0 grams
Potassium alum 50.0 grams
Sodium iodate 0.2 grams
Citric acid 1.0 grams
Chloral hydrate 50.0 grams
Distilled water 1000.0 ml
Preparation procedure:
Haematoxylin
1.-The haematoxylin was dissolved in the distilled water at 60 °C.
2.-The alum was then added and dissolved, again at 60 °C.
3.-The sodium iodate, citric acid and chloral hydrate were then added.
4.-The mixture was boiled for five minutes, then cooled and filtered. 
Eosin:
Reagents
Eosin 3 grams
Absolute alcohol 100 ml
Preparation procedure:
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The saturated eosin solution was prepared by adding the eosin to the absolute 
alcohol.
Staining of histological sections:
1. Sections were placed and agitated in xylene for 1-2 minutes.
2. Transfer to absolute alcohol and leave for 1 minute.
3. Remove and place in methylated spirits for 1 minute.
4. Rinse in water.
5. A few drops o f iodine were added and left in the solution for 1-2 minutes.
6. The sections were rinsed in water for 30 seconds and hypoed for 1 minute with 
5% sodium thiosulphate.
7. Washed again in water and immersed rapidly three times in acid alcohol.
8. Washed again in water for 30 seconds.
9. Blued in Scott's tap water (2g potassium bicarbonate and 20 g magnesium 
sulphate in 1 litre distilled water) for 90 seconds.
10. Washed in water for two minutes and rinsed in methylated spirit.
11. Dehydrate, cleared and mounted in DPX.
II.- Martius, Scarlet, Blue (MSB).
This stain was prepared and used as described by Lendrum et al (1962).
Reagents for M artius yellow
Martius yellow 0.5 grams
Phosphotungstic acid 1.0 grams
95% Alcohol 100 ml
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Preparation :
The Martius yellow and the phosphotungistic acid were dissolved in the 95% 
alcohol.
Reagents for Brilliant crystal scarlet (1%)
Brilliant crystal scarlet (acid red 44) 1.0 grams
Glacial acetic acid 2.0 ml
Distilled water 100 ml
Preparation:
Brilliant crystal scarlet was dissolved in glacial acetic acid and water was added .
Reagents for Methyl blue (0.5%)
Methyl blue (acid blue 93) 0.5 grams
Glacial acetic acid 1.0 ml
Distilled water 100 ml
Preparation :
Methyl blue was dissolved in glacial acetic acid and water was added to make up 
this solution.
Staining of histological sections:
1. Sections were dewaxed and washed in water.
2. They were taken through the preliminary stages as described for haematoxylin 
staining up to the acid alcohol treatment stage.
3. Following a good wash in tap water, sections were rinsed in 95% alcohol.
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4. Stained in 0.5% Martius yellow/phosphotungstic acid for two minutes.
5. Rinsed in distilled water and stained in 1% brilliant crystal scarlet for ten 
minutes.
6. Rinsed in distilled water.
7. Treated with 1% phosphotungstic acid in distilled water for ten minutes.
8. Rinsed in distilled water.
9. Stained in 0.5% methyl blue solution.
10. Rinsed in 1% acetic acid.
11. Rinsed in water.
12. Dehydrated.
13. Cleared an mounted in DPX.
2.12. EXAMINATION OF HISTOLOGICAL SECTIONS.
Sections of testis and epididymis (head, body, tail) were examined under light 
microscope at magnifications of x 125, x 250, x 500 and x 1250. All the fields in 
each slide were examined to determine changes in the cell population of 
seminiferous tubules, the main findings reported were in relation to:
Testicular tissue:
1 Generation of germinal cells present in the seminiferous tubules.
2 Presence or absence of spermatids and spermatozoa in the lumen of the 
seminiferous tubules.
Epididymis:
1.Changes to the number of cell layers
2. Changes in the cellular arrangement.
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Table 1. Protocol for the Medroxyprogesterone acetate (MPA) treatment of an adult male 
beagle (Fred) for two months.
Days Procedure
-7 Semen collection
-6 to -4 Daily bleeding
-3 Bleeding every 15 min. for 1 hour.
3 Samples collected at: 2,3,5 hours later.
0 Semen collection
Insertion of a 100 mg-progesterone implant 
(Organon Laboratories Ltd. Cambridge UK).
1-60 Daily bleeding.
2 Depot injection of 1/2 ml
27 Depot injection of 1 ml
Of 150 mg/ml of Medroxyprogesterone acetate (MPA) 
(Depoprovera, Upjohn Ltd. West Sussex UK)
+7,14,21 Semen collection
30 Hemicastration
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Table No. 2 Protocol for the Medroxyprogesterone acetate treatment of an adult male 
beagle (Gus) for 3 months.
Days Procedure
-7 Semen collection
-7 to -2 Daily bleeding
-1 Bleeding every 15 min. for 2 hours
0 1st 50 mg. MPA depot injection
2-4 Daily bleeding
20, 34, 48, 62, 76 100 mg Depot injection of MPA
18-20 & 21-23 Daily bleeding
32-34 & 35-37
46-48 & 49-51
59-62 & 63-65
74-76 & 77-79
+ 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84. Semen collection
20, 34, 48, 62, 76 Scanning
90 Bleeding every 15 min. for 2 hours
52
C h a p t e r  2-A
Table 3. Examination of the external genitalia of this animal (Fred) during the 
first month of treatment revealed little evidence of any change in scrotal contents. 
Several unsuccessful attempts to collect semen took place before the first 
ejaculate was obtained on the 28th of June. The initial two ejaculates were 
yellowish in colour but the subsequent ones were cloudy. On the 23rd of July the 
ejaculate evaluation showed an increase in tailless sperm. On the 5th of August 
before the 2nd injection was given, the ejaculate collected contained blood. On 
the day the injection was given a slight enlargement o f the left epididymis was 
noticed. It felt soft as if  fluid filled. On August 13th the left testis was removed. 
After removal of the left gonad no attempt was made to collect semen, but the 
dog did attempt to mount a bitch in oestrous.
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Table 4. Presents the results of clinical examination of the reproductive tract of 
an adult beagle dog (Gus) as well as the frequency with which the treatment was 
given at fortnightly intervals for a total o f three months. In addition, the seminal 
characteristics in ejaculates collected whenever possible during the same period 
are shown. Note that semen was only collected when there was a bitch in oestrus 
used as a teaser and that semen was only collected on two occasions towards the 
end of the treatment period. There was no clinical evidence of changes in any 
aspects of the external genitalia during the treatment period. On the two 
occasions that semen was collected, libido was excellent and colour and 
percentage live were within normal range.
55
Tib
to 
4. 
Cj
jnj
og
l 
W
nd
<n
o»
. U
totd
o 
and
 
—
mu
 
•v
fa
itt
om
 
of 
■ 
dop
 
(G
iw
) 
tre
ate
d 
wt
tti 
M
ed
nw
yp
ro
g—
tor
on
> 
ao
tat
o 
far
 3 
m
on
th
*.
C h a p t e r  2-A
<
3
—J 
<  
>  
IU
Z
IU
2
IU
Ui
1
1
.3=o
11JZ 4Z
i  i  
1133
S I
i l
«
i i i i i i i i  i  i  § § § i l l  § § § Jcescisis'scis e c <see <= <s is is is is is
o o o o o o o  o o  o o o  o o o  o o n o
8 I § § §
«• «• «■ v> ^ t* T" r* v ^ f* i" i" t* ^ T“ f* f“ ^ f" ^ i" N Ni i i issssississssssssssssss
56
C h a p t e r  2-A
Figure 1. The frequent bleeding carried out prior to Fred's treatment indicated 
that the circulating plasma concentrations of LH ranged between (2-75ng/ml) 
and those of testosterone between (5-22 nmol/l). The concentrations o f both 
hormones were greater in blood samples collected in the afternoon compared to 
those collected in the morning. Notice the unusually high (55.24 ng /ml) LH in 
the sample taken at 17 hours.
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Figure 2. The frequent bleeding programme carried out prior to treatment does 
not show much variation in the concentration of either hormone assayed in the 
blood samples collected at 15 min intervals.and during the two hour period. 
Notice that the higher values are in the morning samples.
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Figure 3. Before treatment commenced, the circulating plasma concentrations of 
LH and testosterone were all below 10 ng/ml and 10 nmol/1 respectively. After a 
100 mg. progesterone implant (im) was inserted no dramatic increase in 
circulating plasma progesterone occurred. Subsequently a 75 mg.(in) 
Depoprovera (Medroxyprogesterone acetate, MPA) depot injection was 
administered and after this injection, the circulating plasma LH and testosterone 
concentrations, showed no indication of being suppressed. Indeed, just prior to 
the administration of the second depot injection in some instances, an increase in 
the circulating plasma concentrations was recorded. Following the second (in) 
depot injection which was increased to 150 mg., the circulating plasma LH and 
testosterone concentrations continued to show little evidence of being suppressed. 
After removal of the left testis (h), circulating plasma concentrations of both 
testosterone and LH were generally higher than before removal of the gonad. In 
the final fortnight before the animal was sacrificed, the circulating plasma 
concentrations of both LH and testosterone were in some instances nearly 20 LH 
ng/ml and 20 nmol/1 respectively. Notice that in this animal there was only one 
period of frequent bleeding (w) before the implant was inserted, thus 
corresponding to figure 1.
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Figure 4. The hormonal profiles of testosterone and LH show no evidence of 
suppression of either LH or testosterone plasma concentrations during the three 
months treatment with six subcutaneous injections of Medroxyprogesterone 
acetate (MPA) and these are indicated by 0 and *. There are indications of a 
rise in the circulating LH concentrations towards the end of each monthly period, 
i.e. just before administration of the next depot injections. Notice that two 
frequent bleeding periods are indicated by (w) in the figure. The first was on the 
day the treatment started and the second at the end ( Figures 2 and 5).
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Figure 5. Presents the results o f testosterone and LH concentrations in blood 
samples collected every 15 minutes for two hours from Gus. These samples were 
taken at the end of the treatment period (w in figure 4). The LH levels ranged 
between 4.4-10.60 ng/ml and testosterone from 3.75-16.16 nmol/1.
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Figure 6. Histological sections of testes from a) normal dog and b) a dog treated 
with Medroxyprogesterone acetate. Notice in the normal dog, the very uniform 
arrangement of the seminiferous tubule. Also the evidence of ongoing 
spermatogenesis within the seminiferous tubules indicated by the presence of a 
full germ cell complement with clearly identified spermatids (s) around the lumen 
o f the tubules. There is little evidence o f degenerating cells within the lumen of 
these tubules. The section from the treated dog reveals very little difference, 
other than an increase in the amount of cell debris within the lumen of 
seminiferous tubules. Magnification 54 x. Both slides stained with MSB. A blue 
microscope filter was used in the bottom photograph.
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Figure 7. Histological sections of epididymis from a) normal dog and b) dog 
treated with Medroxyprogesterone acetate. Note, in the section from the normal 
dog, the regular arrangement of the cells lining the epididymis and the position of 
the nucleus with regards to the basement membrane. In comparison, the nuclei in 
the cells lining this tubule in the treated dog are much more irregular in position 
with the majority o f them lying much closer to the basal membrane than those of 
the normal dog. In addition, it is obvious that the cytoplasm of the cells of the 
treated tissue has lost its normal homogeneity, with numerous vacuoles present 
within the cytoplasm. Magnification 100 x. Both slides stained with MSB. A blue 
microscope filter was used to take both photographs.
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Figure 8. Presents an example of spermatozoa removed from the head of the 
epididymis of a) normal dog and b) from the head of the epididymis of the dog 
(Fred) treated with Medroxyprogesterone acetate. In the sperm from the normal 
dog, the acrosome is closely and firmly attached to the head of the sperm, 
whereas in the sperm from the treated dog, the acrosome has a fan like 
appearance due to the separation of the cap from the underlining sperm allowing 
it to form folds. Magnification 100 x. Both slides were stained with Spermac.
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Figure 9. Presents an example of spermatozoa removed from: a) head of the 
epididymis of a normal dog b). From the head, c) body, d) tail, e) from the 
ejaculate o f a dog (Gus) treated for three months with MPA. Notice in the normal 
dog the acrosome is closely attached to the head of the sperm, whereas in the 
sperm from the treated dog, the acrosome has a fan like appearance in the 
samples taken from sections of the head,body and tail of the epididymis. Notice 
also the presence of sperm with no acrosome which begin to appear in the body 
section. The numbers of spermatozoa with no acrosome increases in the samples 
taken from the tail section. In the ejaculate sample (e) the equatorial region looks 
wider and is seen here as a pale band surrounding the edge of the acrosome. 
Magnification used 100 x. Both slides were stained with Spermac.
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Figure 10. Presents the histological sections of prostate taken from a) normal dog, 
b) beagle Fred treated with Medroxyprogesterone acetate. There is a slight 
hyperplasia of the gland as the secretory cells from the treated dog have a very 
large cytoplasm and a flattened nucleus in the proximity of the membrane. In the 
normal dog, the cells cytoplasm is smaller with a round nucleus. Magnification 
100 x . Both slides stained with MSB.
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Fig. 11. Ultrasonographs of the prostate taken from Gus, the second dog treated 
with Medroxyprogesterone acetate. Notice that the measurements were taken 
longitudinally. The first measurements were made prior to treatment on October 
16 and the length at that time was 5.2 cm and the width 3.1 cm. In the second 
photo taken on November 13, both measurements show a decrease, the width 
being 2.6 cm and the length 4.8 cm.
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Table 5. Morphological characteristics of spermatozoa collected from the head of 
the epididymis o f a dog (Fred) treated with Depoprovera (Medroxyprogesterone 
acetate, MPA) after one month of treatment and at post mortem after a further 
two month’s treatment. Sperm with abnormal acrosomes were removed from both 
epididymides. The degree of separation of the acrosome from the head of the 
sperm varied. In some cases it was completely absent. After one month's 
treatment, the commonest abnormality was swollen acrosome found in sperm 
removed from the body and tail region whereas, in the sperm removed from the 
same area o f the epididymis after two months the most common was tailless 
sperm. Although the sperm were recovered after different lengths of treatment, 
the percentage of spermatozoa with either detaching acrosomes, or absence of 
acrosomes was virtually the same in the epididymides.
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Table 6. Looking at the results of the abnormalities found in the spermatozoa 
removed from the epididymides after 3 months treatment with MPA, it is of 
interest to see that the commonest abnormality was that of detaching acrosomes, 
a change which was present in all the spermatozoa removed from the head 
region, in 30 % from the body and 15% from the tail. Tailless sperm were found 
in both the body and tail.
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Figure 12. This figure presents the standard curve, for the standards used in the 
radioimmunoassay for the evaluation of testosterone in plasma samples. It 
presents the repeatability of the radioimmunoassay used in the present work, and 
is described in material and methods in this chapter.
84
C h a pt e r  2-A
O)
GO
CD
ID
CO
CM
O O
CO
O
CM
85
St
an
d
ar
ds
Ch a p t e r  2-A
Figure 13. This figure presents the standard curve, for the standards used in the 
radioimmunoassay for the evaluation of LH in plasma samples. It presents the 
repeatability of the assay used in the present work, and is described in material 
and methods in this chapter.
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Figure. 14 This is a photograph of the material used for semen collection in the 
dog, showing the latex cone with a plastic centrifuge attached to it as ready to be 
used.
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4. DISCUSSION
The main reason for using a progestogen for hormonal manipulation of fertility in 
the male dog was because of recent interesting findings in man (Wu and Aitken 
1989). In this instance, the progestogen Medroxyprogesterone acetate (MPA) was 
used in conjunction with testosterone, but it was felt that the use of testosterone 
in the human was mainly as a means of maintaining normal libido and that it 
would be of interest to investigate the effect of progestogens alone on male 
fertility.
Natural and synthetic progestogens are supplied in various forms, such as depot 
injections, compressed pellets, or silastic implants. The first treatment chosen 
was an implant of progesterone (Tables 1 and 3) as it was then possible to 
monitor the rate o f absorption of the progesterone relatively rapidly by 
determining the circulating plasma progesterone concentrations with a 
commercial ELISA kit, using the method described by Eckersall and Harvey 
(1987). Several days after initiation of this treatment, there was no apparent 
increase in circulating plasma progesterone concentrations (Figure 3) although 
the implant used contained a relatively large amount of progesterone (100 mgs).
Little is published in the literature about the concentrations achieved by giving 
hormones as implants in any species, but the results of the monitoring carried out 
indicated that this method of administration was of little use in increasing the 
amounts of the preparation in the plasma (Figure 3). This warrants further 
investigation, as even the firms who produced the implants were unable to supply 
information regarding the levels being released into the blood, even in humans, 
and there was absolutely no information regarding this aspect in dogs.
It was therefore decided that this means of administering progesterone was of no 
use for the purposes intended, so, at that point, a depot injection of Depoprovera 
(Medroxyprogesterone acetate, MPA) was administered (Table 3).
The amounts of MPA and testosterone administered by depot injection to the 
human male was calculated on a weight basis of 2.85 mg per kg and this 
achieved suppression of circulating plasma LH in these patients after 7 days (Wu 
and Aitken 1989). In the initial canine experiment, Depoprovera was 
administered as depot injections at a dose calculated on a similar weight basis to 
that adopted in the human males (3 mg/kg). The subsequent results of daily
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monitoring of the circulating plasma LH concentrations. (Figures 3 and 4) 
indicated that there had been no apparent suppression of the circulating LH or 
testosterone concentrations. Even though there is some discrepancy in the levels 
reported in previous studies they are still within those limits (1.38-20.76 nmol /l) 
reported by de Palatis et al. (1978); ( 5.55-11.07 nmol/1 in Tremblay and 
Belanger (1985); (10.38 -13.84 nmol/l) in Vickery et al (1984), (3.08 ±0.21 to 
1.57 ±0.25) Taha et al. 1981.
The same applies to the LH levels found throughout the present study (3.2- 
15.29 ng/ml) (Figures 1, 2, 16, 24, 30) which are just slightly higher than those 
reported by de Palatis et al. (1978), (0.2-12 ng/ml). The only exception was the 
one sample in figure 1 of 55.24 ng/ml, which may well have been due to faulty 
processing of the sample. Unfortunately there was not enough sample to retest 
the sample.
This lack of suppression may have been due to the absence of testosterone in the 
treatment. This is confirmed by later studies in which MPA is still being used 
with androgens in man as reported by the World Health Organisation (1993). In 
a study in Indonesian men, 43 of 45 men achieved consistent azoospermia when 
MPA was combined with T enanthate and 44 out of 45 when the combination 
was made with a 19-nortestosterone ester. Testosterone also acts via the 
hypothalamus to reduce the release of GnRH and so the release of 
gonadotrophins. On the other hand, it might well be that metabolism of 
progesterone is much more rapid in the dog than in the human. Interestingly in 
the bitch in which MPA is given to suppress oestrus, 50 mg /kg the doses used 
namely (Sokolowski et al.1973; Sokolowski et al. 1974) and 75 mg/kg (McCann 
et al. 1987), are relatively much higher than those given to humans, for example 
150 mg used by Shrimanker et al. (1978).
In retrospect, it would have been extremely interesting to monitor the uptake of 
MPA in the dogs treated, as there is an assay available to do so (Shrimanker et al. 
1978). This would have allowed more accurate deductions to be made as to the 
levels obtained and the half life of this substance in this species. However in 
these experiments, this was not undertaken and it was decided to double the 
amount given by depot injection (Table 3).
Just before the increased amount of progesterone was administered, an attempt 
was made to determine whether there were any changes in the testes, 
epididymides and developing spermatozoa. Hemicastration of one of the animals
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was undertaken. (Table 3). Up to this stage, semen samples had been obtained on 
several occasions and was obvious that this dog’s libido was not affected by the 
progestogen treatment.
In the male, sexual activity such as libido and ejaculation requires testosterone to 
manifest itself and to be maintained. Proof that this is so arises from the fact that 
in castrated dogs, although this behaviour does not disappear immediately, it does 
slowly decline. Therefore in this dog, the fact that semen could be collected 
could indicate that testosterone production in this animal was still sufficient to 
maintain this aspect of normal male fertility (Sachs and Meisel, 1988). 
Progestogens are initially administered to male dogs to suppress unwanted 
sexual behaviour (Gerber and Sulman ,1964; Gerber et al. 1973; Evans, 1976; 
Wright et al. 1979). However there are no evaluations as to the degree of 
suppression of testosterone required to produce an effect on sexual behaviour.
Even before commencing the progestogen treatment in this dog (Fred), his libido 
was scored as less than normal (Table 3). This was most probably due to the 
animal being collected from by a stranger, as semen had been obtained from him 
on previous occasions by other people. However, within a fortnight his libido 
improved markedly and a semen collection was achieved fortnightly thereafter.
After a certain amount of training, semen collection from normal male dogs is 
usually successfully carried out even without the presence of a bitch in oestrus. 
However as mentioned before the libido in this particular animal (Fred ) was 
never very high and after hemicastration, no attempt was made to collect from 
him since, as anticipated, there was a fair degree of scrotal swelling. However he 
did attempt to mount an oestrous bitch (Table 3).
The profiles of both the circulating plasma LH and testosterone throughout the 
treatment period in both dogs treated with Depoprovera (Tables 3 and 4), suggest 
that initially in Fred, there may have been some suppression of the two hormones 
due to the presence of the progestogen depot. When the depot became reduced 
in amount toward the end of the first month of treatment, it allowed the 
concentrations o f LH and testosterone to increase as indicated by the peak of both 
hormones around this time (Figure 3).
The window bleedings demonstrated that the normal concentration of both 
hormones in the pre-treatment samples (Figures 1 and 2) could be as high as any 
of the concentrations recorded during the treatment period (Figures 3 and 4).
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Thus one must accept that all that can be deduced from the hormone results is 
that the amount of Medroxyprogesterone acetate (MPA) given did not produce 
any maintained suppression of LH or testosterone in either o f the male dogs, 
although Gus was treated with 6 subcutaneous injections in a time period that 
was just 17 days longer than Fred (Table 2 Figure 4). These results are in 
agreement with the findings of Bamberg and Forsberg (1992) who also reported 
that dogs treated with MPA at doses ranging between 3-8 mg/kg twice weekly 
did not show any reduction in their circulating plasma LH or testosterone. 
However they did not agree with those of Wright et al (1979), who reported a 
58% reduction in testosterone concentrations in dogs after 7 weeks of receiving a 
Depoprovera injection of 4 mg/kg. However, the 58% figure quoted represents 
the mean of the results from 4 dogs, and it does not take into account the fact that 
there is a great deal of variations between dogs, which has also been reported by 
others (Taha et al 1981) or that there are oscillations in the testosterone secretion 
pattern, as can be seen in Figures 3 and 4.
Before the treatment began the colour of the ejaculate in one of the dogs, Fred 
(Table 3) was recorded as yellow. This yellow colouration was due to the 
presence of a few urine drops which occurred in this dog even when he urinated 
immediately prior to collection. With time, this problem was overcome as the 
dog became more used to the collector and subsequently uncontaminated semen 
was collected. On another occasion, the ejaculate from this same dog contained 
blood. This was probably of urethral origin since the integrity of the penis was 
checked, as it is sometimes possible to cause trauma to the erect penis by contact 
with the collecting receptacle. No evidence of penile trauma was found.
No spermatozoa was found in this ejaculate, although they had been present 5 
days previously (Table 3). This was because, as soon as the bloody ejaculate 
was seen, further collection ceased and so only the first fraction containing the 
blood was collected and the sperm rich fraction was not obtained.
It has been suggested that blood may be detrimental to semen when collected for 
artificial insemination as it is always recommended not to use semen of an 
abnormal colouring as it indicates contamination either by urine, or blood (Hafez, 
1987). However, the engorged state of the erect penis makes it very prone to 
bleed, so that it is almost certain that in many instances of successful natural 
matings there is a degree of bleeding from the penis, besides the fact that mating 
occurs when the bitch is bleeding due to oestrus.
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An interesting finding in this dog (Fred) was that, at the end of the experimental 
period, he was found to have a very enlarged prostate which when examined 
histologically revealed benign hyperplasia (Figure 10). Prostatic hyperplasia is 
relatively common in the older male dog and can lead to blood being voided in 
both urine and semen. It is not clear if the progestogen played a role in the 
occurrence of this abnormality in this first dog, as no examination of this 
structure was undertaken before the start of the experiment. However, because 
of this finding, in the animals subsequently treated, ultrasound scanning of the 
prostate gland was included as part of the clinical investigations.
It was thanks to the scanning photos of the second dog (Gus) that it was possible 
to determine an interesting effect of the treatment, which was the apparent 
shrinking of the gland. The difference can be appreciated in the first photo taken 
prior to treatment (Figure 11a) and the last photo taken almost at the end of 
treatment (Figure 1 lb). This finding would agree with Bamberg and Forsberg 
(1992) who also reported a decrease in size with one 3 mg/kg body weight dose 
of MPA, which they used for treating benign prostatic hyperplasia in the dog. 
The post-mortem  examination in this second dog (Gus) also revealed a 
hyperplastic condition but to a lesser degree than that of the first animal.
Before hemicastration was carried out, palpation of the scrotal contents suggested 
that there was some swelling of the left epididymis( Table 3). This finding 
indicated that this would be the testis removed, as this would allow a thorough 
histological examination of this structure. No obvious macroscopic changes of 
this epidiymis were recorded at post-mortem  and subsequent histological 
examination failed to reveal any explanation for the swelling. Manual 
examination of scrotal contents is very subjective and only very obvious changes 
tend to indicate meaningful changes.
In the studies reported here, attempts were made to collect the second ejaculated 
fraction on its own, but this is almost impossible to achieve, as the second 
fraction tends to be ejaculated immediately following expulsion of the first 
fraction. A noticeable pause exists between the ejaculation of the second and 
third fraction (Allen et al. 1979) and thus, the ejaculate collected from these dogs 
represented a mixture of the first and second fractions and therefore, not a great 
deal of notice can be taken of the volume recorded. However, the more sperm 
produced, the more dense the sample is and so the description of cloudy tends to 
suggest that the concentration in the ejaculate in one of the dogs (Table 1) was
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on the low side, as generally a good stud dog will produce a milky to creamy 
second fraction.
Routinely, sperm concentration is assessed by the number of spermatozoa present 
in the drop when semen is examined microscopically for initial motility and only 
if  there is indication that there is a very low count, is a scientific method then 
adopted. In the first animal used in these studies, only visual examination was 
carried out (Table 3).
Histological examination of sections from the testes removed at hemicastration 
from Fred, the dog treated with MPA for two months, revealed an increase in the 
amount of debris occupying the lumen of several of the seminiferous tubules 
(Figure 6). Some workers have suggested that this sloughing of cells is due to 
dysfunction of the Sertoli cells as during the final stages of spermatogenesis they 
"pull o f f " the excess cytoplasm from the spermatids and retain this residual body 
within their own cytoplasm (de Kretser and Kerr, 1988). The sloughed material 
could represent accumulation of these residual bodies or on the other hand it 
could represent spermatids which were degenerating because the Sertoli cells had 
lost their ability to remove the excess cytoplasmic droplets.
The most obvious histological changes in both dogs were in the head of the 
epididymis (Figure 7). If these changes were associated with a suppression of 
testosterone which is transported to the epididymis by ABP, then this would tend 
to suggest that these changes were the culmination of exposure for two months to 
the two injection of progestogen. However, if  the changes were brought about 
by the action of the progestogens directly on the epididymis then it would appear 
that the head region is more sensitive to progesterone than are body or tail of the 
epididymis. The changes were an obvious displacement of the nucleus of the 
epithelial cells lining the head of the epididymis and an increase in the number of 
vacuoles present within these cells. The functions of these cells include the 
reabsorption of some of the large amounts of fluid which accompanies the 
spermatozoa from the seminiferous tubules and occurs mainly in the head 
regions. A second function is the exchange of glycoproteins, ions and small 
organic molecules to and from the epididymal lumen, and finally by means of the 
microvilli located in the luminal surface of the cells, propulsion of the 
spermatozoa during ejaculation (Robaire & Hermo,1988). Thus the alterations 
found in the cells lining the head of the epididymides could have affected any of 
these functions.
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However, the most dramatic change identified in both dogs was that in the 
spermatozoa removed from the lumen of the head of the epididymis (Figure 8). 
This involved the swelling and loosening of the acrosome and in some sperm the 
acrosome completely separated from the head. In the dog which was 
hemicastrated after one month's treatment, the acrosomal changes were present in 
the head region as the acrosome was either beginning to detach or had already 
detached. This particular acrosome defect appears in a study of sperm 
abnormalities in Spermac stained spermatozoa (Oettle, 1986) where it is 
classified as a secondary acrosomal change in which acrosomal contents have 
been lost (Oettle and Soley, 1988).
Under normal circumstances the acrosome containing the enzymes acrosin and 
hyaluronidase is shed immediately prior to penetration of the mature egg by the 
sperm (Bazer et a\. 1987 ). This event takes place in the Fallopian tube of the 
female (Yanagimachi, 1988) and at this particular time, there is an increase in the 
circulating plasma progesterone in the bitch. Therefore the acrosomal changes 
seen in both dogs (Figures 8 and 9) after the progestogen treatment, could suggest 
that although the amount of progesterone given was not sufficient to cause a 
determinable change in the circulating plasma LH levels and testosterone 
concentration, it was sufficient to affect the epididymal environment and 
subsequently to have an affect on the spermatozoa during their passage through 
this area of the male reproductive tract. Again, as with the cellular changes in 
this region, this could be by one of two routes, either by direct action of the 
progesterone on the epididymis or by the progesterone affecting the amount of 
testosterone reaching the epididymis (Lobl et al, 1983) where it is essential for the 
normal function of this region.
At the end of the experimental period, LH concentrations were still not 
suppressed in either dog and sperm were still being produced (Figures 3, 4, 5). 
Therefore, it is unlikely that the testicular testosterone production was reduced 
nor its transport to the epidiymis affected by the progestogen administration. 
Furthermore, as this type of acrosomal change occurs normally in sperm while 
within the female whilst under the influence of raised concentrations of 
progesterone, it is more likely that the acrosomal changes found in the dogs 
treated with MPA were the result of a direct action of progestogen on the 
epididymis itself. This seems to be likely as the rate of fluid absorption is 
highest in the head of the epididymis, which would thus allow for greater 
concentrations of MPA in this region.
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This, however appeared to be a cumulative effect as after one month's treatment 
only the sperm in the head region of the epididymis showed these changes 
(Figure 8). It would be of interest to study sperm kept in an environment of 
elevated progesterone to investigate whether acrosomal changes would be 
induced, or if  the progesterone required other factors present in the epididymis to 
bring about those changes.
There is another possibility that would explain the absence of acrosome in some 
of the sperm. It has been reported (de Kretser and Kerr, 1988) that, as the 
acrosome contains enzymes, it is possible that they can digest the acrosome in 
dead or dying spermatozoa. This is known as false acrosome reaction 
(Yanagimachi, 1988) and it could explain why some sperm had no acrosome, as 
they may have been dying due to the different environment created by the MPA.
In the hemicastrated dog, there was still the presence of sperm with the 
acrosomal defect already described in the material removed from the epididymis 
at post-mortem , also noted was the presence of tailless spermatozoa. (Table 5). 
This was probably due to the change in environment of the epididymis because of 
the trauma to this region after the removal o f the left testis. Similar samples taken 
from Gus's epididymides showed the highest percentage of sperm with acrosomes 
in the process of losing their acrosome and reported as detaching acrosome in 
Table 6, which may be related to the increased number of injections given.
As scrotal enlargement was very obvious for quite some time after the operation, 
this would lead to degeneration of the epididymal sperm. This would include 
those spermatozoa already present and those arriving in this region during this 
time. Spermatogenesis would almost certainly have been affected during the day 
immediately following the operation due to the inflammation and the consequent 
increased temperature of the scrotum, so that sperm concentration would also 
have been affected.
Unfortunately the dog in which hemicastration was not carried out could only be 
collected from when a bitch in season was available, as only in these 
circumstances was his libido such as to allow semen to be collected (Table 4). A 
bitch in oestrus was only available towards the end of the treatment period and so 
no real deductions can be drawn from the semen picture obtained in this animal, 
as no semen had been collected before the treatment began. However, after the 
three months of treating this animal with MPA, the sperm in the ejaculate had an 
increased equatorial region (Figure 9). This type of change was also reported by
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Oettle and Soley (1988) in their study on sperm abnormalities in the dog. 
Furthermore, the swollen acrosomal change seen in the first dog was present in a 
relatively large percentage of the sperm removed from all three areas of the 
epididymis at post-mortem  (Figures 9, a, b, c). These findings tend to suggest 
that the extended length of time over which this animal was treated, increased 
the acrosomal abnormalities, thus supporting the hypothesis of a cumulative 
affect of MPA.
In conclusion, the results of these two experiments showed that the Depoprovera 
(MPA) treatment did not suppress either LH or testosterone production and thus 
spermatogenesis continued in an apparently normal way. However the MPA 
regime did affect the epididymal environment therefore indicating a very 
interesting potential for a contraceptive mechanisms, by damaging the fertilising 
capacity of the spermatozoa during maturation in the epididymis.
However, as the aim of this project was to study the changes in the 
spermatogenic cycle by inhibiting the LH release from the pituitary, with the 
subsequent reduction in the production of testosterone, another method of 
achieving this required to be investigated.
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1. INTRODUCTION
A great deal of information about the use of synthetic GnRH agonists and antagonists 
as a means of manipulating fertility in both humans and laboratory animals is available 
in the literature. In the human they were used initially for treatment of infertility 
cases where abnormal amounts of gonadotrophins were detected. However it was 
established that GnRH desensitisation occurs at the pituitary level and in the rat at 
gonadal level as well since GnRH-like receptor sites have been identified in their 
Leydig cells (Sharpe, 1986). Although there have been several reports of the use of 
both agonists and antagonists in the dog, most of the work has been associated with 
contraception in the bitch. However Vickery and colleagues (Vickery, et a l  1982; 
Vickery et al. 1983; Vickery and McRae, 1984; Vickery et a l  1984; Vickery et a l 
1985; Vickery et a\. 1986; Goodpasture, Bergstrom and Vickery, 1988; Vickery et 
al 1989), have done extensive studies of their use in the male dog and their results 
demonstrated the ability of the GnRH agonist to suppress circulating plasma 
concentrations of both testosterone and LH. It was therefore decided to undertake 
preliminary investigations of the use of a Nafarelin derivative kindly donated to us by 
Dr. Patrick Concannon (Cornell University) and subsequently Nafarelin acetate 
donated by Syntex (Palo Alto, California). And the aim was to determine the 
optimum conditions for administration of the drug in the dog, such as the length of 
treatment required to produce continued suppression of circulating plasma testosterone 
and the subsequent changes in testes, epididymis and prostate
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2. M ATERIALS AND M ETHODS.
Animals used
Name Breed Age, years Weight, kgs. Body condition
Adam Beagle 1 17' good
Baxter Beagle 1 17 good
Dexter Beagle 1 17 good
2.1. MAINTENANCE
As discussed in chapter 2-A
2.2. TESTICULAR MEASUREMENTS
As discussed in chapter 2-A
2.3. SCANNING
As discussed in chapter 2-A
2.4. LIBIDO EVALUATION
As discussed in chapter 2-A
2.5. SEMEN COLLECTION
As discussed in chapter 2-A
2.6. SEMEN EVALUATION
As discussed in chapter 2-A
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2.7. ALKALINE PHOSPHATASE EVALUATION
100 microliters of ejaculate were analysed for alkaline phosphatase contents, using a 
commercial kit code no. 980941, by the DEA buffer, and 37°C. by the method of the 
(Empfehlunger der Deutschen Gesellschaft fur Klinische Chemie, 1970 and 1972) and 
measured in a Dynamic selective analyser from Kone Instruments. The results are 
expressed as units/litre.
2.8. BLOOD SAMPLE COLLECTION AND PROCESSING.
As discussed in chapter 2-A
2.9. MEDICATION USED
Nafarelin derivative No.RS 49947-298 supplied by courtesy of Dr. Patrick Concannon 
(Cornell University). This was administered by osmotic pumps which were 
subcutaneously implanted and by daily subcutaneous injections.
Nafarelin acetate supplied by courtesy of ( Syntex Research, Palo Alto, Ca. USA). 
This was used as subcutaneous daily injections only.
2.10. ADMINISTRATION OF MEDICATION
By subcutaneous osmotic pumps and subcutaneous injections
The pumps used were Alzet model no. 2ML4 (Alzet Charles River UK. Ltd) for 
subcutaneous implant.
1. The empty pump was weighted together with the flow moderator.
2. Filling the pump was achieved by means of a syringe and a blunt-tipped filling tube 
as follows: Drawing the solution into the syringe to which the loading tube was 
already attached, making sure that both syringe and tube were free of air bubbles.
3. With the flow moderator removed and holding the pump in an upright position, the 
filling tube was inserted thorough the opening at the end of the pump until it could go 
no further, to the bottom of the pump reservoir.
4. By slowly pushing the plunger o f the syringe, whilst holding the pump in an upright 
position until the solution appeared at the outlet.
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5. Excess solution was wiped off and the flow moderator inserted until the cap was 
flush with the top of the pump. The insertion of the flow moderator displaced some of 
the solution from the filled pump.
6 The filled pump was weighed and the difference in the weights from steps 1 and 6 
was taken as the net weight of the solution loaded. For most dilute aqueous solutions, 
the weight in milligrams is approximately the same as the volume in microlitres. The 
total volume should be over 90% of the reservoir volume specified. If so, the filled 
pump is then ready for use. If not, there may be some air trapped inside the pump. 
Evacuate the incompletely filled pump and refill.
2.11. PUMP INSERTION
a) Under local anaesthesia.
b) Under general anaesthesia.
a). With local anaesthesia.
Premedication, 0.8 ml of ACP (0.004 ml /kg)
The incision site was the area in the back between the shoulder blades, and the skin 
over this area was clipped and washed with an antiseptic solution (Pevidine A BK. 
Veterinary Prods Ltd.), rinsed with 70% alcohol and then infiltrated with Lignocaine- 
A
b) With general anaesthesia.
Pre-Medication 0.8 ml ACP (0.004 ml/kg)
Anaesthesia was induced with 5.0 ml iv Thiopentone (Intraval sodium, May & Baker 
pharmaceutical) followed by administration of Halothane, Oxygen and Nitrous oxide 
through a face mask.
Subcutaneous implantation:
1. An incision was made in the neck between the shoulder blades. By inserting artery 
forceps through the incision and opening the jaws, the subcutaneous tissue was dilated 
to create a pocket for the pump, until sufficiently large to allow movement of the
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pump. The pocket was not made too large, as this allowed the pump to turn around or 
slip down towards the flank of the animal.
2. The filled pump was inserted into the pocket portal end first .This minimises 
interaction between the compound delivered and the healing of the incision.
3. The subcutaneous tissue was then sutured with simple dissolvable interrupted 
stitches. The skin was closed with continuous stitches and silk.
4. After either procedure, the dog received an intramuscular injection of 1.7 ml
Duphapen LA ( Duphar Veterinary Limited)
2.12. HORMONE ASSAYS 
Same as discussed in chapter 2-A
2.13. TISSUE PROCESSING FOR HISTOLOGY.
Same as discussed in chapter 2-A
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3.- RESULTS
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Table 7 Protocol for the Nafarelin derivative treatment of an adult male beagle 
(Adam) treated for 75 days
Days Procedure
-3 Daily bleeding
-2 +5, then weekly Semen collection
-1 Bleeding every 15 min. for 3 hours
26 Bleeding every 15 min. for 2 hours
Nafarelin derivative administration
0-28 First pump inserted releasing 17 ug/day
28-41 Second pump releasing 17 ug /day
41-54 Third pump releasing 34 ug/day
54-75 Daily injection 24 ug.
15,36,53,78. Scanning of prostate
Weight taken.
Daily Body temperature taken
-2+4 then weekly Genitalia evaluation.
105-1
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Table 8. This table presents details of the experimental protocol in Adam. The 
Nafarelin derivative treatment to this dog was initially given by means of osmotic 
pumps inserted subcutaneously, the initial dose of 17 ug/day being changed in the 
third pump to twice that dose. Even when some problems arose with the use of 
the osmotic pump, this did not cause any systemic reaction as gauged by body 
temperature and the animal’s well-being. The treatment was changed to daily 
subcutaneous injections with doses which were modified several times until the 
final dose of 50 ug/day was selected. Notice that there was a small decrease in 
the size of the testis toward the end of the treatment period. There was also an 
associated change in consistency o f the gonads, these changes in the testes being 
reflected by similar changes in the epidydimides.
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Table 9 The libido in this animal only twice reached the normal score (3), but it 
was sufficient to allow semen to be collected on numerous occasions. Note that 
even before administration of the GNRH agonist, this dog's ejaculate contained a 
high percentage of abnormal sperm, the highest percentage o f which were sperm 
with bent necks. An interesting point is the decrease in ejaculate produced at the 
end o f the treatment and the high spermatozoal concentration in the last sample in 
which it was possible to evaluate concentration.
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Figure 15. This figure presents the results o f the frequent bleedings undertaken 
prior to treatment which indicated that the circulating plasma concentrations of 
both LH and testosterone showed similar variations at 15 minute intervals to 
those found during daily bleeding. All LH and testosterone values were below 10 
ng/ml nmol respectively. It is the first such window taken during the experimental 
period and is indicated in figure 16 by a (w).
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Figure 16. The hormonal profiles in Adam, taken before and during treatment 
indicate that the circulating plasma LH and testosterone concentrations were 
within normal range until after the agonist was administered by subcutaneous 
injection. The levels dropped to 0.01 (LH ng/mg, testosterone nmol/1) and were 
maintained until the end of the experimental period except for one small peak 
that occurred on the 4th day after the injections started. Otherwise, wide 
variations in concentrations occurred throughout the experimental period, with 
most being below 10 (LH ng/mg, testosterone nmol/l)* Overall, the testosterone 
concentrations tended to mimic the pattern of the LH concentrations.
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Figure 17. This is the second bleeding window which appears in fig. 16 (w). It 
was carried out during the administration of the agonist by means of a 
subcutaneous pump. The blood samples were taken every 15 minutes for a total 
o f 2 hours and they showed more variation in testosterone concentrations which 
were between 1.04-8.27 nmol/1 than with LH where the levels were maintained 
between 3.28-8.77 ng/ml. Observe the slight LH increase in the last 2 samples.
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Figure 18. Histological sections of testes from a) normal dog, b) and an adult 
beagle dog (Adam) treated with Nafarelin derivative, by subcutaneous osmotic 
pumps for 54 days plus daily subcutaneous injections for 21 days. Notice in the 
normal dog the presence of a full germ cell complement with clearly identified 
spermatids (pointed by the arrows) around the lumen of the tubules, which have 
almost totally disappeared from the treated dog testis, where neither spermatids 
or spermatozoa can be seen. The tubular lumen has disappeared as well. The only 
cells found in most o f the tubules are Sertoli cells and the spermatogonia closest 
to the membrane. Magnification 10 x. Both slides stained with MSB. A blue 
microscope filter was used to take both photographs.
1 1 6
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Figure 19. Histological sections of a different area of the head of the epididymis 
from a) normal dog and b) beagle dog treated with Nafarelin derivative (Adam). 
Notice the presence of vacuoles in an area o f the tubule in the treated dog, 
whereas in the normal dog nothing similar was found. Also note the absence of 
spermatozoa from the lumen of the tubule in comparison to the normal dog. 
Magnification 10 x. Both slides stained with MSB. A blue microscope filter was 
used to take the top photograph .
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Figure 20. Semen sample from a) normal dog b) beagle dog treated with 
Nafarelin derivative (Adam). Note that the neck o f the sperm in the normal dog is 
as straight as the tail, whereas in Adam the neck is bent and in some instances it 
looks almost broken. This defect was noticed even before treatment started. 
Magnification 100 x. Both slides stained with nigrosine-eosin.
1 2 0
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Figure 21. This is an example of a histological section of a prostate, taken from a) 
normal dog, b) beagle dog treated with Nafarelin derivative (Adam). In the 
treated animal, the prostatic alveoli have a shrunken appearance and an increase 
in the connective tissue that surrounds the alveoli indicative of the gland's 
atrophy. Notice also the absence o f secretion in Adam which is abundant in the 
normal dog's prostate. Magnification 54 x. Both slides stained with MSB.
1 2 2
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Figure 22. Ultrasonographs of Adam's prostate on April 10 (width 1.7 cms and 
length 2.1 cms) shows is a small decrease by May 21st (width 0.9 cms and 
length 1.2 cms) indicating a difference of 0.8 cms in the width and 0.9 cms in the 
length at the end of treatment.
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Table 10 Protocol for the Nafarelin derivative treatment of an adult male beagle 
(Baxter) treated for 48 days
Days Procedure
-3 Daily bleeding
-2+6, and then weekly Semen collection
-1 Bleeding every 15 min. for 3 hours
26 Bleeding every 15 min. for 2 hours.
Nafarelin derivative administration
0-28 First pump inserted releasing 17 ug/day
28-41 Second pump releasing 17 ug/day
41-48 Third pump releasing 34 ug/day
15, 36 Scanning of prostate
Daily Temperature taken
-2 +4 and then weekly Genitalia evaluation.
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Table 11. This table shows details of the experimental protocol in Baxter. The 
Nafarelin derivative treatment to this dog was administered by subcutaneous 
osmotic pumps only. The results indicate that, even when problems arose with 
the use of the osmotic pump, this did not cause any systemic reaction as gauged 
by body temperature with the first two pumps. However, complications with the 
insertion o f the third pump made it necessary to end this experiment. The 
testicular measurements taken during treatment, except for small differences in 
the length, do not indicate a marked or continuous decrease in size. There were 
no changes to the consistency o f either testis or epididymides.
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Table 12. The libido in this animal reached the normal score (3) three times only 
, but it was sufficient to allow semen to be collected on numerous occasions, 
even without the aid o f a teaser bitch. No alterations to any of the parameters can 
be seen except for a small decrease in the amount o f the last ejaculate.
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Figure 23. This figure presents the results of samples that were taken every 15 
minutes for a total o f 3 hours. It was undertaken prior to treatment with 
Nafarelin derivative by osmotic pumps. It indicates higher circulating plasma 
levels of testosterone during the morning samples. The LH profile does not show 
much variation during the same period with a range of 3.02-4.52 ng/ml, whereas 
testosterone values show a wider fluctuation from 0.72-17.64 nmol/1. This is the 
first of the two window (w) bleedings indicated in figure 24.
131
Fi
g.
 
23
 
C
ir
cu
la
ti
ng
 
pl
as
m
a 
LH
 
& 
te
st
os
te
ro
n
e 
co
n
ce
n
tr
at
io
n
s 
in 
sa
m
pl
es
 
co
ll
ec
te
d 
ev
er
y 
15 
m
in
ut
es
 
fo
r 
3 
ho
ur
s 
in 
B
ax
te
r
LH 
ng
/m
l 
T
es
to
st
er
on
e 
nm
ol
/l
Chapter 2-b
o
CD
O
ID
O O
CO
o
CM
ID
CO
O
O
CO
CD
cvi
o
CO
cvi
ID
cvi
O
o
cvi
ID
O
CO
ID
O
O
ID
O
T “
o
CO
o
ID
o
(D
E
i-
o
CO
o
ID
O O
CO
O
CM
132
T
es
to
st
er
on
e
Chapter 2-b
Figure 24. In this figure the circulating plasma concentrations o f LH and 
testosterone show little evidence of a maintained suppression during the periods 
when the subcutaneous pumps (P) containing the Nafarelin derivative were in 
situ. Note the reduced amount o f circulating plasma LH at the end of the 25 days 
during which the first pump was in position. This reduction continued for the 
first few days following insertion of the 2nd pump, but was not sustained. The 
range of LH was 2.4-21.84 ng/ml and that of testosterone 0.02-23.82 nmol/1.
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Figure 25. During the administration of the Nafarelin derivative, a frequent 
bleeding period was undertaken. LH maintained very constant levels (2.04-3.85 
ng/ml) during the two hours, whereas testosterone showed greater variations and 
an increase in the afternoon samples, with plasma concentrations of (3.64-12.72 
nmol/l)- Magnification 54 x . Both slides stained with MSB. A blue microscope 
filter was used to take the photograph o f the normal dog.
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Figure 26. Histological sections o f testes from a) normal dog, b) and an adult 
beagle dog (Baxter), treated with Nafarelin derivative by subcutaneous osmotic 
pumps. Comparing the normal with the treated dog, there are no obvious 
differences between them, as evidently spermatogenesis has not been interrupted 
in either sample. The only difference appears to be a slight increase in cellular 
debris in the lumen o f the tubules. Magnification 54 x . Both slides stained with 
MSB. A blue microscope filter was used to take the photograph o f the normal 
dog.
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Figure 27. Example of a histological section of the head of the epididymis from 
a) normal dog and b) dog treated with Nafarelin derivative (Baxter) administered 
by subcutaneous pump for 48 days. Both samples appear similar, as there is 
neither evidence o f alteration to the homogeneity of the cell's cytoplasm nor to 
the regular arrangement of the cells lining the epididymis. Notice the presence of 
spermatozoa in the lumen of the tubules in both dogs. Magnification 10 x. Both 
slides stained with MSB. A blue microscope filter was used to take the 
photograph o f the treated dog.
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Figure 28. Histology sections from prostate of a) normal dog, b) beagle dog 
treated with Nafarelin derivative (Baxter). Both samples show functioning cells 
with a full cell cytoplasm. The comparison of both samples does not show much 
difference between the normal and the treated dog. Magnification 10 x. Both 
slides stained with MSB. A blue microscope filter was used to take the 
photograph o f the treated dog.
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Table 13 Protocol for the Nafarelin derivative treatment of an adult male beagle 
(Dexter) treated for 23 days.
Days. Procedure
-5 to -2 Daily bleeding
-1 Bleeding every hour for 6 hours
1 to 23 Daily bleeding
1 to 23 Daily injection of 50 ug. Nafarelin acetate
-7, +7, 14, 21 Semen collection, genitalia evaluation and 
body temperature taken.
143
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Table 14. Presents details o f the clinical findings in the external genitalia in 
Dexter, in whom the Nafarelin acetate was administered by daily subcutaneous 
injections for 23 days. Temperature and weight remained within the normal limits 
with no major changes. Notice the slight decrease in testicular size and 
consistency changes towards the end of the 23 day treatment period. The only 
apparent change was in the testicular consistency o f the gonad at the end of 
treatment.
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Table 15. The libido of this animal (Dexter) was normal (3) but only in the 
presence of a teaser bitch. The first ejaculate was collected on the same day that 
treatment started, and was collected before the first injection was given. Note that 
only one drop of ejaculate was produced 21 days after start o f treatment, but the 
libido score was normal (3) with a prolonged erection.
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Figure 29. This figure presents the hourly bleeding period undertaken prior to 
treatment and shows LH values which ranged between 3.31 to 7.64 ng/ml with 
testosterone showing variations in the range of 5.35-15.36 nmol/1 within the 6 
hour period. This window is indicated in figure 30 (w).
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Figure 30. The hormonal profile of this dog (Dexter) shows the normal levels of 
both LH and testosterone before treatment started. Note the high testosterone 
levels on the day the first of the 23 daily subcutaneous injections was 
administered and the sharp decline 4 days later.
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Figure 31. Histological sections of the testes from a) normal dog b) beagle dog 
treated with Nafarelin acetate (Dexter). In the normal dog, the seminiferous 
tubule has a very uniform arrangement and the e^dence o f ongoing 
spermatogenesis is indicated by the presence of a full germ cell complement with 
clearly identified spermatids (indicated by arrows) around the lumen of the 
tubules. These have begun to disappear in some of the treated seminiferous 
tubules but where some spermatids can still be seen (see arrows). Magnification 
10 x. Both slides stained with MSB. A blue miscroscope filter was used to take 
the normal dog photograph.
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Fig. 32. Histological sections of the body of epididymis from a) normal dog, b) 
beagle dog (Dexter), treated with Nafarelin acetate. Notice a few empty spaces in 
between the cells in the treated beagle which gives it an irregular appearance, 
whereas in the normal dog the cells have a very even and uninterrupted 
arrangement.
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Figure 33. Histological sections o f prostate from a) normal dog, b) beagle dog 
(Dexter) treated with Nafarelin acetate. Notice that the size of the alveoli in the 
treated dog look smaller and there is an increased amount of connective tissue 
indicative of a slight atrophy in the treated animal in comparison with the very 
wide lumina in the normal dogs. Note also the presence o f abundant section in 
the lumen of the alveoli in the normal dog whereas in the treated uog it is absent. 
Magnification 10 x . Both slides stained with MSB
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Figure 34. A slight decrease in the measurements of the prostate can be 
appreciated in Dexter's ultrasonographs There is a 0.1 cm difference in both 
length and width between those taken on June 12th and those taken 13 days later 
on the 25th.
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Table 16 This table presents the testosterone concentrations in blood samples 
taken from both the jugular and testicular veins from a control group. Baxter and 
Adam which were treated with Nafarelin derivative and Dexter which was 
treated with Nafarelin acetate. The mean found in testicular veins is 62.8 ±30.5 
nmol/1 which means that the 0.3 nmol/llevels found in the treated dogs, is well 
below the lowest limit of 32.3 nmol/1 And the jugular vein testosterone levels of 
12.2±6.47nmol/l means that the 0.3 nmol/1 levels found in Adam and Dexter are 
below the lowest limit o f 5.73 nmol/1. Note that Baxter who had treatment 
problems has jugular levels similar to those in control animals.
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4 DISCUSSION
In order to achieve long term suppression of LH and testosterone by 
administering GnRH agonists, the treatment would appear to require to be given 
in a defined amount on a daily basis (Auclair et al. 1977; Conn, 1986; 
Handelsman and Swerdolff, 1986; Vickery, 1986). Initially, it appeared 
that the use of subcutaneous pumps would be the ideal method to use as they 
removed the need for daily administration and the amount released was reported 
to be at a slow, consistent rate (Concannon et a l 1988; Concannon, 1989) 
reported that this was an efficient method for administration of such drugs in 
bitches over an extended period
However, in Baxter, who was one of the first three dogs in which this method 
was attempted, problems arose as can be seen in Table 11. These included 
allergic reaction, irritation and oedema around the site of insertion of the pump 
and it was assumed that these changes were preventing the drug from being 
absorbed as desired Furthermore, preliminary results of circulating plasma 
LH concentrations indicated that no suppression of this hormone was being 
achieved in either of the first two dogs (Baxter and Adam) treated by this method 
(Figures 16, 17, 24, 25). It was not possible to determine whether this lack of 
suppression was due to an insufficient amount of drug being given or to faulty 
use of the subcutaneous pumps. With more experience, the use of the
osmotic pumps could have proved successful. However, economics and the 
lack of available research animals made it impossible for this sophisticated 
method to be successfully adopted
In the case of Baxter (Table 10) who had the problems, it was decided to 
terminate the experiment and determine whether the treatment given had resulted 
in any identifiable changes in the genital tract from histological examination of 
sections from testes and epididymides obtained at post-mortem examination 
(Figures 26 and 27). With regard to Adam (Table 8), it was decided to 
continue administration of the agonist by daily subcutaneous injections, whereby 
the amount given could be controlled The animals subsequently treated this 
way showed neither physical nor physiological reactions to this approach.
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Pre treatment blood samples were collected in the three animals (Figures 15, 23, 
29). The baseline levels of LH show a very flat profile where the amplitude of 
the oscillations is very similar in all the samples, whereas the testosterone shows 
a slightly higher amplitude and shorter frequency pulses. Both hormone levels 
in normal dogs have been mentioned in section A and the concentrations found in 
these pre treatment samples are within the reported range.
When treatment with an increased amount of the drug was administered by 
subcutaneous injection both to the remaining dog already treated by osmotic 
pumps (Adam, Table 7) and one other dog (Dexter, Table 13) the circulating 
plasma testosterone and LH concentrations subsequently dropped . This 
occurred almost immediately after commencing the injections in Adam (Figures 
16 and 17). In Dexter, who only received treatment by injection (Table 14), this 
happened some 4 days after the injection (Figure 30) a similar finding to that of 
Vickery et al. (1989). The very rapid response in Adam was probably due to the 
cumulative action of the drug from the subcutaneous pumps, which in 
conjunction with the additional amounts given by injection brought about the 
marked reduction in the circulating plasma hormone concentrations.
Maddocks and Sharpe (1988) suggested from work in the rat that the circulating 
plasma concentrations of testosterone need not necessarily be related to the 
situation at testicular level. Their results indicated that the testis maintained the 
amounts of testosterone necessary for its requirements and only released the 
surplus into the general circulation. However, the amount of testosterone 
required for the continuation of spermatogenesis has as yet not been established 
(Sharpe, 1987). In a later report, Sharpe, et al. (1988) indicated that to maintain 
normal spermatogenesis, testosterone levels must be at least 24-46% of the 
concentrations normally found within the testis, but it is argued by the same 
workers that these levels could be underestimated (Sharpe et a l 1988). Were this 
aspect determined, then obviously the manipulation of spermatogenesis and male 
fertility would become much more accessible.
In an attempt to identify changes in the concentration of testosterone at testicular 
level, blood samples were collected from the superficial testicular veins 
(Maddocks and Sharpe, 1988) just prior to euthanasia in the treated animals and 
before castration in the control dogs (Table 16). However, in the existing 
circumstances where collection of semen was an essential part of the work, it was 
not possible to collect similar testicular blood samples prior to the
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commencement of the studies. It was not possible to say therefore whether there 
was any real evidence of a change in the amount of testosterone in the testicular 
veins following the treatment givea However when comparing the results from 
the normal dogs, it would appear that there was indeed a drop in the amount of 
testosterone being produced, as the concentrations were markedly lower in the 
blood samples from the treated animals than from those of the normal dogs 
(Table 16). Whilst levels in spermatic venous blood (62 8 + 30.5 nmol/1) in the 
normal dogs, the 0.3 nmol/1 values in the treated animals are markedly below the 
lowest normal value in the untreated dogs. The same applies to the findings in 
the jugular vein values.
There were also individual variations in these testicular testosterone values, 
similar variations in human testicular testosterone production have also been 
reported by Qureshi and Sharpe, (1993). These testicular blood concentrations in 
comparison are similar to those recorded in the rat where the higher testosterone 
concentrations were also found in the testis by Maddocks and Sharpe (1988) with 
spermatic venous blood levels of 269.50 + 30.63 nmol/1 and in the circulation 
4.55 + 0.55 nmol/1. The decrease in circulation levels due to dilutioa However 
it also indicates that a high testosterone environment is required by the testicle to 
maintain the ongoing spermatogenesis function of the seminiferous tubules.
The first indication that the administration of the agonist by s/c injection was 
potentially affecting each dog’s fertility was a decrease in the volume of 
ejaculate. This tended to be accompanied by changes in testicular size and 
consistency, but libido was not affected in either dog. This was similar to what 
happened with the dogs given MPA and the explanations presented there would 
apply in this situation.
During both types of treatment namely MPA and GnRH agonists, difficulties 
were experienced in recording changes in external genitalia The method devised 
for measurement of the testes was not very precise, especially when the gonads 
began to lose their resilience and became flabby. At this point it became difficult 
to hold the measuring tape around the testicle without applying such pressure as 
to introduce a variation in the measurements recorded However, in Adam, 15 
days after initiation of the subcutaneous injections of the agonist, the change in 
the gonads was veiy obvious, this being more of a change in the consistency of 
the testicle, which by then had become flabby (Table 7).
164
Ch a pter  2-b
The consistency of the testes depends mainly on the cellular content of 
seminiferous tubules but partly on its fluid content which comprises blood 
supply, the fluid contained within the seminiferous tubules. An interesting 
finding at the end of the treatment was that the testes appeared paler than normal 
and the blood vessels on their surface were much less obvious and reduced in 
size, when compared to those of normal male dogs. Thus, these small flabby 
testes appeared to have a reduced blood supply which would reduce the amount 
of LH reaching the Leydig cells and this particular find agrees with some studies 
where it is suggested that testicular weight and blood flow are closely associated 
(Wang et a l 1983; Damber et a l  1985; Boujrad et a l  1992; Steele and Leung, 
1992; Leung and Steele, 1992; Verhoeven et a l 1992). This in turn would 
affect the transfer of fluid to the interstitial tissue. As the communication 
between Sertoli and Leydig cells is through the interstitial fluid, the amount of 
testosterone transferred to the seminiferous tubules, especially to the Sertoli cells, 
would be less than normal, thereby affecting their function. This would 
subsequently result in ever decreasing amounts of testosterone being produced by 
the Leydig cells and eventually producing a cessation of spermatogenesis.
Sertoli cells are also involved in the production of ABP which transports the 
necessary testosterone to the epididymis and also produces the fluid which carries 
both the ABP and the immature spermatozoa forward into the epidiymis. This 
could explain the changes which were recorded in the only clinically palpable 
part of the epididymis the tail, which became less and less easily palpable as 
treatment continued such, that by the end of the study, this aspect of the male 
genital tract was almost indiscernible in both dogs. Therefore the changes 
recorded, other than that of libido, would tie in with the decrease in circulating 
plasma LH and testosterone.
During treatment, although libido was maintained, the volume of ejaculate 
decreased such that by the end of the treatment, only a few drops were expelled. 
These findings would suggest that as well as cessation of spermatogenesis, a 
decrease in the production of seminal plasma was also taking place. Several 
possible explanations for this finding need to be considered. Firstly, that there 
was reduction in the amount of fluid being produced in the seminiferous tubules 
by the Sertoli cells, which transports the sperm into the epididymis. This could 
have happened because of the treatment affecting these cells as well. Even 
though only LH was actually measured the desensitization effect of the pituitary
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by the GnRH treatment would also affect the release of the FSH required by the 
Sertoli cells to function properly.
Another possibility could be that there was either a reduction in the amount of 
fluid produced by the epididymides themselves, or an occlusion at this level 
caused by cell debris or dead sperm, which reduced the passage of fluid. The 
epididymis depends on testosterone to function properly, (Moore and Bedford 
1979; Lobl et al. 1983) and as the levels of testosterone had indeed been affected 
by the treatment it may explain the fact that when attempting to make smears of 
the epididymal sperm in the same way as with the MPA dogs, which was done by 
gently pressing the epididymis and extracting the epididymal fluid over glass 
slides it was not possible in the case of the the GnRH treated dogs, as the 
epididymis sections were apparently dry.
Finally, as most of the seminal plasma is produced by the prostate, these findings 
would tend to indicate abnormal prostatic function. This would appear to be the 
case as the prostate histological sections (Figures 21 and 33) showed that both 
Adam and Dexter had an atrophied gland, with the lobules of the prostate shrunk 
in size, the secretory cells hardly visible and there was an increase in connective 
tissue around the alveoli. However, in Baxter similar changes were not observed 
in any of the histological preparations (Figure 28).
Attempts to monitor the changes in the prostate during treatment, and to associate 
these with the reduction in the production of seminal plasma, were made by 
carrying out ultrasound scanning of this region at frequent intervals during the 
experimental period. Again, experience is required in devising the best method 
of measuring and recording the various parameters of this organ in order to 
accurately determine meaningful changes. Making certain that the same aspects 
were being compared on the different occasions proved difficult and time 
consuming. However, in both dogs there did appear to be a reduction in the size 
of the prostate by the end of the treatment period (Figures 22 and 34). 
Because of this effect on the prostate, GnRH agonists have been used as a 
treatment both of benign prostatic hyperplasia in the dog to produce the 
regression of the gland (Vickery, et a l 1982; Dube et a l 1984). And in man 
for in the treatment of prostatic cancer (Atala and Amin, 1991; Chrisp and Goa, 
1990; Prevost et a l 1993; Harris et a l 1993; Kakar, et a l 1992).
In order to investigate the role of the epididymis in the decrease of ejaculate, the 
alkaline phosphatase content of the ejaculates were evaluated Alkaline
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phosphatase is produced mainly in the epididymis with smaller amounts 
produced by the testes and prostate (Frenette et a l 1986). Olson (1991), used this 
information to detect abnormalities or obstructions in the epididymis, whereby 
any dramatic drop in 27,000 iu/L levels in the alkaline phosphatase contents of 
the ejaculate, would indicate a problem in the epididymis. However, in that 
report, the actual method by which alkaline phosphatase was measured is not 
indicated and in the present work the levels obtained were 10 times higher 
(Tables 8,11,14) than those reported by Olson. There are several methods of 
analysing this enzyme, which use different temperatures when processing the 
samples, so it would seem that the differences found in this work and Olson's 
may be due to the temperature treatment, the samples in the present studies being 
processed at 37°C. Therefore, the results presented here cannot be compared to 
Olson's as far as the actual amounts are concerned, but the fact that any drop 
from the pre-treatment levels would indicate a problem and could be used for a 
comparison in this case.
No drop in the concentration of alkaline phosphatase was found in any of the 
ejaculates examined from Baxter or Adam (Tables 9 and 12). However in 
Dexter, there was a very low concentration of alkaline phosphatase in the 
ejaculate collected eleven days after initiation of the treatment (Table 15). This 
animal would only allow collection of semen when in the presence of an oestrus 
bitch and so, the number of ejaculates obtained were fewer (Table 14) than in 
Adam and Baxter who did not require much training (Tables 9 and 12). Thus, no 
further results of the alkaline phosphatase concentration in the ejaculate of this 
animal are available, as only one further collection was possible, and that was 
obtained towards the end of the experimental period when only a few drops of 
ejaculate were expressed. This was not sufficient to carry out any laboratory 
tests. However, in this particular case it may indicate that the reason why the 
alkaline phosphatase was so low was not due to an obstruction of the epididymis 
but more to a lack of fluid arriving from the rete testes, because of an impaired 
Sertoli cell function as previously suggested.
Before commencing the treatment, the initial clinical examinations of the external 
genitalia of the three dogs revealed no major abnormalities. However, in one of 
the dogs (Adam), a percentage of sperm with curved mid pieces (Figure 20) was 
noted on the several occasions that semen was collected. This type of 
abnormality is not one commonly reported in the dog although there is a 
published photograph of one such sperm (Allen et al 1979). As the abnormality
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apparently did not affect the morphology of the sperm in that the attachment of 
the head and neck seemed normal, it would appear that this change in the sperm 
occurred after spermiogenesis or during maturation in the epididymis. The 
degree of curvature was such that those particular sperm were not capable of 
achieving normal progressive motility rather going round in circles. As there 
were repeatedly high percentages of this type of sperm in this animal's ejaculates, 
he should perhaps have been excluded from the experimental programme. 
However, it was decided that as he was both amenable to collection of semen and 
was an easily handled animal, he was included in the treatment It also seemed 
possible that the treatment might produce some interesting and enlightening 
findings on spermatogenesis and/or changes in epididymal histology. During the 
treatment period, the frequency of these abnormal sperm did not appear to 
increase (Table 8) except that in some sperm the neck appeared to be close to 
breaking. No other obvious type of abnormality was seen in the ejaculates 
obtained from the other two dogs, either prior to, or during the treatment period 
(Tables 12 and 15).
Histological examination of sections from the testes of Adam and Dexter 
revealed that in both cases spermatogenesis had been affected to varying degrees 
(Figures 18 and 31). In Baxter who had only received treatment with the osmotic 
pump and in which there had been no apparent decrease in circulating plasma 
testosterone or LH concentration, there was no real evidence that 
spermatogenesis had been affected, as sperm was still present in the last ejaculate 
prior to sacrifice (Table 12).
In Adam and Dexter, who became azospermic before treatment was stopped, the 
degree of change present in their seminiferous tubules was not uniform. In 
Dexter (Figure 31) some tubules were devoid of most of the germ cell stages, 
containing only Sertoli cells and spermatogonia, whilst others contained various 
stages of developing cells. However, only a few elongated spermatids and 
secondary spermatocytes were seen in any of the sections examined. On the 
other hand in Adam who had been treated the longest, all the tubules were 
affected to the same degree, as these seminiferous tubules are almost totally 
devoid of germ cells, except for the presence of the spermatogonia closer to the 
basal membrane and the Sertoli cells (Figure 18). The degree of spermatic arrest 
was obviously determined by the length of the treatment period (Figures 18 and 
31). Dube et a l  (1987) reported the presence of seminiferous tubules containing 
only Sertoli cells and spermatogonia and only a very few primary spermatocytes,
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following four months treatment with GnRH agonist A similar atrophy to the 
seminiferous tubules in dogs was also reported by Labrie et a l (1985). However, 
these spermatogonia apparently are in a state of suspended animation and are 
capable of resuming spermatogenesis, even after treatment lasting for at least a 
year (Vickery et al. 1984; Vickery et al. 1989). Thus, treatment with GnRH 
agonists appears to be reversible (Sandow et al. 1980; Dube et a l  1987; Cavitte, 
etal. 1988).
Several reports (Parvinen, 1982; Sharpe, 1983; Parvinen et a l 1986), outlined the 
intricacies and the particular requirements of each stage of the spermatogenic 
cycle. A mini-environment is created around each seminiferous tubule which 
depends on the interaction of germ, myoid and Sertoli cells inside the tubule and 
which varies according to the stage of the cycle taking place at a particular time 
(Ritzen, et a l  1981; Kasuga, et a l  1989; Ojeifo et a l 1990; de Kretser, 1990) 
It is these requirements which are transmitted to the Leydig cells in apposition in 
the interstitial tissue.
The need for a local mechanism must first consider that the seminiferous tubules 
lack blood vessels to directly supply their needs and that therefore they must rely 
on the interstitial blood vessels to do so. However, the continuous transformation 
of germ cells in the tubules which demands the creation, of a mini environment 
around each particular stage of the seminiferous cycle, which must be constantly 
changing to adjust to the tubule's ever-changing demands. Such requirements 
would need a faster mechanism than that provided by the general circulation 
(Sharpe, 1983; Sharpe and Cooper, 1983; Spiteri et a l 1993).
Evidence that such a local control exists and is provided by the interaction 
between the seminiferous tubule and the interstitial tissue is suggested by earlier 
work showing that Leydig cell cultures increased their testosterone production 
when they were co-cultured with Sertoli cells, or with cell medium removed from 
Sertoli cell cultures (Papadopoulus et a l  1987). Other evidence suggested that 
Sertoli cells could convert androgen precursors into oestrogen in the absence of 
Leydig cells. In rats oestrogens reduced testosterone synthesis independently of 
LH, which pointed to the possible role of oestrogens as the mediator between 
Sertoli and Leydig cells (diZerega and Sherins, 1981). However, more recent 
information arises from studies on the effects on the germ cell stages of androgen 
withdrawal caused by Leydig cell destruction. The observed damage was a 
shrinkage of the nucleus of cell in stages VII, IX and XI, which began to return to
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their normal size within two days after supplementation with testosterone (Kerr, 
Millar, Maddocks and Sharpe, 1993). A similar experiment showed that the 
withdrawal of androgens altered the Sertoli cell junctions by dilating the 
intercellular spaces, but without alteration to the tight junctions (Kerr, Savage, 
Millar and Sharpe, 1993).
There is evidence that stages VII and VIII are under androgen control (Parvinen, 
1982), but some researchers believe that testosterone acts only at stage VII 
(Sharpe 1990). Thus, if testosterone production is suppressed, the tubules 
containing these stages of the spermatogenic cycle, namely pachytene 
spermatocytes, round and elongated spermatids, would tend to be the first tubules 
to show signs of degeneration (Figures 18 and 31). Such tubules would thus be 
seen only to contain developing cells, up to the primary spermatocyte stage. 
Furthermore Parvinen, (1982) and Sharpe (1990) indicated that FSH requirement 
of the Sertoli cells is highest in the earlier stages, I to V, and as the treatment 
used suppressed both gonadotrophins, this could explain the appearance of the 
tubules in which this was the situation. It would have been of interest to 
determine the concentration of FSH in both the testicular vein blood samples and 
the circulating plasma in these dogs, but this was not undertaken in the studies 
reported here.
Histological examination of sections from the epididymides and sperm therein 
contained, did not reveal the more dramatic changes which were seen in the dogs 
treated with MPA (Figure 8). Although some vacuolization of the epithelial cells 
lining the epididymis (Figures 19 and 32) in all areas was seen, it was nothing 
like the marked degree seen in the MPA treated dogs.
These findings in the dogs treated with the GnRH agonist would tend to support 
the hypothesis, presented in the case of the MPA dogs, that the changes in the 
epididymal sperm removed from the MPA treated dogs were due to the 
progestogens having a direct action on the epididymis .
These preliminary experiments with live dogs served to identify a suitable drug 
for manipulation of spermatogenesis and the best route of administratioa It 
also identified the best parameters to be monitored during such studies and 
formed a basis for further studies of the histological changes which can be 
expected to occur at testicular level when such treatment is used. They also 
provided information regarding the effects of GnRH agonist in the hormonal 
profile and in the tissue changes in their reproductive organs which was part of
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the aim of this section. However, in order to find out more about the role the 
Leydig cells played in causing these changes, it was necessary to work directly 
with the cells themselves isolated from the interstitial tissue, as this has been the 
approach used by researchers studying Leydig cell function (Dufau et al. 1974; 
Janszen et a l 1976; Conn et al. 1977; Payne et al. 1980; Hsueh, 1980; 
Browning et al. 1981; Rommerts et al. 1982).
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CHAPTER 3
ISOLATION AND CULTURE OF LEYDIG 
CELLS
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1. INTRODUCTIO N
Preparations of freshly isolated Leydig cells, obtained from the testis of both human 
males and animal species, mainly rat and mice, have been used extensively in the 
investigation of testicular function (Conn, et al. 1977; Browning, et al. 1981; 
Browning, et al. 1983; Aquilano & Dufau, 1984; Bhalla, et al. 1987).
Many techniques have been developed, to isolate, purify and identify Leydig cells in 
the above mentioned species. However very little similar work has been reported to 
any extent in the dog.
The purpose of this work was to attempt to develop the necessary techniques that 
would allow similar work to be done in dog Leydig cells.
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2. M ATERIALS AND M ETHODS_________________________________
2.1. TISSUE COLLECTION
Rats and mice.
Testes from rats and mice were obtained immediately after euthanasia and transported 
to the laboratory for immediate processing.
Dogs.
Testes removed at castration were transferred to the laboratory where they were 
immediately placed in plastic lidded containers and covered with swabs moistened 
with normal saline until they were processed.
2.2. FREEZING OF TESTICULAR TISSUE;
Method 1.
5 Centimeters, cubes of testicular tissue were placed in labelled cryotubes and plunged 
into liquid nitrogen where they were stored until required for processing.
Method 2.
5 Centimeters, cubes of testicular tissue were placed in labelled cryotubes containing 
Medium 199 with Hanks salts, L-glutamine and 24 mM Hepes (Gibco BRL UK) and 
then stored in liquid nitrogen until required for processing.
Method 3
5 Centimeters, cubes of testicular tissue were placed in labelled cryotubes containing 
M l99 plus 1.5 Dimethyl sulfoxide (DMSO) and immersed in liquid nitrogen, where 
they were stored until required.
Method 4
Testicular homogenates (see below) were placed in labelled cryotubes containing 
Medium 199 with Hanks salts, L-Glutamine and 24mM Hepes. (Gibco BRL UK) and 
immersed in liquid nitrogen in which they were stored until required.
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2.3. THAWING:
Method 1.
Without removing the frozen pieces of testes from the cryotubes they were left to 
thaw at room temperature.
Method 2.
Without removing the frozen pieces of testes from the cryotubes they were placed in a 
beaker o f water at 37°C for two minutes, or until thawed.
Method 3.
Without removing the frozen pieces of testes from the cryotubes they were placed in a 
beaker of water at 32°C for two minutes or until thawed.
Method 4.
Without removing the frozen pieces of testes from the cryotubes they were left to thaw 
at refrigeration temperature of 4°C.
2.4. TISSUE DISSOCIATION. 
lst.method.
A 2 cm cube of fresh testicular tissue was placed in a Petri dish containing Hepes 
medium (Gibco Life Technologies Ltd, Paisley Scotland). The dish was placed on a 
hot plate and the collagenase added in very small quantities at a time, until dissociation 
was obvious.
2nd Method.
Required cell medium preparation
Reagents
100 ml Cell culture medium 
199
(ICN Flow Herts UK)
•05 g. Bovine serum albumin Sigma Chemical Co. Ltd. Dorset England
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1 ml 200 mM ><II
'w' Gibco Life Technologies, Paisley Scotland
Glutamine UK
Medium B.
40 ml Medium A Sigma Chemical Co.Ltd D
Dorset England.
.800 ml Trypsin inhibitor 99
57 mg Collagenase C-9881 99
Tissue dissociation procedure:
Testicular tissue was cut into small pieces with scissors and approximately 2 grams 
were then placed in universal bottles containing 6 ml medium B. The universals and 
contents were placed in a shaking water bath incubator (Gallenkamp, Fisons Scientific 
Equipment, Loughborough, England) at 37° C at a speed of 80 cycles until all tissue 
had been dissociated. The solution was then filtered through a mesh filter of 45 um 
pore diameter (Millipore, UK Ltd, Research Park Riccarton, Edinburgh), centrifuged 
at 500 g for 10 minutes (Figure 55).
Third method
After thoroughly drying the testes (in the rats and mice) and removing all traces of 
blood, the whole testes were decapsulated. In the dog, two circular incisions were 
made around the middle of the testicle and the capsule was removed from this by 
holding the cut edge of the capsule from one side with a needle and scraping the 
testicular tissue off with a scalpel blade. The tissue was then cut into 12 segments of
0.5 g ea. Two pieces of the tissue were then placed in universal bottles containing 7 ml 
of medium B.
The universals and contents were placed in the shaking water bath incubator 
(Gallenkamp, Fisons Scientific Equipment, Loughborough, England) at 37° C and a 
speed of 80 cycles and left until in the rat the thread like tubules were seen to have 
separated. In the dog, when the tissue had dissolved into a thin homogenate with no 
large lumps, the bottles were removed from the water bath. To stop the digestion
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process, cold medium A was added to fill the universals and then the mixture was 
allowed to stand for 10 minutes to allow settling of debris to the bottom.
The supernatant was then decanted and passed through a nylon mesh to eliminate the 
debris and then the solution was passed through an 80 um filter (Millipore, UK Ltd, 
Research Park Riccarton, Edinburgh). Both filters were washed with additional 
medium A, to free any cells retained in them. Additional medium was also added to 
the debris that had settled in the bottom of each universal bottle, and filtered again. 
The resulting filtrates were centrifuged for 10 minutes at 800 g.
The resulting pellets were resuspended in 0.5 ml of medium A by drawing them in and 
out of a Pasteur pipette, the additional 4.5 ml of medium A was added. This final 5 ml 
was used for the Percoll gradient purification
2.5. CELL VIABILITY AND IDENTIFICATION
1st. Method.
The identification of cells resulting from the 1st. method of tissue dissociation (see 
below) were stained with Diff Quick staining set (Baxter, Dade. Thetford, Norfolk 
England). Smears were made by placing a drop of the tissue homogenate on glass 
slides (Gold Star, Chance Propper Ltd. England), left to dry at room temperature, and 
then fixed and stained according to the manufacturer’s instructions. However this 
method was just used for the initial crude collagenase tissue dissociations.
2nd. Method.
A small volume (10 ul) of cell suspension was added to an equal volume of 0.4% 
trypan blue in 0.9% saline 10 ul of this solution was placed in a hemocytometer 
chamber (Newbauer, Weber, England ) and viewed under a light microscope. Cells 
excluding the dye were considered to be live, and were therefore counted.
Third Method.
The cells were prepared with the trypan blue as above but were viewed under an 
Olympus BH2 phase contrast microscope. Cells excluding the dye and showing the 
bright yellow halo around as reported by Schumaker et al (1978), Joffre et al. (1984), 
Gale et al. (1982), Hunter et al. (1982) were considered to be live Leydig cells and 
were therefore counted as such before culture.
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Viability and identification was performed at various stages of the cell purification 
process in order to determine whether damage was occurring to the cells at each step.
1. After collagenase dispersion.
2. After each rinsing before placing in the Percoll gradient.
3. Using each band collected from the Percoll gradient.
4. After rinsing the Percoll off the cell suspension.
5. During different incubation times.
2.6. CELL PURIFICATION BY PERCOLL GRADIENT
Method A. Continuous gradient.
Continuous gradient was prepared by the method described by Schumacher, Schafer, 
Holstein and Hilz (1978) with some modifications, as follows.
1.- Preparation of solutions
2 -  Gradient Preparation
3.- Pump loading.
Reagents
For the following solutions the reagents were purchased from Gibco Life 
Technologies, Ltd., Paisley Scotland UK.and from Sigma Chemical Co. Ltd. Dorset 
England
Solution preparation
Solution 1
10 ml
10 fold concentrated. Earl’s balanced salt 
solution.
7 mg BSA
2.4 mg Hepes 20 mM A
1 7 8
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Solution 2
To 1 part of solution 1 add 9 parts of Percoll to make Percoll solution.
Solution 3
20 ml Earl's balanced salt solution
0.07 g. BSA
Solution 4
To 9 ml of 2nd solution add 1 ml of 3rd. solution
Pump preparation
Pump used was a LKB Bromma 2120 Varioperpex II (LKB Bromma Sweden)
Rinse pump wells with distilled water.
Solution 3 is placed in the left pump well 
Solution 4 is placed in the right pump well.
The hose is placed against the tube wall and held there until the whole gradient is
finished, the density of this gradient is 0-90 %. The cell suspension is then placed in
top of the gradient and centrifuged at 3000 g for 30 minutes.
Collecting cells from the gradient:
A cannula attached to a syringe was placed in the centre of each band, collecting the 
topmost layer first, and in the same way proceeding to collect the others
Rinsing Percoll off the cells
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Each collected band was then transferred to a 14 ml centrifuge tube, to which more 
medium A was added. The tubes were then centrifuged at 800 g for 10 minutes, the 
supernatant was removed. The resulting pellets were collected from all the tubes by 
rediluting in 0.5 ml medium and transferred to a 14 ml centrifuge tube, which was then 
filled with A. medium and centrifuged again for 800 g for 10 minutes. The supernatant 
was removed and the resulting pellets were collected from all the tubes by rediluting in 
0.5 ml medium and rediluted again for cell culture. After this procedure the cells were 
ready for the next step of culture or staining.
METHOD B. Discontinuous gradients:
1st. Method.
This method as described by Simpson, Wu and Sharpe, (1987) was used with some 
modifications.
Medium B. Isotonic Percoll.
2.5 ml Medium A (as described before).
22.5 ml Percoll, density 1.13 +- 0.005 (Pharmacia 
LKB, Biotechnology, Uppsala Sweden).
Gradient preparation.
Formula 1
No. Density Isotonic Percoll (ml.) Medium A (ml)
1 1.00 0 10.0
2 1.03 2.55 7.45
3 1.05 4.3 5.7
4 1.07 6.0 4.0
5. 1.09 7.7 2.3
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The following formulas were variations of this first formula
Formula 2.
No. Isotonic Percoll (ml) Medium A (ml)
1 1 9
1 9
2 2 8
3 3 7
4 4 6
5 5 5
Formula 3
No. Isotonic Percoll (ml). Medium A (ml).
1 6 4
2 7 3
3 8 2
4 9 1
5 10 0
Formula 4
No. Isotonic Percoll (ml) Medium A (ml).
1 7.7 2.3
2 6.0 4.0
3 4.3 5.7
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4 2.55 7.45
5 0 10.0
2.7. GRADIENT PREPARATION
Material required for gradient preparation.
50 ml Plastic centrifuge tube Greiner Labortechnik, Ltd.( Dursley UK)
12 Ga X 2” Intravenous cannula Aloe Medical Mfg. (St. Louis Mo. USA)
10 ml. Syringe
Preparation of gradient.
The loaded syringe with the cannula attached was placed firmly in the bottom of the 
tube and the Percoll concentrations starting with no. 1, were deposited by slowly 
pushing the syringe plunger.
Cell purification
5 ml were removed from the topmost layer of the prepared gradient to make room for 
the 5 ml of cell suspension that was placed on top. The tube containing the gradient 
and the cell suspension was then centrifuged at 3000 g. for 30 min.
Collecting cells from the gradient:
The cell bands were collected from the gradient with the same type of material as used 
for setting the gradients, but for each band a different syringe and cannula were used. 
The cannula was placed in the centre of each band, thus collecting the topmost layer 
first and, in the same way, proceeding to collect the others.
Rinsing Percoll off the cells.
As indicated before.
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2.8. HISTOCHEMISTRY 3 
HSD
First method
The method used was as described by Lobl and Levy (1968) and modified by 
Salaheddine (1993)
All reagents were purchased from Sigma (Chemical Company Ltd, Poole, Dorset, 
England),
First the following five stock solutions were prepared .
Solution 1
6.35 g. Polyvinyl pyrrolidone (PVP)
45 ml 0.1 M Phosphate buffer pH 7.4
Solution 2
20 mg Nitro-tetrazolium blue
20 ml Distilled water.
Solution 3
30 mg B- Nicotinamide Adenosine Dinucleotide 
(NAD)
5 ml Distilled water
Solution 4.
15 mg 5-androsten 3B-ol7-one
5 ml Dimethyl formamide
Solution 5.
30 mg NADH-2 (Grade III)
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5 ml Distilled water
These solutions were stored at 4o C for up to 2 weeks as this was found not to 
interfere with the reactions when compared with freshly made solutions. Final 
incubation media contained:
Incubation medium is made up of
Solution 1 4.7 ml
Solution 2 2.0 ml
Solution 3 1.0 ml
Solution 4 0.3 ml
Staining procedure for cell preparations.
10 ul cell suspension samples were placed in a glass slide and dried at room temperature 
and stored at 20° C .
Slides were stained by adding drops of the incubation medium to the previously 
prepared slides, and an equal number of slides were stained with solution 5 to verify the 
presence of the 3pHSD enzyme.
2.9. CELL CULTURE 
Material used.
24 & 12 multiculture dishes
60 x 15 mm individual bacteriological Petri dishes
140 x 20 mm individual bacteriological Petri dishes
The culture dishes were from Nunc, Flow Laboratories, Herts England.
Cell culture medium M l99 with 25mM Hepes, Earle's salts and L-Glutamine, from 
(Gibco BRL, Life Technologies, Ltd., Paisley, Scotland UK.)
Procedure
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Not all the wells were used but the ones that were, were filled with 1 ml medium + lul 
cell suspension. To avoid evaporation during incubation some wells were filled with 
distilled water which were interspersed in between the wells containing cells. This 
measure reduced evaporation considerably.
The multi well culture dishes were changed to individual 60 x 15 mm bacteriological 
Petri dishes 3 each of this dishes were placed in a larger Petri dish 140 x 20 mm, the 
bottom of these larger dishes was covered with distilled water.
Incubation.
Initially the cultures were incubated in a LTE incubator (Laboratory Thermal 
Equipment Ltd, Greenfield, NR. Oldham UK) at 37°C.
This was changed to 32 °C and incubated in an automatic C 02’ model 160 incubator 
(ICN, Flow Laboratories, Herts England).
Third step, examination of the cultures.
Initially 100 ul aliquots were removed from the dishes and viewed under the light 
microscope. But this was changed to examination of the culture dishes with an 
inverted Will-Wetzlar GMBH-D-6330-21 microscope (Wetzlar W. Germany).
Fourth step, viability evaluation.
The evaluation of viability was initially made by removing small aliquots of the cell 
suspension after 3, 5, 8 hours, stained with trypan blue to verify viability in the light 
microscope. Also by removing the supernatant and staining with trypan blue the 
bottom of the culture dish to evaluate the viability of the cells that remained in the 
bottom.
As well as by examination of the whole culture dish without removal of supernatant 
under the inverted Will-Wetzlar microscope.
2.10. HORMONE DETERMINATION IN THE CELL CULTURE 
SUPERNATANT
Method used as described in Chapter 2-A.
Except that in these samples the ether extraction step was omitted.
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The limit of detection was 0.35 to 7.0 nmol/1 and was defined from the point where the 
standards CV changes to more than 22%. the interassay coefficient of variance 
calculated from 8 assays was 8.82% at 0.3 nmol/land 18.03 % at 4.0 nmol/1. The intra­
assay coefficient of variance was 6.54% and was assessed by the duplicate samples of 
a randomly selected assay and was calculated by the same method and formula as 
indicated in Chapter 2-A. The repeatability of the standard curve is presented in Figure 
58.
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3. RESULTS
18 7
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Figure 35. This figure presents some of the initial attempts at separating and 
identifying Leydig cells from dog testis.
(a,b,c ). These show different aspects of the cell suspension contents.The three 
smears were stained with Diff Quick and are seen at 100 x magnification.
a) and b) Are an example o f a cell suspension which is not very clean, where 
tissue debris has not been eliminated (t), where there are sperm heads (h), and 
what may be cell nuclei (n) c) Another type of cell that was occasionally 
observed in these initial unidentified cell preparations.
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Figure 36. Fresh cell preparations stained with trypan blue.
a).Notice the dead blue cells in the background, and the unstained cells and 
spermatozoa which appear to be floating in the surface( lOx) b) Shows the detail 
of a whole cell, and a sperm tail (lOOx).
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Figure 37. Represents the attempts at detecting the presence of the 3pHSD 
enzyme. Notice first the indiscriminate staining where everything stains blue, 
debris, cells. The only difference is the variation in staining intensity. Notice also 
that however progressively cleaner the suspensions are, the staining preparation 
continues to be totally blue.
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Figure 38. (a and b). Percoll purified dog Leydig cells showing some 
contaminating spermatozoa and debris in the background forming clumps. Notice 
that the characteristic Leydig cell yellow halo is shared by three different size 
cells, small (s), medium (m), large (1) Phase contrast microscope and stained 
with trypan blue before (magnified x 100).
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Figure 39 (a , b, c.). This figure presents an example o f culture dishes showing 
the varying numbers o f Leydig cell attachment to the bottom of cell culture 
dishes, a), before removal of supernatant. b) and c) after removal of 
supernatant.
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Fig. 40
14irt 
12 ml
10 ml 
8m) 
6ml 
A ml
2m)
V
Discontinuous method.
1.* Large ft medium cells unidentified cells 
and spermatozoa
2.- Large and medium unidentified cells, 
some dead cells, many live spermatozoa.
3.- Erythrocytes.
This is an example of the discontinuous method, notice the cell formation 
between the 1st and 2nd bands. The separation between the bands is not 
very d e a r  and all s izes of still unidentified cells as well as tissue debris 
are found in all the bands.
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Fig. 41
Formula 1
- 5 0
. 4 5
1
2
3
4
5
1 Wide cloudy band, few Leydig cells, many 
germ cells of different sizes, some tissue 
debris.
2.-Thick band, mostly Leydig cells, some 
germ cells, very little tissue debris.
3.- Many live spermatozoa and tissue debris.
4.- Erythrocytes.
5.- Debris.
Fig 41 This is an example of the method of Simpson et al (1987} and it shows 
the number of resulting bands. The first and third bands looked cloudy 
and very close to the second band in which the Leydig cells were found,
but this band was very clean of tissue debris. The cleanest and best 
separated band was the fifth which contained only erythrocytes.
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Fig. 42
- 50
1 .15
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. 35
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Formula 2
1.- Small, medium, large germ cells, many dead 
some sperm, tissue debris
2.- Leydig cells, very clean, the best band.
3.- Very few cells, some Leydig cells, large amounts 
of tissue debris, a few spermatozoa, crenated cells.
Method 2 is a variation of method 1. Notice the difference in cell band 
formation, the 1 st and 2nd bands being very thin. The third band is very 
wide and contained some Leydig cells as well, but there were many 
damaged cells in this band.
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Fig. 43
Formula 3
-501
.45
- 40
2 - 35
•30
.25
. 20
1.- Germ and Leydig cells mixed up, not much tissue  
debris.
2.- Few cells, many erythrocytes.
Formula 3 Is another version off the ffirst method. Only two bands were formed, 
but the germ and Leydig cells were ffound in the sam e band. Even the erythro­
cytes were not clearly separated as their band included tissue debris as well.
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Fig. 44
Formula 4.
.30
.45
1
2
— 30
3
.25
4
1 Germ and Leydig cells In this band 
mixed with cl' ~ p s  of debris.
2.- Germ and Leydig cells in clumps 
also clumps of debris.
3.- Larger clumps of cells and debris.
4.* Erythrocytes.
Formula 4 is  a lso  a modification to the first method. In this gradient all the 
contents of the cell suspension  separated in bands but in clumps of both 
tissu e debris and cells.
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Fig. 45
■ 50
.45
- 40
1
2
3
. 20
4
5
Formula 4
Using one day old refrigerated tissue or 
frozen tissue.
1, 2, 3 Bands very few cells of all kinds, all dead, 
large amounts of debris.
4, 5 Narrow bands, once collected no cells were 
recovered.
This is again formula 4, but using refrigerated one day old tissue, or frozen 
tissue. Noticr F i t  the first bands contained mostly debris and that the few 
cells which were found were dead. Bands 4 and 5 were very narrow. Once 
Percoll was rinsed off, no cells were recovered from the last two bands.
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Fig. 46
1
.13
First method, using a deaner cell 
suspension.
1 Cloudy band, very few cells, some 
tissue debris.
Z.-Thick band, many Leydig cells, dean 
of debris.
3.- Few spermatozoa and some debris. 
4 ft 5 Very thin bands.
This is the first method using a cleaner cell suspension. The Leydig cell 
harvest was very good and the extra cell bands were very thin. Much of 
the contamination by tissue debris and spermatozoa has been eliminated. 
Once Percoll was rinsed off bands 4 and 5, no cells could be recovered.
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Fig. 47
First formula.
.50
.45
- 401
- 35
-30
.25
2
. 20
3
Using a cleaner and more diluted 
cell suspension.
1 •- Leydig cells mixed with small amounts 
of tissue debris.
2 - More Leydig cells, almost no debris
3.- Erythrocytes.
This figure shows the results of using a cleaner and more diluted cell 
suspension. Most tissue debris, spermatozoa and erythrocytes have 
been eliminated. Notice that there are no more cloudy bands and that 
the bands present are very clearly defined.
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Figure 48. This is the actual photograph of a discontinuous gradient as shown in 
figure 47. Notice the width of the first band, in which most of the three sizes of 
Leydig cells were found, with smaller numbers of the same cells in the second 
band. Erythrocytes were found in the third.
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Figure 49. This figure shows the production of testosterone in 3 culture dishes, 
each containing 100 ul o f dog cell suspension after incubation for 24 hours. The 
Leydig cells were still not identified at this stage. For this reason the amount of 
testosterone produced is per 100 ul of cell suspension and not per 1000 cells. 
Notice that although the three dishes have the same amount of cell suspension, 
the testosterone production is not the same, suggesting that they may not contain 
the same numbers of cells.
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Fig. 49.  T e s t o s t e r o n e  p ro d u c ed  by dog cell c u l tu re s
a f te r  incuba t ion  for 24 hours .
nmol / l  pa r  100 ul 
ca l l  s u s p a n s i o n
3
Dish 208
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Figure 50. The results presented in this figure represent the amount of 
testosterone produced in two different culture dishes incubated at different times. 
Again the amount of testosterone is per 100 ul/dish. Notice there is almost twice 
the amount of testosterone after 24 hour incubation than after 12 hours.
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Fig. 50.  T e s t o s t e r o n e  p ro d u c e d  by initial u n t r e a t e d  dog
cei l  c u l t u r e s  i n c u b a t e d  for 12 and  24 hours .
nmot / l  pe r  100 ul 
c t l l  s u s p e n s i o n
2 0  - i -----------------------
12 hours 24 hours
2 Dishes 210
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Figure 51. The results presented in this figure represent the amount of 
testosterone produced in two different culture dishes incubated at different times. 
Again the amount of testosterone is per 100 ul/dish. Notice the increased 
testosterone after 36 hours incubation than after 12 hours.
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Fig. 51. T e s t o s t e r o n e  p ro d u c e d  by u n t r e a t e d  dog cell
cu l tu re s  i n cu b a ted  for 12 and  36 hours .
nmol / l  ( pe r  100 
ul ce l l
s u s p e n s i o n )
12 hours 36 hours
2 Dishes.
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Figure 52. Represents one of the first cell cultures where Leydig cells could be 
counted. Notice that although the cells were counted prior to incubation the first 
supernatants are not uniform in the first supernatant collected,which may be due 
to the presence of cell clumps. The following supernatants also show a great deal 
of variation in their response to the hCG treatment. The first supernatant was 
collected after 8 hours incubation without treatment.
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Fig. 52 T e s t o s t e r o n e  p ro d u c e d  by dog Leydig cell
cu l tu re  during 2 d a y s  of t r e a t m e n t  with 0.15 iu HCG
(Chorulon)
nmol / l  P e r  (10)7 
c e l l s
■
■  D i • h 1 
s  Dish 2
■ Dish 3 
id  Dish 4
Supernatant 214
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Figure 53. This figure presents the results of another experiment following the 
same protocol as fig 52. The first supernatant shows a more uniform testosterone 
amount reflecting more similarity in the amount of cells in the culture as well. 
Notice the increase in testosterone production in the 2nd supernatant which was 
collected 24 hours later In comparison there was a decreased cell response in the 
third supernatant collected 3 hours later. Two interesting points to note are the 
decrease in testosterone production in the 4th supernatant which was collected 24 
hours later and the cell's response to the treatment in the 5th supernatant collected 
3 hours later.
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Fig.53. T e s t o s t e r o n e  p r o d u c e d  by Leydig cell  c u l tu re
during 3 d a y s  of t r e a t m e n t  with 0.15 iu rlCG (Chorulon
nmol/l p«r (10)7 
c • 11 s
0
■ Dish 1 
® Dish 2
■ Dish 3 
m Dish 4
Supernatant
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Figure 54. The results of a 2 day culture are presented in this figure. Notice that 
in the first supernatant the production of testosterone is between 1-3 nmol/1 Per 
1000 cells. Notice dishes 1 and 2 which had levels over 1 nmol in the first 
supernatant, 24 hours later decreased their production to below 0.5 but after they 
were treated they improved on the third supernatant. Whereas dishes 4 & 5 
which had the highest levels initially with increased their testosterone 
production in the 2nd supernatant and maintained it in the third. However dish 3 
with the lowest initial supernatant, increased dramatically on the 2nd and was 
above the initial levels by the third collection.
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Fig. 54.  T e s t o s t e r o n e  p r o d u c e d  by dog Leydig cell
c u l tu re  during 2 day incuba t ion  and t r e a t m e n t  with
0.15 iu HCG (Chorulon)
nmol/l per (10)7 
cells
■ Dish 1 
s  Dish 2
■ Dish 3 
id Dish 4
■ Dish 5
Supernatant 218
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Figure 55. This figure presents the results of a culture in which the cell 
resuspension was improved to eliminate cell clumps. Notice the first supernatant 
values in the 3 dishes show more uniform testosterone levels. The values that 
were high in the first collection, dishes 1 and 3, were low in the second collection 
whereas dish 2 where the values were lower are high in the second, but with a 
decline in the third supernatant.
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Fig.55 T e s t o s t e r o n e  p ro d uc ed  by Leydig cell  cu l ture ,  
with improved  cell  s u s p e n s i o n ,  during 2 d a y s  of 
t r e a t m e n t  with 0.15 iu HCG.
nmol / l  pe r  (10)7 
c e l l s
■ Di sh  1 
s  Di sh  2
■ Di sh  3
mmall
Supernatant 220
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Figure 56. This is a photo of dead purified Leydig cells stained blue with trypan 
blue. Note how clean this cell suspension is, there is no tissue debris, no 
spermatozoa. This is a result of the improved Percoll gradient method 1.
221
Chapter  3
C h a p t e r  3
Figure 57. Materials used for filtering the dog testicular tissue; a) plastic strainer 
b) glass funnel with the attached millipore filter, c) syringe and needle used for 
setting up gradients, as well as for cell collection from the gradients.
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Figure 58. Presents the standard curve for repeatability o f testosterone evaluation 
in cell cultures.
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Fig. 58 Repea tabi l i ty  of s t a n d a r d  cu rve  for t e s t o s t e r o n e
in Leydig cell cu l ture .
g Q  % binding
50
20
10
Standards
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DISCUSSION
The main difficulty in working with dog testicular tissue, was in obtaining 
frequent and fresh material with which to work Several attempts were made at 
freezing the tissue, as there are several reports in the literature of successfully 
storing endometrial tissue, (King et a l 1987), or endometrial and luteal tissue in 
liquid nitrogen, (Dunlop, 1991).
Different approaches were tried first by using different size tissue portions of 
1,2,3 cms^. which were frozen whole or cut into very tiny pieces also as 
homogenised tissue. In the case of the larger pieces they where either plunged 
directly into the nitrogen or already inside the cryotube. These trials also 
included adding cell culture medium to the tissue either by itself or with dimethyl 
sulfoxide (DMSO), to which either bovine serum albumin, or foetal calf serum 
were also added However, these trials proved unsuccessful as once thawed, and 
different thawing times were tried as well, they produced tissue which 
disintegrated completely and where few if any identifiable cells were found but 
these were dead An example of trypan blue stained dead cells (Figure 56).
Because dog testicular tissue could not be stored fresh for any length of time and 
was not readily available, it was decided to undertake the initial investigations to 
determine the best methods of handling this type of tissue by using rat and mouse 
testes which were easily obtained Such studies require multiple duplication of 
samples and relatively large amounts of the tissues being investigated.
There are several techniques described for cell separation such as mechanical 
dissection, collagenase dispersion or a combination of both (Sharpe and Cooper, 
1982). In this work, the initial approach used was a combination of mechanical 
dispersion by cutting the tissue in small pieces (Schumacher, et a l 1978 ) but this 
did not produce high number of cells, so then digestion of the supportive 
connective tissue using collagenase enzyme was used (Joffre, et al. 1984; Gale, 
et al. 1982). And to purify and isolate the Leydig cells, Metrizamide (Conn, et 
al. 1977) Ficoll (Janszen et a l 1976) and Percoll density gradients have been 
widely used (Pertoft, et al. 1977; Browning et al. 1983; Joffre et al. 1984; 
Simpson et a l 1987; Klinefelter et a l  1987). Percoll was chosen over the other
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products for the present studies, because being the latest developed product it was 
thought it would give better results.
The differences in testicular tissue between dog and the laboratory animals were 
immediately obvious. Rat and mice testis disperse much more readily and 
produced much less debris than dog tissue. The recommended speed of the 
shaking water bath incubator used for rat and mice tissue had to be increased 
from 80 (Rommerts et al. 1982), to 100 cycles for the dog as dog tissue left at 
the slower speed became like cooked meat and little cellular separation occurred 
Testicular tissue from older dogs was much tougher than that from dogs of two 
years and under and took longer to disperse. In addition, the number of Leydig 
cells harvested from testes from older dogs was markedly reduced This may 
have been the result of the animal's age or to the extended exposure time to 
collagenase required to break down the tougher connective tissue.
Determining how much time was required for dispersal to take place presented 
another difficulty, as the published reports on this aspect in rats and mice 
indicated that tissue breakdown ceases when the seminiferous tubules present the 
appearance of clumps of threads. These were easily identified in the rat tissue 
but were not so clear when dog tissue was used With more experience, it was 
established that material from young dogs required to be exposed to collagenase 
for between 15-20 minutes and for about 30-35 minutes in older dogs.
Another important factor recognised was the freshness of the dog material. 
Testes from rats and mice were processed within 5-10 minutes of their removal. 
Sacrificing of laboratory animals can be programmed and all the necessary 
solutions and equipment prepared in advance. This was not possible with dog 
testes, as this tissue became available at unexpected times. Thus there was a 
delay of at least an hour in processing after their removal from the animal, to give 
time to prepare the necessary solutions. Initially, a small amount of dog tissue 
was not preserved in any way immediately after castration as theatre staff was not 
available to undertake these procedures. Immediately on arrival at the 
laboratory, the testes were placed in a plastic container to avoid further loss of 
fluid. Later in the study the removed testis were kept in 36°C saline solution 
immediately upon their removal from the dog. Efforts were made to keep the 
interval from castration to processing to a minimum
All external blood was removed from the intact dog testes with a paper towel, as 
the first attempts to separate Leydig cells on a Percoll gradient indicated that
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blood cells interfered with this purification stage. Although the entire capsule 
was removed from the rat and mice testes, decapsulating the whole dog testes 
was considered unnecessary and time consuming, as the whole testes was not 
used.
In the rat, the very small amounts of tissue debris present at the end of 
collagenase digestion, was easily eliminated by filtering the resulting homogenate 
through an 80 um Millipore filter. However, such large quantities of debris were 
present in the dog tissue at this stage that they clogged the filter. Therefore, a 
plastic strainer was used prior to the homogenate being passed through the 
Millipore filter (Figure 55). These extra procedures were bound to have an 
effect on the numbers of viable cells ultimately collected.
Initially a continuous Percoll gradient was used to purify Leydig cells. 
However, preparation of such a gradient required about 1 hour and time was 
critical since as mentioned before, fresher tissue produced better results therefore 
they had to be processed as quickly as possible. Another disadvantage observed 
in this gradient was that it did not produced well defined bands, where cells were 
not separated from the contaminating spermatozoa or debris (Figure 39). 
However, as mentioned below better results would have been possible by using a 
cleaner more diluted cell suspension.
In their work in the rat, Simpson et a l (1987) used a more practical discontinuous 
gradient that could be quickly prepared as the different solutions required could 
be prepared in advance and kept refrigerated. This reduced the time factor and 
when used for the separation of the rat and mice Leydig cells produced 
reasonable results and thus this was the method adopted for the dog tissue and 
with some experience also produced acceptable results.
However, initially when using this gradient the same problems that had occurred 
with the previous discontinuous one arose, such as undefined cell bands, with 
cloudy layers of cells located before and after the 2 nd band where most of the 
viable cells could be found (Figure 40). At this point some modifications were 
made to Simpson's original formula gradients (Figures 41, 42, 43, 44) in an 
attempt to improve the separation of bands since it was difficult to harvest the 
bands without aspirating cells from other bands as well.
The modifications to the first formula were done by using different amounts of 
Percoll and medium therefore formula 2, 3, and 4 originated. The first thing that
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became apparent was that, in the original formula, it was possible to visually 
appreciate the different concentrations of the gradient by placing the gradient 
tube against the light and seeing the change in light refraction. However, this 
was not the case in the later methods tried and the results of these modified 
formulas did not show any improvement on the band separation. (Figures 41, 
42, 43) for they did not eliminate spermatozoa or debris but did increase the 
number of dead cells.
While trying out these new gradient modifications, work was also going on, in an 
attempt to improve the first original method, which finally did happened by using 
a cleaner and more diluted cell suspension (Figures 45, 46, 47).
The cleaner cell suspension was the result of making such changes as whipping 
the blood off the dog testicles, before slicing off the testicular capsule thus 
markedly reducing the amount of erythrocytes. Most of the tissue debris was 
eliminated by filtering once through a plastic mesh and then through an 80 um 
filter (Figure 56). The spermatozoa were mostly eliminated by rinsing the pellet 
with medium, centrifuging and resuspending the resulting pellet with more 
medium
Considering that the cell suspension to be purified is placed in top of the 
gradient, then by reducing the presence of unwanted material, it becomes easier 
for the Leydig cells to go down through the different densities and settle down in 
cleaner bands. If not purified they could become trapped in the topmost layer 
and also because there was a tendency for the Leydig cells to stick together in the 
gradient bands forming clumps that were difficult to separate. As this occurred 
when very concentrated cell suspensions were used, the problem was reduced by 
increasing the dilution. It is easy to see, that one reason why the erythrocytes 
separate better, always going to the bottom of the gradient, might very well be 
because they are the smallest cell found in the cell suspension and they do not 
stick to each other, so they can even go through thick cell suspensions. .
It is important to realise that all the changes introduced to the discontinuous 
Percoll gradient were necessary only for dog tissue, but not for the mice or rat, 
since in these later species the amount of contaminating tissue was very small. 
In the rat, it was actually possible to eliminate most of the blood contamination 
by pulling off all the major blood vessels from the decapsulated testis. This 
meant that from the beginning, the discontinuous Percoll gradient produced very 
good results, as the bands were very clear and well defined.
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As a general comment regarding Percoll gradients, it would seem that the number 
of bands obtained by this method as the four bands reported by Simpson et a l 
(1987) in the rat might not be so much species related, but due to a more 
heterogeneous cell suspension used for purification. Therefore this was the 
method that was used for the remainder of the experiments and no more 
modifications were made.
It was actually while using formula 4 (Figure 44) to separate dog tissue from an 
animal which had been castrated the day before, that it became apparent that the 
tissue had to be fresher as the resulting bands were full of debris and the few 
cells found were dead. Similar findings resulted when frozen tissue was used.
The identification of the isolated Leydig cells presented difficulties. Initial 
attempts at identification were made by observing a fresh cell preparation stained 
either with Diff Quick (Fig. 35a, b, c) with trypan blue (Figures 36a and b) and 
observed under a light microscope. However, it was not possible at that stage to 
do a proper identification.
Another method for identifying these cells was to demonstrate the presence of the 
3pHSD enzyme in isolated Leydig cells. This enzyme is contained in steroid 
producing cells and this method was attempted but the results were also 
disappointing (Figures 37, a, b, c, d) because the cell preparation either did not 
stain at all, or although with different degrees of intensity stained everything 
blue.
Since identification of the Leydig cells was proving difficult, some cell 
suspensions were cultured to determine testosterone concentrations in the cell 
culture supernatant, as this would be an indication of the presence of Leydig 
cells.lt was encouraging to determine that there was indeed testosterone 
indicating the presence of Leydig cells in these initial crude preparations (Figure 
48 ). Furthermore the longer the cells remained undisturbed, the greater 
testosterone production (Figures 49 and 50).
However, the attempts at devising a reliable identification method continued. 
Schumaker et a l (1978), Joffre et a l (1984), Gale et a l .( 1982) and Hunter et 
a l (1982) reported that using phase contrast microscopy, rat Leydig cells had a 
distinctive bright yellow halo around them Initial attempts at using this method 
in the dog were unsuccessful.
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Eventually, by using a more sophisticated contrast phase microscope, it was 
possible to detect the yellow halo in the Leydig cells, (Figures 38 a and b). This 
was the identification method that was subsequently used in all the cell culture 
experiments.
Once identification of cells was possible, three different sizes of Leydig cells 
were seen in the preparations from all three species, namely mice, rats and dogs 
(Figure 46).The most common were medium sized fewer small and even fewer 
large ones. Unfortunately it was not possible to correlate these findings with 
differences such as age of the animal not only because of the small amount of 
dog tissue available, but because of the very diverse population of rats, mice and 
dogs.
The heterogeneity of the Leydig cell population has been reported by other 
researchers. Qureshi & Sharpe. (1993 ) found in man that Leydig cells can be 
light or dark. Aquilano and Dufau, (1984) that when using centrifugal 
eleutration and Metrizamide gradients Leydig cells settled into different 
sedimentation velocities while Molenaar et al. (1983) found differences in the 
amounts of testosterone produced when stimulating with hCG, Laws et a l  (1985) 
also reported finding at least two cell bands in the Percoll gradient with the cells 
in one of the bands actually containing a smaller number of hCG receptors. A 
similar finding was also reported by Bhalla et a l 1987.
A different approach to identification of the Leydig cells was tried 
simultaneously with o the development of a better Percoll gradient Based on 
work by Molenaar et a l  (1983), Hunter et a l (1981), Rommerts et a l  (1982), 
Themmen et a l (1987). Viable Leydig cells attach to culture dishes, whereas the 
erythrocytes and germ cells float to the surface of the dish. It was thought that 
by trying this method it would be easier to obtain and identify viable Leydig 
cells.
However, these initial cell culture attempts failed due to lack of experience in this 
area, for example until distilled water was added in the empty wells of the culture 
dishes, the cell medium evaporated, leaving dead dried cells in the bottom of the 
dish. Also a problem with the original incubator went undetected, and the 
temperature was set at 37°C and considering that Leydig cells are part of the 
testis which is maintained at a lower temperature, this could have accounted for 
the high dead cell rate observed in the first cultures, the temperature was 
changed to 32°C. The over frequent observation of the dishes probably
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contaminated the cultures. To avoid this contamination, the multiwell dishes 
were eliminated in favour of individual dishes that made examination easier.All 
material used in the entire process was sterilised the solutions, gradients and 
cultures were prepared in a positive pressure sterile hood
However there were very small probabilities of identifying one particular cell 
type in the initial heterogeneous cell suspensions which contained everything 
from spermatozoa, erythrocytes, interstitial tissue to Sertoli and germ cells . The 
germ cells would be contaminating the suspension because as mentioned before it 
was not possible to eliminate the dog seminiferous tubules before they digested 
thus adding to the confusion of detecting Leydig cells. Specially because in the 
beginning the impression was that Leydig cells were all the same size, as later it 
was learned that this was not so plus the fact that the improved cell suspensions 
increased the number of viable cells attaching to the dishes, identification became 
easier.
Considering the possibility that dog cells were not attaching to the culture dishes 
because they required longer incubation periods, different times were tried from 
3-7 hours up to 24 and 36 (Figures 49 and 50,). However, these initial figures 
present results on two different dishes which were left untouched until the end of 
the incubation period when the supernatant was collected and the bottom of the 
dish examined. Once the supernatant was removed, trypan blue was added , and 
the dishes showed varying numbers of cells still attached to the bottom of the 
dishes.(Figures 38 a, b, c), this particular find just proved that Leydig cells were 
present in the culture and that the longer they were left untouched they were able 
to continue producing testosterone.
As mentioned before, a characteristic that was noticed in Leydig cells was that 
after Percoll centrifugation the cells in the pellets proved difficult to disperse as 
the cells tended to form clumps. This problem became apparent in the initial 
cell cultures that showed a very uneven testosterone production in the first 
supernatant collected after 7 horn s of plating (Figures 51 and 52). Although the 
concentration of the cell suspension had indeed been evaluated prior to culture, it 
was obvious that the culture dishes did not contain the same amount of cells to 
begin with because they still contained some cell clumps which however small 
could still account for increased testosterone amounts produced in a particular 
culture dish.
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A better resuspension was achieved when instead of using glass Pasteur pipettes, 
disposable plastic pipettes (Merck Ltd Lutterworth, UK) were used and it was 
noted that the cells tended to stick less to these than to glass. By adding .5 ml of 
medium to the pellet and softly but repeatedly passing the cell pellet through the 
plastic pipette, it was possible to produce a more homogeneous suspension that 
was then diluted further until an appropriate suspension was obtained By 
agitating the cell preparation container repeatedly while pipetting into the culture 
dishes, the problem of the cells settling to the bottom was reduced An example 
of this improvement can be seen in Figures 53 and 54, as it shows more 
homogeneous testosterone production levels in the first supernatant collected 
from all the dishes.
However, the problem of the variable numbers of cells attaching to the dishes 
continued as demonstrated in the very varied testosterone found in the next 
supernatants. It was not always possible to relate the increase or decrease in 
testosterone contents in the subsequent supernatants to the initial values, for it 
was not possible to be sure whether the lack of testosterone production was due 
to a problem in the cells themselves or just due to a decrease in testosterone 
producing cell numbers.
Although the problem of cell attachment was not entirely satisfactory, at this 
point it was decided that the initial work was producing viable cells and that it 
was time to try a more advanced approach to cell culture that would provide more 
information regarding Leydig cell function in the dog.
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CHAPTER 4.
LEYDIG CELL FUNCTION STUDIES
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1. INTRODUCTION
The results thus far had shown that the Nafarelin acetate treatment was 
suppressing the production of LH and testosterone in the dog, and that the degree 
of inhibition was related to length of treatment. At the same time, the isolation 
and purification techniques used so far were producing viable dog Leydig cells. 
Therefore a more advanced study of the Leydig cells mechanisms appeared 
feasible. The aims were to monitor the injection effect over an extended period 
of time, in an attempt to find out if the suppression of LH and testosterone was 
through desensitisation of the pituitary as in most species, or also directly on the 
gonad as in the case of the rat. In this species GnRH-like receptors have also 
been identified in the gonads (Hsueh & Erickson, 1979; Sharpe and Fraser, 
1980; Hsueh and Jones, 1981; Popkin, et a\. 1985; Huhtaniemi, et al. 1986 ). 
It was also intended to study the effects of LH and testosterone suppression in the 
Leydig cells and therefore with the purpose of obtaining these cells, two more 
dogs were treated with Nafarelin acetate, one for 30 days and a second for 60 
days and their Leydig cells were used for the study.
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2. M ATERIALS AND M ETHODS
2.1. ANIMALS USED
a) Testes from untreated animals: Dogs, mice, rats.
b) Testes from 2 dogs treated with daily subcutaneous injections of Nafarelin 
acetate.
c) Testes from 16 mice: 8  Treated with daily subcutaneous injection of Nafarelin 
acetate for 30 days, 8  mice were kept as control.
Identification Breed Age,
years
Weight
kgs.
Body
condition
Treatment
length
Kenny Beagle 7 2 1 .2 good 60 days
Dennis Beagle 7 2 1 .2 good 30 days
2.2. DOG’S MAINTENANCE.
As discussed in chapter 2, section A.
2.3. TESTICULAR MEASUREMENTS
As discussed in chapter 2, section A.
2.4. SCANNING.
As discussed in chapter 2, section A.
2.5. LIBIDO EVALUATION
As discussed in chapter 2, section A.
2.6. SEMEN EVALUATION
As discussed in chapter 2, section A.
2.7. ALKALINE PHOSPHATASE
As discussed in chapter 2, section A.
2.8. BLOOD SAMPLE COLLECTION AND PROCESSING.
As discussed in chapter 2 , section A.
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2.9. MEDICATION USED.
The two dogs and the 8  treated mice were given Nafarelin acetate, kindly 
supplied by Syntex Labs. Palo Alto, California administered at a dose of 62 
ug/day by subcutaneous injections.
2.10. TISSUE COLLECTION
As discussed in chapter 3.
2.11. TISSUE DISSOCIATION
Using the third method discussed in chapter 3.
2.12. CELL COUNTS, VIABILITY AND IDENTIFICATION
As discussed in chapter 3.
2.13. CELL PURIFICATION
As discussed in chapter 3
2.14. CELL CULTURE METHODS
The method used was as described by O’Shaughnessy et al (1991).
Material used.
1. 20 ml poly propylene vials. ( Bibby Sterilin Ltd. Tilling Dr., Stone, Staff., 
England ST 150SA)
2. 2 ml Eppendorf tubes with perforated caps(Merck Ltd. Lutterworth, Leics. 
England).
3. Disposable pipettes (Merck Ltd., Lutterworth, Leics., England).
4. Boiling water
5. Aluminium foil
Method number 1 for the treatment of isolated Leydig cells, to determine cell 
viability by their testosterone production response.
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□
Cell experimental design
Tube Cell medium Treatment suspended in Cell suspension
No.
(Ml) (hD (HO
1 -2 900 no treatment 0 1 0 0
3-4 890 hCG- ( 2 0 0  m IU ) 10 1 0 0
5-6 890 dbcAMP (2mM) 10 1 0 0
7-8 892 22 ROHC (25 uM) 8 1 0 0
In this method the following extra treatments were added to the above protocol.
Additional treatments.
Tube Cell medium 
(Hi)
Treatment suspended in 
(Hi)
Cell suspension 
((HO
9-10 890 Nafarelin acetate (8 mM) 10 1 0 0
1 1 - 1 2 890 Nafarelin acetate (4 mM) 10 1 0 0
13-14 890 Nafarelin acetate (2 mM) 10 1 0 0
15-16 890 Nafarelin acetate (1 mM) 10 1 0 0
17-18 890 Nafarelin acetate (0.00058 ug/ml) 10 1 0 0
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2.15. INCUBATION
The 20 ml culture tubes were incubated in a ICN 160 model automatic CO2  
incubator (ICN Flow Laboratories, Herts, England) at 32°C and 5% CO2  for 3 
hours.
Cell culture was collected after incubation
1. The cell culture medium was transferred from the incubating tubes into the 
Eppendorf tubes with perforated caps.
2. The Eppendorf tubes were inserted in the aluminium foil circle which was then 
placed over a container full of boiling water and allowed to boil for 2  minutes. 
This was done with the purpose of bursting the cells open thus releasing all 
remaining testosterone into the medium.
3. The contents of the perforated tubes were transferred into Eppendorf tubes 
with intact caps.
4. The tubes were then centrifuged in an Eppendorf centrifuge 5415 (Eppendorf 
Geratebau, Hamburg Germany) at 14000 rpm/min for 1 minute.
5. The tubes were decanted and the supernatant was transferred to another 
identified set of Eppendorf tubes with intact caps and stored frozen for future 
analysis.
HORMONE ANALYSIS.
As discussed in chapter 3.
Histochemistry 3BHSD staining.
Method 1
As described in chapter 3.
Method 2.
This method was the one described by Payne, Downing and Wong (1980).
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Material required for method 2.
1 0 0  ml Phosphate buffered saline
0 .0 0 1  gr Bovine serum albumin. (No. A.9647)
99.5 mg Nicotinamide adenine dinucleotide (No. 7004)
20.4 mg Nitro blue tetrazolium ( No. 6639)
5.8 mg Ethiocholan (No. E5252)
All reagents were purchased from Sigma (Chemical Co. Ltd., Poole, Dorset, 
England).
Preparation procedure. This solution is prepared by dissolving all the reagents 
in the 1 0 0  ml of phosphate buffered saline, the ethiocholan having been dissolved 
in 1 ml of methanol. This solution is prepared fresh just prior to use as it loses 
efficacy with storage.
Staining o f slides. 100 ul samples of cell suspension were placed in a glass slide 
and dried at room temperature. Immediately after drying, the cells were covered 
with the solution.
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GnRH RECEPTORS
Labelling o f  GnRH The Chloramine-T method was used as described by 
Jeffcoate et al. (1978).
Material used:
Material used
1. GnRH Code no.L-7134. (Sigma Chemical, Co. Ltd., Dorset, England)
2. 1 ml polystyrene vials with rubber stoppers (Luckhaus LP3)
3. Phosphate buffer.
Phosphate buffer made up as follows
A.-6.9 g Na H2  P 0 4 dissolved in 1 0 0  ml distilled water
B.-7.1 g Na 2 HPO4 dissolved in 1 0 0  ml distilled water
Add A to B to make up the pH 7.5 solution.
RADIO IODINATION OF GnRH.
1 Place 2.5 ug GnRH (2.4 pi) in the 1 ml vials.
2 Add 25 ul of 0.5 phosphate buffer (pH 7.5).
3 Add 1 mCi 125 I (20 pi).
4 Count to determine accuracy of iodine addition.
5 Stopper reaction vial and add 40 pi Chloramine-T (20 pg).
6 Shake gently for 15 sec.
7 Add 100 pg (50 pi) of sodium metabisulfite (2mg/ml).
8 Add 100 pi of 1% BSA-PBS and shake gently.
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9 Transfer reactive mixture to surface of 11 ml. column of Sephadex G-25 
(fine). Column pre-saturated with 1 0  ml.
1 0 Elude column with 0.05m (PBS + BSA, 25%).
11 Collect 1 ml fraction.
1 2 Count 10 or 20 pi fractions to determine peptide peak.
13 1 0 0  pi aliquots were made and stored frozen for further use.
PREPARATION OF HOMOGENATED TISSUE.
Material used
1 Round bottom polystyrene tubes 130 mm x 17mm diameter 
(Sarstedt Ltd. Leicester England).
2 Ultra-turrax-T25 homogeniser ( Janke & Kunkel IKA Labortechnik, 
Germany).
3 Tris buffer.
4 14 ml. centrifuge tubes (Greiner Labortechnik Ltd., Dursley, 
England).
Homogenising procedure
1 500 gram pieces of tissue sample plus 1 ml of tris buffer were placed in 
the bottom of the round polystyrene tube.
2 The tissue was homogenised in a Ultra- turrax-T25 at 20,500 rpm.
3 The homogeniser's probe was rinsed with an additional 1 ml of buffer by 
adding it a little at a time as the procedure had to stop every few seconds 
to avoid overheating of the tissue.
4 The tube containing the tissue was placed in crushed ice during these short 
resting periods, this being continued until the tissue was completely 
homogenised.
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5 The homogenate was then transferred into 14 ml centrifuge tubes (Greiner 
Labortechnik Ltd. Dursley) and resuspended into an additional 6  ml of 
buffer.
6  The mixture was thoroughly mixed by turning the tube by hand before 
placing in the centrifuge and spun at 3000 g for 5 minutes.
7 The tubes were decanted and the pellet was resuspended in 2 ml. This 
preparation was then set up for incubation as follows.
M aterial used for incubation
1 Labelled GnRH.
2 Incubation tubes. Rohren 3.5 ml, 55 x 12 mm dia. (Sarsted, 
Leiscester England).
3 Tris buffer.
4 Crushed ice.
Protocol for determination of GnRH receptors in the Leydig cells.
Tube no. Labelled pi 
GnRH
Unlabelled Nafarelin pi 
acetate
Tissue
1 ,2 1 0 0
3,4,5,6 , 1 0 0 1 0 0
7,8,9,10 1 0 0 1 0 0 1 0 0
1 1 ,1 2 1 0 0 50 1 0 0
13,14 1 0 0 2 0 1 0 0
15,16 1 0 0 10 1 0 0
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Table 17 Protocol for the Nafarelin acetate treatment of an adult male beagle (Kenny) 
treated for 60 days. ( Day of 1st. treatment^ day 1).
Days Procedure
-7 Semen collection
-7, 1 and then weekly Animal weighed
-17 t o -14 Daily samples taken.
-13 8  Hourly samples.
1, 2, 3, 4, 5 and then weekly 1 Blood sample before injection 
3 Hourly samples taken after injection
-3 +10 and then weekly One blood sample
1 to 60 Daily injection and body temperature taken
7 and then weekly Semen collection, libido evaluation, scanning.
59 8  Hourly samples.
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Table 18. This table presents the protocol details of the treatment period o f a 
male beagle dog (Kenny) that was treated for 2 months with daily subcutaneous 
injections o f Nafarelin acetate. Note that when 4 blood samples were obtained, 
the first one was taken prior to the daily injection, whilst the other 3 were 
collected at hourly intervals following the injection. The well being of the 
animal was observed daily. Temperature and body weight were monitored on 
regular basis. There was no indication o f the treatment having an effect on 
either o f these two parameters.
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TaMa 18. Btaadktg and toartmant protocol of a  mat# baagla dog (Kanny)
traatodw tthklafaratln acatota
D a te »■-» ■» - - ■» » N W H I f i  WCmtto
Inug
Blaadtug Tamp. >*■-!-«-*■ 
m  k m
14/03/93 102
15/03/93 102 21.81 M B/93 •02
17/03/93 1018
18/03/93 102
19/03/93 B 101 21.720/03/93 B 101.2
21/03/93 B 102
22/03/93 B 101.8 21.123/03/93 it IIiWwiOOw •31.4
24/03/93 B 101.8
29/03/93 101.8
28/03/93 B 101.6
29/03/83 B 101.8 20.230/03/93 B 101.2
31/03/83 B 101
01/04/93 101
0204/93 101.8
03/04/93 101.2
04/04/83 101.2
09/04/93 62 4 aamptaa 101.2 2108/04/93 4 aamptaa 101.2
07/04/83 4 aamptaa 101.2
08/04/93 4 aamptaa 101.2
09/04/83 4 aamptaa 101.2
12/04/83 4 aamptaa 101 202
13/04/93 100.8
14/04/93 B 100.7
1304/93 101.2
16/04/83 B 101.2
19/04/93 4 aamptaa 102 202
21/04/93 B 101.8
22/04/93 101
23/04/93 100.8
24/04/83 B 101
2604/93 4 aamptaa 101 20.1
27/04/83 101.2
28/04/93 B 101
29/04/63 101
02/06/93 102
03/06/63 101 4 19.9
04/06/93 4 aamptaa 101
06/06/83 B 100.8
06/06/83 B 1001
07/06/93 B 101
10/06/93 4 aamptaa 1003 197
1106/83 1018
12/06/83 B 101
13/06/93 100.9
1406/93 B 101.1
170603 4 aamptaa 101 20.2
180603 102
190603 B 102
200603 102
21/0603 B 101.9
240603 4 aamptaa 101.4 196
2 606 0 3 101.3
2 806 0 3 B 1012
2 9 0 6 0 3 1013
3 1 0 6 0 3 101.2 19.8
0 208 0 3 vrindow6hr 101 204
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Table 19. The evaluation o f external genitalia in this animal (Kenny) starts 
showing a decrease in testicular size, as well as a change in consistency that can 
be appreciated on the 30th of April, i.e. 25th day of treatment until the end of the 
60 day treatment period. Libido in this animal was low and the numerous 
collection attempts both prior to and during treatment proved unsuccessful with 
just one exception on the second day of treatment. A second positive response 
was observed 25 days after treatment in the presence of an oestrous teaser as he 
developed an erection and attempted to mount but an ejaculate was not 
produced.
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Figure 59. This figure presents the results of daily bleeding in Kenny both
prior to and during treatment. It shows the results of daily blood samples. On 
the days when 4 samples were taken only the first pre-injection sample is 
included. Note the testosterone levels on the first sample and the dramatic
decrease o f testosterone 0.01-16.99 nmol/1 to almost undetectable (by our assay) 
levels by the 4th day post injection this low levels were maintained until the end 
o f treatment. However, LH continued to be synthesised in some instances to 
levels that were even higher than in the pre-treatment period H 0.05-7.2 ng/ml.
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Figure 60. This figure includes only the days when 4 samples were taken. The 
first sample was collected prior to the application o f the daily injection and the 
next 3 samples at hourly intervals post injection. The first 5 o f these sampling 
periods took place daily for the first week of treatment and every 7 days 
thereafter. Notice the stimulatory effect that can be appreciated in the 3 hourly 
samples collected after the first injection. By the following day this stimulation 
effect has decreased and by the third day there is a dramatic increase in 
testosterone production which by the fourth and fifth day have diminished 
considerably. The suppression of both hormones but testosterone in particular 
was maintained throughout the remainder o f the treatment period The ranges 
were for LH 0.0-25.3 ng/ml and for testosterone 0.0-33.06 nmol/1.
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Figure 61. In this animal (Kenny) two hourly bleeding periods were taken, one 
prior to initiation of treatment (The range for LH 0.01-3.71 and for testosterone 
1.16-5.28 nmol/1), and the second towards the end (Range values for LH 1.5-3.7 
and for testosterone 0.11-0.58 nmol/1) No major hourly oscillations can be 
appreciated in either hormones, but particularly i. e LH. However, there is a 
clear suppression of testosterone in the second bleeding period, which apparently 
did not occur in LH, with levels of this being almost normal.
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Figure 62. These are the histological sections of testes from a) normal dog, b) an 
adult beagle dog (Kenny) treated with Nafarelin acetate by daily subcutaneous 
injections for two months. Notice that in the normal dog the seminiferous 
tubules have a complete germ cell complement seen as a continuous progression 
o f germ cells which start from the basal membrane towards the tubule's lumen. 
In comparison in the treated dog testis, the only cells present are those closer to 
the basal membrane. Note the disappearance of all other germ cell associations 
as well as the tubular lumen. Magnification 10 x. Both slides stained with MSB. 
A blue microscope filter was used for the photograph of the normal animal.
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Figure 63. Histological sections o f epididymal body a) from a normal dog b) 
from a beagle dog (Kenny). Note in the normal dog the uniform cellular 
arrangement indicated by the position of the nuclei which are almost all placed at 
the same distance from the basal membrane. In the nuclei from the treated dog 
there is a somewhat disarranged appearance with the placement of the nucleus at 
different distances from the basal membrane. The presence o f spermatozoa in 
this section o f the epididymis is not as abundant as in the head, but in the normal 
dog they can be seen in one o f the tubules. However none are apparent in the 
section from the treated dog. Magnification 10 x. Both slides stained with MSB.
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Figure 64. This figure presents histological sections taken from the prostate of 
a) a normal dog b) from a beagle dog ( Kenny) treated with Nafarelin acetate. 
In the treated animal the prostatic alveoli have a shrunken appearance compared 
to those in the normal dog. This also shows secretion in the alveoli lumen that is 
not present in the treated animal's sections which show an obvious increase in 
connective tissue as an indication of the gland's atrophy. a) Photograph 
magnification lOx .A blue microscope filter was used for this photograph b) 
photograph 54 x . Both slides stained with MSB
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Figure 65. Ultrasonographs of the prostate show the difference in sizes 
between those taken prior to treatment on March 29 (1 ) , and the ones taken 56 
days later (2). The longitudinal axis o f the left prostate is shown in photos A -1 
and A-2 and the right side shown B -l and B-2. Notice that the greatest 
difference is in the width with a decrease of 0.7 cm from the initial diameter and 
0.2 cm in the length, both left and right.
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Table 20 Protocol for the Nafarelin acetate treatment of an adult male beagle (Dennis) 
treated for 30 days.
Days .Vocedure
-7 Semen collection
-7,1 and then weekly Weight taken
-17 t o -14 Daily blood samples
-13 8 Hourly samples
1,2, 3, 4, 5 and then weekly 1 Blood sample before injection 
3 hourly samples after injection
-3, 10 and then weekly One blood sample
1 to 30 Daily injection and body temperature taken
+7 and then weekly Semen collection, libido evaluation, scanning.
30 8 Hourly samples.
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Table 21. This table presents the protocol details of the treatment period of a 
male beagle dog (Dennis) that was treated for 1 month with daily subcutaneous 
injections of Nafarelin acetate. Note that when 4 blood samples were obtained, 
the first one was taken prior to the daily injection administration, whilst the other 
3 were collected at hourly intervals following the injection. The well being of 
the animal was observed daily and temperature and body weight were monitored 
on a regular basis and there is no indication of the treatment having an effect on 
either o f these two parameters.
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Table 21. Bleeding and treatm ent protocol o f a  mala heaoie don irw ,«k.»
treated  wtth Nafarelin acetate
Data Nafarelin acetate Bleeding Temp. Weight 
in knain ug o F
1 W W 3 102
1503/83 101 4
17/09/83 101.8
18/03/83 102
18/03/83 B 101 21.720/03/83 B 101.4
21/03/83 B 102
22/03/83 B 101.8 21.123/09/83 7 hour bleeding window 102
24/03/83 B 101.8
25/03/83 101.8
28/03/83 B 101.6
28/03/83 B 1018 20.230/03/83 B 101.2
31/03/83 B 101.1
01/04/83 101
02/04/83 101.8
03/04/83 101.8
044)4/83 101.4
06/04/83 62 4sam p ies 101.2 21
08/04/83 4 aamplee 101.2
074)4/83 4 aamplee 101.2
08/04/83 4 aamplee 101.2
08/04/83 4 aamplee 101.2
12/044/3 4 aamplee 101.2 202
13/04/83 100.8
14/04/83 B 1007
15/04/83 101.2
18/04/83 B 101.2
18/04/83 4 aamplee 102 202
214)4/83 B 101 8
22/04/83 101
23/04/83 1008
24/04/83 B 102
28/04/83 4 aamplee 101 20.1
27/04/63 101.2
28/04/83 B 101
284)4/83 101
02/06/83 101.1
03/06/83 101 188
04/06/83 7 hour bleeding window 101.3
054)6/83 B 1008
06/06/83 B 101
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Table 22 As this table indicates, the libido in this animal (Dennis) was poor (0 
and 1) even on those occasions when an oestrus bitch was used to collect semen. 
Note that the testicular measurements started decreasing in size by the 23th day 
of treatment, but no obvious changes were appreciated in the epididymis.
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Figure 66. This figure presents the results o f daily bleeding in Dennis both prior 
to and during treatment. It shows the results of daily blood samples and for 
those days when 4 samples were taken, only the first pre injection sample is 
included. Note the testosterone levels on the sample taken one day before the 
treatment started and the decrease of testosterone to almost undetectable (by our 
assay) levels by the 5th day, which were maintained until the end of treatment. 
However, LH continued to be synthesised in some instances to levels that were 
even higher than in the pre treatment period. The range of both hormones was 
(LH 1.87-8.69 ng/ml; testosterone 0.01-30.99 nmol/1).
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Figure 67. This figure includes only the days when 4 samples were taken. The 
first sample was collected prior to the application of the daily injection and the 
next 3 samples at hourly intervals post injection. The first 5 of these sampling 
periods took place daily for the first week of treatment and every 7 days 
thereafter. Notice the stimulatory effect that can be appreciated in the 3 hourly 
samples collected after the first injection, but by the next day this effect has 
decreased. By the fifth day both hormones, specially testosterone, have 
diminished considerably and this is maintained throughout the remainder o f the 
treatment period. The range o f both hormones was (LH 2.13-35.67 ng/ml; 
testosterone 0.06-54.07 nmol/1).
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Figure 68. This figure presents the results o f two 7 hour periods when samples 
were taken every hour. As can be appreciated both testosterone and LH show 
variations in their oscillatory pattern during the pre treatment sampling (LH 
3.21-7.31 ng/ml; testosterone 2.03-15.55 nmol/1) which disappears by the end of 
treatment( LH 1.91-7.01 ng/ml; testosterone 0.3-23.56 nmol/1). Except for the 
initial peak of both hormones in all the remaining samples testosterone is almost 
undetectable. However, although LH levels are lower than in the pre treatment 
period they never show the marked suppression of testosterone.
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Figure 69. Histological sections of testes from a) normal dog, b) and c) male 
beagle (Dennis) treated with Nafarelin acetate by daily subcutaneous injections. 
Notice in the normal dog, the presence of a full germ cell complement which 
occupies the space between the basal membrane and the lumen of the tubule. 
The cell's nuclei in the normal dog appear almost all at the same distance from 
the basal membrane, whereas in the treated cells their nuclei appear to be at 
different levels, giving the impression of a disorganised epithelium. 
Magnification of (a) and (c) photographs 54 x, and (b) photograph is 10 x . The 
three slides were stained with MSB. A blue microscope filter was used for 
photograph (a).
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Figure 70. Histological sections of epididymal body a) from a normal dog b) 
from a beagle dog (Dennis). Note the uniform cellular arrangement indicated by 
the position of the nucleus which are almost all placed at the same distance from 
the basal membrane, whereas in the treated nucleus there is a somewhat 
disarranged appearance with the placement of the nucleus at different distances 
from the basal membrane. The presence o f spermatozoa in this section of the 
epididymis is not as abundant as in the head but in the normal dog they can be 
seen in one of the tubules, while none are apparent in the section from the treated 
dog. Magnification for photograph (a) 10 x and for (b) 54 x. Both slides stained 
with MSB.
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Figure 71. This figure presents histological sections taken from the prostate of 
a) a normal dog b) from a beagle dog ( Dennis) treated with Nafarelin acetate. 
In the treated animal the prostatic alveoli have a shrunken appearance compared 
to those in the normal dog. The latter also shows secretion in the alveoli lumen 
that is not present in the treated animal's sections, but where an obvious increase 
in connective tissue can be appreciated as an indication of the gland's atrophy. 
Magnification of (a) photograph lOx, and of (b) is 54x . Both slides stained with 
MSB.
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Figure 72. Ultrasonograms photos of the prostate of Dennis. This series 
shows the differences in sizes between the ones taken prior to treatment on 
March 29 (1), and those taken on April 28 (2). Longitudinal axis o f left prostate 
A-l and A-2 width difference of 0.4 length 0.8 cm. In the sagittal axis photos 
B -l Vs B-2 , the difference in width is 0.3 cm and length 0.4 cm.
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Experiment 1.
Figures. 73-1 and 73-2 
To evaluate technical aspects of Leydig cell isolation.
Figure 73-1. Cells were isolated from 6 groups of mice (36 mice total ) and 
cultured for 3 hours: a) with no additives; b) hCG (200 mlU ml); c) dbcAMP 
(2mM); d) 22 R-hydroxycholesterol.( 25 ji M). The results seen in this graph 
indicate that the cell isolation and culture procedure produced cells capable of 
responding to exogenous stimulation.
Further analysis of the results using the interaction as the error term showed that 
there was a significance (P<0.001) difference between treatments.
”5 1 I Q
C2=— — = 9.8= PO.OOl
3.15
C l = ^ 3 = 0.7 = P <0.01
3.15
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F l 9 c J l l s'^y . i tHr0nSHte/ 0neo Puro duced  by pooled mouse  Leyci  cel l s  cu l tu red  for 3 hours  with HCG, dbc AMP and
22ROHC (6 g rou p s  36 mice total)
nmol/l  p •  r (10)7 
ce l l s
Basal HCG dbcAMP 22ROHC
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Figure 73-2. Leydig cells from control dogs (n= ll). These cells were 
incubated for 3 hours: with a) no additives; b) hCG (200 mlU ml); c) dbcAMP 
(2mM); d) 22 R-hydroxycholesterol ( 25 pM). The results seen in this graph 
show an increase in testosterone production with the additives o f a similar 
magnitude to that observed with the mouse cells. The results indicate that the 
procedure produced functional dog cells capable of responding to exogenous 
stimulation.
Statistical analysis shows there was significant interaction between animals and 
treatments (C2*C2= P<0.026)
And further analysis o f the results using the interaction as the error term showed 
that there was a significance (P<0.001) difference between treatments.
C2= = 1 5 . 2 ^ ^  = 10.5 == P<0.001
1.89 1.89
19 91C l= ——  = 10.5= P<0.001
1.89
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Fig. 73-2  T e s t o s t e r o n e  p ro d u c e d  by dog Ley dig ce l l s  
cu l tu red  for 3 hours  with HCG and dbcAMP, 22ROHC
(11 dogs)
900
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nmol/ l  p s r ( 1 0 ) 7 
c e l l s
Basal HCG dbcCAMP 22ROHC
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Experiment 2
Figures 74-1 and 74-2
The cells used were obtained from animals previously treated with daily 
subcutaneous injections of Nafarelin acetate.
74-1. Treatment o f 8 mice for 30 days resulted in a greater than control 
stimulation of testosterone production for all treatments.
The statistical analysis shows no interaction effect but a significant difference 
between animals (C l=  P=<0.0001). And between treatments (C2=P=<0.039)
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Fig. 74-1. Tes tos terone produced by Leydig cells from 8 nvc9
t rea ted  for 30 days with daily injections of Nafarelin ac e ta t e
compared with 8 control mice
900
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c a l l s
T
C
Basal HCG dbcAMP 22RO HC
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74-2. Cells from the dogs treated for 30 or 60 days with Nafarelin were 
cultured. These cells showed an increase in testosterone production when 
treated with : a) no additives; b) hCG (200 mlU ml); c) dbcAMP (2mM); d) 
22 R Hydroxycholesterol (25 microM). In fact the response to these stimulants 
for the 60 day dog was several hundred times that of control (71-2).
Statistical analysis shows there was significant difference in the interaction 
between animals and treatments (C2*C2= P<0.003)
Further analysis o f the results using the interaction as the error term showed that 
there was no significance between treatments
C 2 = - ^  =4.54 NS
11.57
The interaction shows that the animals responded differently to treatment 
(P=< 0.003)
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Fig. 74-2 .  T e s t o s t e r o n e  p ro d u c e d  by Leydig ce l l s  f rom 
d o g s  t r e a t e d  with Nafarel in  a c e t a t e  for 30 and  60 d a y s  
a n d  then  cu l tu red  for 3 hours  with no add i t iv e s ,  HCG,
dbcAMP and  22ROHC
nmol / l  p » r ( i o f  
cells
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Experiment 3
Figures 75-1 and 75-2
In this experiment 5 different concentrations o f Nafarelin acetate were added 
(N l, 8 mM; N2, 4mM; N3, 2mM; N4, 1 mM; N5, 0.00058 ug/ml.) to the initial 
a) no additives; b) hCG (200 mlU ml); c) dbcAMP (2mM); d) 22 R- 
hydroxycholesterol ( 25 micro M). —
75-1. The cells from 4 dogs responded to the initial hormone treatment same as 
before, but show no response to the Nafarelin acetate (N1-N5) treatment.
Statistical analysis shows there was significant difference in the interaction 
between animals and treatments (C2*C2=P<0.0001)
Further analysis o f the results using the interaction as the error term showed that 
there was a significant (P<0.01) difference between treatments, but not between 
animals (P= 2.67)
C l= 47-:-°5 = 2.67 not significant
17.6
C2=—  = 3.78=P<0.01
17.6
292
Chapter 4
Fig. 75-1 T e s t o s t e r o n e  p ro d u c e d  by dog Leydig ce l l s  
cu l t u r e d  for 3 hours  with: No add i t ives ,  HCG, dbcAMP 
a n d  22ROHC, and  5 c o n c e n t r a t i o n s  of Nafare l in  a c e t a t e
(N1-N5). (4 dogs)
nmol/l per (10)7 
cells
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75-2. Rat cells, which are supposed to have GnRH-like receptors at Leydig cell 
level, were treated as above. No testosterone response to N1-N5 was seen. The 
statistical analysis shows difference between animals (P=<0.001) but not between 
treatments (P= 0.307).
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Fig. 75-2 T e s t o s t e r o n e  p ro du c ed  by ra t  Leydig ce l l s  
cu l tu red  for 3 hours  with no add i t ives ,  HCG, dbcAMP 
and 22ROHC and 5 c o n c e n t r a t i o n s  of Nafarelin a c e t a t e
(N1-N5) (9 ra ts )
nmol/l per(10)? 
cells
800
0 HCG dbc 22R N1 N2 N3 N4 N5
Treatment
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Experiment 4
Figures 76-1, 76-2 and 76-3
For this experiment labelled GnRH was used in combination with Unlabelled 
Nafarelin acetate. The results are expressed in counts/minute
76-1. Indicated a high degree of total binding, in the rat tissue, and the gradual 
binding interference caused by the Unlabelled Nafarelin acetate.
Further analysis of the results using the interaction as the error term showed that 
there was a significance (P<0.001) difference between treatments.
34 12_  ^ ±  = 9.12 = P <0.001 
C2= 3.74
2 9 6
Chapter 4
Fig.76-1. R a t  t e s t i c u l a r  h o m o g e n a t e d  t i s s u e ,  t r e a t e d  with 
l a b e l e d  GNRH to d e t e r m i n e  GNRH r e c e p t o r s  in Leydig
cel l s  (9 r a t s )
6000 counts/minute
5000
4000
3000
2000
1000
NSB 100 50 20 10
Unlabelled GNRH 297
Chapter 4
76-2. The dog homogenate and the total non specific binding are the same and 
there is no effect in the degree of binding when different amounts of Nafarelin 
acetate are added.
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Fig. 76 -2 .  Dog t e s t i c u l a r  h o m o g e n a t e d  t i s s u e ,  t r e a t e d  
wi th  l a b e l e d  GNRH to  d e t e r m i n e  GNRH r e c e p t o r s  in
Leydig ce l l s  (11 dogs) .
6000
C o u n t s / m i n u t e
5000
4000
3000
2000
1000
NSB 100 50 20 10
Unlabelled GNRH
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76-3. The testicular tissue from the two treated dogs, was treated the same way 
and the 30 day dog shows even lower binding than the control group (74-2). 
However the 60 day animal shows a higher degree of binding, but no relationship 
was seen between binding and the amount o f unlabelled Nafarelin acetate used. 
The statistical analysis shows a difference between animals only ( C l=  PO.OOl). 
There was no significant difference between animals and/or treatment.
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Fig. 76-3 .  Dog t e s t i c u l a r  h o m o g e n a t e d  t i s s u e  f rom 2 
d o g s  t r e a t e d  for  30 an d  60 d a y s  with Nafare l in  a c e t a t e  
T r e a t e d  with label led GNRH to d e t e r m i n e  GNRH 
r e c e p t o r s  in t h e  Leydig ce l l s .
6000 C o u n t s / m i n u t a
5000
4000
3000
2000
1000
NSB 100 ul 50 ul 20 ul 10 ul
Unlabelled GNRH 301
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Figure 77. This figure presents two methods for the detection of the 3BHSD 
enzyme in isolated Leydig cells. First (a) examples of the method of Lobel and 
Levy (1968) which was used in the previous chapter. Secondly the method of 
Wang et al. (1980) (b) and (c). With the second method, only the Leydig cells 
stain blue whereas the remaining cells remain transparent. Note also that the 
cell suspension is very clean and there is hardly any tissue debris as in figure (a) 
where everything stains blue and purple and it is not possible to distinguish a 
particular type of cell.
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Table 23. This table presents the testosterone concentrations found in 
circulation and testicular vein blood plasma samples. Notice that the mean of 
the untreated dogs is about 5 times that o f the circulation blood levels. The 
mean found in testicular veins is 47.13 42 ± 18.55nmol, means that the 0.3 nmol/ 
1 levels found in both treated dogs, is well below the lowest limit o f 28.58 
nmol/1. And the jugular vein testosterone levels o f 8.88±1.75 nmol 1 means that 
the 0.66 and 0.3 nmol/1 levels found in both treated dogs is also below the lowest 
limit o f 7.13 nmol/1
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4. DISCUSSION
The original daily bleeding protocol that was followed in the previous dogs, 
namely Adam, Baxter and Dexter, was used for the two dogs used in this section, 
Dennis and Kenny. However, as indicated before, it was modified to allow for 
a closer observation of the effect of the daily injection (Tables 17, 18, 20, 21). 
The results of the daily bleeding showed a decline in both hormones by days 4 
and 5 in both Kenny and Dennis (Figures 59 and 66) respectively . This was 
similar to that in Adam's, which was discussed in chapter 2-B and which agree 
with Vickery et al. (1985) who found depressed hormone levels also by the 5th 
day.
However, as a result of the modifications to the protocol it was possible to 
observe the hormone increase one hour post injection in both animals, an increase 
that was maintained for the next three hours (Figures 60 and 67). As no further 
samples were taken it must be assumed that the effect of the injection is of at 
least 3 hours. This same type of response although more subdued continued 
throughout the treatment period.
An interesting observation is again the difference in individual hormone levels, a 
finding which has been observed all throughout the experiments beginning with 
the MPA treated dogs and which was seen again in Kenny (Figure 60) who has 
the lowest hormone profile with levels in the range of 0.0-25.3 ng/ml of LH and 
0.0-33.06 nmol/1 of testosterone. In contrast, Dennis (Figure 67) had the 
highest plasma concentrations of both hormones 2.13-35.67 ng/ml of LH and 
0.06-54.07 nmol/1 of testosterone. The difference in normal pre-treatment 
levels can also be appreciated in the two window bleedings taken prior to 
treatment (Figures 61 and 68) where again Dennis showed a higher hormone 
profile than Kenny. However, in the window taken at the end of treatment, the 
suppression effect is almost the same in both dogs.
A general observation regarding the hormone levels in all the dogs treated with 
either Nafarelin derivative or Nafarelin acetate, is that LH does not show the 
degree of suppression as testosterone. In several instances, the levels are almost 
the same pre treatment as at the end It might be that the daily injection effect
allows LH to recover to almost normal levels which does not occur in the case of
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testosterone, which may be affected by just a temporary alteration to the LH 
stimulus to the Leydig cell.
The histological examination of the testes of both dogs, clearly shows the time- 
related effect of the treatment Kenny who was treated longer (60 days), 
showed seminiferous tubules depleted of most germ cells with only Sertoli cells 
and those spermatogonia found closer to the basal membrane being seen (Figure 
62). In Dennis, who was only treated for 30 days, there appears to be a 
gradual disappearance of cells (Figure 69) in that only one or two tubules show 
the same severe germ cell depletion seen in Kenny.
The examination of the body of the epididymis in both dogs (Figures 63 and 70) 
did not present the vacuoles that had been found in other dogs. The only change 
appeared to be the absence of spermatozoa from the lumen of the tubules, 
otherwise the epithelium was apparently normal.
The prostate sections (Figures 64 and 71) show an increase in connective tissue 
around the alveoli which is more apparent in Kenny where the alveoli look 
smaller than in Dennis, again probably as an effect of the more prolonged 
treatment period. The decrease in the gland's size can also be appreciated in 
the ultrasonographs photos taken of both animals, before and at the end of 
treatment (Figures 65 and 72). This particular effect on the prostate has already 
been discussed and the same arguments would apply here.
The testosterone concentrations from jugular and testicular vein blood were 
evaluated in these two animals and a larger number of control dogs than shown in 
Table 15 was used. The testicular blood showed a five fold increase over the 
jugular blood concentrations. In contrast in the treated animals the same values 
were obtained in both jugular and testicular blood in Kenny and in Dennis, the 
jugular blood values are slightly higher. These differences could very well 
reflect again the time related effect of the treatment which here shows the effect 
directly in the testis. This find has been discussed before in chapter 2-B.
The testicular tissue from both dogs was processed as described in the previous 
chapter in order to isolate the Leydig cells. The only change introduced in the 
process was that the identification of Leydig cells was carried out using the 
presence of 3 (3HSD by the method of Payne et al. (1980). This proved to be 
a very practical method as it did not take long to prepare and it finally produced 
positive results (Figure 77). Although correlations were made between the
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fresh and the 30HSD stained cells, the work so far had depended on counting 
fresh preparations of cells and identification of the Leydig cells continued to be 
made mainly by the presence of the yellow halo as described before.
The approach used to treat these Leydig cells, which had been isolated from 
tissue in which germ cells had been either partially or totally eliminated, was 
similar to that used by Abayasekara et al. (1990) in the rat and O'Shaughnessy et 
al. (1991) in sex reversed mice. In these studies germ cells were also absent 
and it seemed an appropriate treatment to use in this study. The Leydig cells 
capacity for androgen synthesis was evaluated by stimulating the cell at different 
levels with hCG, dibutyryl cyclic AMP and 22-R-hydroxycholesterol.
Therefore, the same method was tested first in mouse cells to compare to 
O'Shaughnessy's results and develop a working routine that would evaluate the 
technical aspects of Leydig cell isolation and culture. These initial results of 
experiment 1 (Figures 73-1 and 73-2 ) proved that the cell preparation techniques 
that were being used in the present work did indeed produce viable cells capable 
of responding to exogenous stimulatioa However, when compared to 
O'Shaughnessy’s work, the present results in the mouse experiment (Figure 73-1) 
showed a 5 fold increase in the amount of testosterone produced by the mouse 
cells. This difference could be explained by the fact that in the present work 
the mice which were available were not always the same strain. There seems 
to be some evidence to the effect that there is a strain-related difference in 
testosterone production (Stalvey and Payne, 1983). Again comparing the 
present results, the basal, the hCG and dbcAMP stimulated cell responses are 
similar. Except in those cells where 22 ROHC was used, which show lower 
levels of testosterone in comparison to what O'Shaughnessy reported in his 
experiments.
Experiment 1 using dog cells (Figure 73-2) produced the lowest response at 
membrane level with the hCG stimulatioa The highest effect was at 
postmembrane level with the other two additives, dbc AMP and 22ROHC. As 
mentioned in the previous chapter, dog tissue required a longer collagenase 
dispersion phase, which could well have caused damage at membrane level 
especially damaging LH-hCG receptors which might have interfered with the 
cell's capacity of response. A similar occurrence appears to take place in isolated 
human Leydig cells, where a tenfold decrease in the sensitivity of these cells in 
comparison to rat cells has been observed (Sharpe, 1990). It appears, However, 
that the cells capacity to respond to the postmembrane treatments were not 
affected by the membrane damage and that both dbcAMP and 22 ROH were able
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to produce the desired stimulation at 2nd messenger and mitochondrial level 
respectively.
In the next study, experiment 2, the Leydig cells were treated with the same 
additives as above, with the difference that these cells were from animals that had 
been previously treated in vivo with the same Nafarelin acetate dose. Once 
again mice cells were used and it was most interesting to see in this experiment 
the clear stimulatory effect that the treatment had in these animals (Figure 74-1). 
In the treated mice the response was several hundred times higher than the 
control group which responded in a similar way to that seen in the first 
experiment ( Figure 73-2). It is reported that in mice the inhibitory effect only 
occurs when high doses of the agonist are used. Bex et al. ("1982) used 100 
ug/mouse/day for 14 days which had no inhibitory effect on testicular weight and 
this dose is 7500 times higher than that required in rats to reduce reproductive 
organ weight A more recent report indicated that very high doses, 1000 
ug/kg of Buserelin, were required to produce the decrease in testis weight and 
sperm production supression (Kher and Kalla, 1993).
The dog cells (Figure 74-2), however, behaved very differently from the mice 
cells, but they also show completely opposite results between the 30 and 60 day 
treatment than what was expected, as the results in the 30 day treated dog 
(Dennis) show lower basal, hCG and dbcAMP responses than experiment 1 
(Figure 73-2). As far as the 22ROHC response is concerned it was several 
hundred times higher. It was expected at the time that an animal that had been 
treated for twice as long as Dennis would have an even more depressed response. 
This was not so in Kenny's case as all the cells responded with an increased 
production of testosterone, except for the cells treated with 22ROHC where the 
lowest stimulatory response was produced.
At this point, one could speculate on the reasons for this contradictory finding. 
The basal response was low because the in vivo treatment had inhibited the cells 
normal testosterone production and as they were incubated with no additives at 
all there was no stimulation. In Dennis, the in vivo GnRH agonist treatment 
would have increased the production of LH in the first days, therefore occupying 
all available LH membrane receptors, so that his Leydig cells would have been 
refractory to the effects of hCG in the culture. This same effect might have 
also affected the 2nd messenger level response which the dbcAMP additive was 
supposed to activate. Nevertheless the cells were able to respond to the 
22ROHC stimulus because they did not go through the membrane but directly to
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the mitochondria and therefore the membrane interference would not affect the 
results of this treatment
In Kenny the results give the impression of cells, which once released from the 
inhibition, being able to respond with more than twice the amount of testosterone 
production to each of the additives as if  it had been holding back reserves. 
There is evidence that in some cases Leydig cells accumulate progesterone when 
exogenous oestrogens are administered which produce a lesion in the 
steroidogenic pathway in the 17-20 desmolase level which does not allow 
progesterone to undergo further transformations (Risbridger, et al. 7981; 
Risbridger, 1990). However, the additives used in the present work produce 
the stimulation way before this particular step in the steroidogenic pathway 
occurs, so that this explanation would not apply in this particular case. But 
this does not discard the possibility that something similar might have occurred in 
Kenny's cells.
Another interesting finding is that when comparing the testosterone produced by 
the cell cultures to the circulating levels in the live animal, the highest 
testosterone cell production came from Kenny who had the lowest circulating 
blood levels initially. On the other hand, Dennis who had the highest
circulation hormone profile, showed the lowest cell stimulation.
This difference between in vivo and in vitro testosterone responses might be 
better explained by an observation made in the gonads of both animals, which 
was that not only the size was reduced (Tables 19 and 22) but during post­
mortem examination they were paler both outside and inside compared with, the 
normal testis. There was very little bleeding when they were removed from the 
dog and what appeared as a reduction in the size of the blood vessels became 
apparent when collecting the blood samples from the surface testicular blood 
vessels, as it proved more difficult than in the untreated dogs. This was
probably due to a reduction in blood flow to the smaller testis. Similar
information has been provided by Damber et al. (1985) in unilaterally 
cryptorchid adult rats stimulated with hCG, which shows that less secretion of 
testosterone is produced by the smaller abdominal testis. However, after hCG 
treatment it had increased therefore proving that it was the reduction of blood 
flow to the testis and not a disability of the Leydig cells to produce less 
testosterone suggesting also that LH-hCG control the blood flow to the testis. 
Similar information arises from an experiment with irradiated rat testes which 
caused a disruption in spermatogenesis, where again they found that the capacity 
o f the testes was limited by a decrease in testicular blood flow, but not by the
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ability o f  the Leydig cells to produce testosterone (W ang et al. 1983. Setchell, 
1990a, 1990b). This explanation would explain the ability o f the cells in the 
present work to respond to additives in cell culture, but it w ould still leave open 
the question about the difference between dogs.
The results from  these two dogs also suggest that the Leydig cell’s capacity to 
produce testosterone might not necessarily be reflected in the actual testosterone 
levels found in circulating plasma. As they have more LH -hCG  receptors than 
they need to m aintain the continuous production o f  testosterone, referred to as 
"spare receptors" by  Catt and Dufau (1973). This could help explain Kenny’s 
increased cell testosterone production suggesting that perhaps his Leydig cells 
had m ore receptors than Dennis's, but that the full capacity o f his cells was not 
reflected in his circulating plasm a levels o f  testosterone, because they w ere not 
required for the dog to function normally. This experim ent does indicate that 
once the cells were removed from an LH deprived environm ent and placed in the 
stimulating cell culture environment, they recovered their testosterone production 
capabilities, which suggests that the absence o f  LH did not apparently cause 
irreversible changes.
One aspect o f  the Nafarelin acetate treatm ent that required further investigation 
was to determine i f  it had produced the suppression o f  LH and testosterone by 
acting at pituitary level alone, or i f  it had been through the previously m entioned 
gonadal GnRH-like receptors as is the case in the rat.
Therefore in experiment 3, the cells were not only incubated w ith the usual 
additives, but w ith different concentrations o f  N afarelin acetate. The results in 
the dog cells (Figure 75-1) were similar to that o f  experim ent 1 in the control 
animals w ith the original additives, but there w ere no indications o f  stim ulation 
to the cells o f  the rat (Figure 75-2). There w ere no indications o f  any type o f  
stim ulation to the Nafarelin acetate additive in either group. The lack o f
stim ulation in the rat cells was surprising in the light o f inform ation provided by 
Brow ning et a l  (1983) in their studies w ith the GnRH agonist H OE 766, where 
they stimulated rat Leydig cells w ith even sm aller concentrations than those used 
in the present work. It is not clear why the rat cells were not stim ulated 
either by the initial additives. However, since the m ain interest in the present 
w ork was to study the dog, no further attempts to study this mode o f  treatm ent in 
the rat was tried.
As the direct treatm ent w ith N afarelin acetate had not proved successful, another 
approach was attem pted which becam e experim ent 4, using hom ogenated
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testicular tissue from  dogs and rats and m easuring the displacem ent binding o f 125 
1 GnRH as no 1251 Nafarelin acetate was available, a sim ilar m ethod has been 
used for pituitary GnRH detection (C layton et a l  1979. The results o f  this 
experim ent in rat tissue (Figure 76-1) shows a gradual dose related interference 
o f  the Nafarelin acetate binding. This part o f  the experim ent indicated that the 
treatm ent procedure was indeed working in detecting the rat’s GnRH-like 
receptors mentioned by others (Hsueh and Erickson, 1979; Hsueh and Jones 
1981; Sharpe and Fraser, 1980; Perrin et a l  1980. Bourne et a l  1980. 
Bourne et a l  1982. Bambino et a l  1980. H uhtaniem i, et al 1986). It 
also showed that it would be an effective w ay o f  assessing the presence o f  such 
receptors in the dog Leydig cells.
However, this experiment in 11 control dogs (Figure 76-2) show no evidence o f  
an interference by the Nafarelin acetate with the 1251 GnRH, as all the counts are 
below  2000 per minute. W hen the hom ogenates from  the tw o in vivo  treated 
dogs, Dennis and Kenny (Figure 76-3) were treated in the same m anner, there 
was a statistically significant difference betw een dogs, but no relationship 
betw een binding and the amount o f unlabelled N afarelin acetate used.
These last results suggest that w ith the m ethods used in the present w ork it was 
not possible to demonstrate the presence o f  G nRH-like receptors in dog Leydig 
cells.
In view  o f the extremely complicated interactions present in the testes it w ould be 
m ost unwise to believe that the results from  only two treated dogs can be 
conclusive, but it points the need to attem pt to answ er some o f  the m any 
questions that have arisen so far, by repeating the experim ents w ith a larger 
population o f in vivo  treated animals.
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This work was undertaken against the background o f  a need for a reliable means 
o f  chemical castration o f the dog. The experim ental approach selected was to 
attempt suppression o f LH and testosterone production and m onitor the effect o f 
this interference on the testes. A  degree o f  suppression w as achieved using a 
GnRH agonist. Subsequent studies focussed on determ ining the m echanism  o f 
action o f  the agonist at the level o f  the Leydig cell.
Treatm ent with M edroxyprogesterone acetate failed to produce the desired 
suppression o f LH or testosterone but produced a very interesting response in the 
epididymis. Spermatozoa recovered from  the area showed severe acrosom al 
damage w hich would be likely to interfere w ith fertilisation. This offers the 
possibility o f  using M edroxyprogesterone acetate as a contraceptive in the male 
dog. Moreover, the effect occured after ju s t one injection and one m onth o f  
treatment. Further investigation is w arranted to determ ine w hether sperm damage 
occured through the direct action o f  the progestogen on the sperm atozoa or as 
result o f a change in the epididymal environment. It w ould be necessary to 
ascertain how  quickly these changes occur and w hether the changes are 
reversible. It may be possible to find a better m eans o f  drug adm inistration than 
subcutaneous injection, such as an im plant or slow -release device releasing a 
known am ount o f progestagen. An electron m icroscopy study o f  the epididym is 
and o f the spermatozoa located in this area m ight contribute to a better 
understanding o f the cause o f  sperm damage.
The results o f the GnRH agonists studies showed that daily subcutaneous 
injections did not totally suppress LH release into the circulation. It is evident 
that LH always maintained detectable levels. C irculating testosterone levels w ere 
apparently more susceptible to interference by the treatm ents. The resistance o f  
LH to suppression suggests that probably a longer, m ore continuous presence o f  
the treatm ent would be required, such as the osmotic pum ps could provide. The 
problem s w hich arose with the pumps would be overcome w ith more experience 
in their use.
It was interesting to observe the capacity o f the gonad to protect its function from  
exogenous influences. Regardless o f the length o f  exposure to GnRH treatm ent, 
the Sertoli cells and the stem spermatogonia always rem ained in the sem iniferous 
tubules, thus safeguarding the gonads capability o f  recovering norm al function.
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As difficult as it was to work w ith Leydig cell cultures it proved to be a very 
interesting area. It was disappointing to have only tw o treated dogs to study and, 
tem pting as it is to speculate about the results, the fact rem ains that a larger 
experim ental dog group is required, how ever this w as not possible during the 
present work due to the high cost o f  each experim ental dog. It is well 
recognized that cell culture systems only provide some answers regarding how  
cells really function. Once isolated from  interactions w ith other substances in 
their norm al environment it is difficult to assess the physiological importance o f  
responses to stimuli. LH and testosterone blood plasm a concentrations varied 
m arkedly between animals. Similar variation w as observed in the cell cultures, 
pointing to regulatory mechanisms in the Leydig cell w hich determine its 
capacity to produce testosterone. A lternatively this could be a reflection o f the 
local interaction occurring at interstitial-sem iniferous tubule level.
It w ould have been very helpful to study the Leydig cells from  the treated testes 
using electron m icroscopy and this is an area w orthy o f  further investigation. 
The existence o f large and small luteal cells w ith  different physiological 
functions has long been acknowledged. The observation o f  three sizes o f  Leydig 
cells in the dog is w orthy o f  further investigation to determ ine w hether functional 
differences exist between m orphological types. O ther types o f  differences have 
been acknowledge by other researchers. A possible reason for these differences 
could be due to the Leydig cells adaptation to the different stages o f the 
spermatogenic cycle taking place w ithin the sem iniferous tubule.
A difference in the testosterone production by Leydig cell from untreated and 
N aferelin treated mice suggested that in this species the GnRH agonist acted at 
the level o f the pituitary and directly at the gonad. Gonadal GnRH-like receptors 
have been identified in the rat by other workers and the finding confirm ed in this 
study. However, using the same m ethodology, no evidence o f gonadal GnRH 
receptors was found in the dog. It m ust be concluded that there are species 
differences in Leydig cell function. The evidence from  this study suggests that 
the GnRH agonists used produced an inhibitory effect on LH  and testosterone by 
down-regulating the pituitary and not by working directly in the gonad. This 
observation might prove useful in future research
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